0001493152-23-028602.txt : 20230814 0001493152-23-028602.hdr.sgml : 20230814 20230814170046 ACCESSION NUMBER: 0001493152-23-028602 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AYRO, Inc. CENTRAL INDEX KEY: 0001086745 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 980204758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34643 FILM NUMBER: 231171727 BUSINESS ADDRESS: STREET 1: 900 E. OLD SETTLERS BOULEVARD, SUITE 100 CITY: ROUND ROCK STATE: TX ZIP: 78664 BUSINESS PHONE: 512-994-4917 MAIL ADDRESS: STREET 1: 900 E. OLD SETTLERS BOULEVARD, SUITE 100 CITY: ROUND ROCK STATE: TX ZIP: 78664 FORMER COMPANY: FORMER CONFORMED NAME: DropCar, Inc. DATE OF NAME CHANGE: 20180201 FORMER COMPANY: FORMER CONFORMED NAME: WPCS INTERNATIONAL INC DATE OF NAME CHANGE: 20020612 FORMER COMPANY: FORMER CONFORMED NAME: PHOENIX STAR VENTURES INC DATE OF NAME CHANGE: 20010424 10-Q 1 form10-q.htm
0001086745 false Q2 --12-31 0001086745 2023-01-01 2023-06-30 0001086745 2023-08-11 0001086745 2023-06-30 0001086745 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2022-12-31 0001086745 2023-04-01 2023-06-30 0001086745 2022-04-01 2022-06-30 0001086745 2022-01-01 2022-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 us-gaap:CommonStockMember 2023-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001086745 us-gaap:RetainedEarningsMember 2023-03-31 0001086745 2023-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-12-31 0001086745 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 us-gaap:CommonStockMember 2022-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001086745 us-gaap:RetainedEarningsMember 2022-03-31 0001086745 2022-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001086745 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001086745 2023-01-01 2023-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001086745 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001086745 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001086745 2022-01-01 2022-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001086745 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 us-gaap:CommonStockMember 2023-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001086745 us-gaap:RetainedEarningsMember 2023-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001086745 us-gaap:RetainedEarningsMember 2022-06-30 0001086745 2022-06-30 0001086745 AYRO:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-08-06 2023-08-07 0001086745 AYRO:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember us-gaap:SubsequentEventMember 2023-08-09 2023-08-10 0001086745 us-gaap:ShippingAndHandlingMember 2023-04-01 2023-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2022-04-01 2022-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2023-04-01 2023-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2022-04-01 2022-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2023-01-01 2023-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2022-01-01 2022-06-30 0001086745 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001086745 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001086745 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001086745 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001086745 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0001086745 us-gaap:ProductMember 2023-04-01 2023-06-30 0001086745 us-gaap:ProductMember 2022-04-01 2022-06-30 0001086745 us-gaap:ProductMember 2023-01-01 2023-06-30 0001086745 us-gaap:ProductMember 2022-01-01 2022-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2023-04-01 2023-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2022-04-01 2022-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2023-01-01 2023-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2022-01-01 2022-06-30 0001086745 AYRO:FleetInventoryMember 2023-04-01 2023-06-30 0001086745 AYRO:FleetInventoryMember 2022-04-01 2022-06-30 0001086745 AYRO:FleetInventoryMember 2023-01-01 2023-06-30 0001086745 AYRO:FleetInventoryMember 2022-01-01 2022-06-30 0001086745 AYRO:ComputerAndEquipmentMember 2023-06-30 0001086745 AYRO:ComputerAndEquipmentMember 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001086745 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001086745 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001086745 AYRO:ComputerSoftwareMember 2023-06-30 0001086745 AYRO:ComputerSoftwareMember 2022-12-31 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-01-30 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-30 2022-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-23 2021-02-24 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2023-01-01 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2023-01-01 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2023-01-01 2023-06-30 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2023-06-30 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember us-gaap:EmployeeStockOptionMember 2023-06-30 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember us-gaap:RestrictedStockMember 2023-06-30 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember us-gaap:WarrantMember 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-01-30 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2023-04-01 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2022-04-01 2022-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2023-01-01 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2022-01-01 2022-06-30 0001086745 AYRO:SalesAndMarketingMember 2023-04-01 2023-06-30 0001086745 AYRO:SalesAndMarketingMember 2022-04-01 2022-06-30 0001086745 AYRO:SalesAndMarketingMember 2023-01-01 2023-06-30 0001086745 AYRO:SalesAndMarketingMember 2022-01-01 2022-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2023-04-01 2023-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2022-04-01 2022-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2023-01-01 2023-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2022-01-01 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-12-31 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerOneMember 2023-04-01 2023-06-30 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerMember 2023-04-01 2023-06-30 0001086745 AYRO:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 AYRO:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerOneMember 2023-01-01 2023-06-30 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerTwoMember 2023-01-01 2023-06-30 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerThreeMember 2023-01-01 2023-06-30 0001086745 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember AYRO:CustomerMember 2022-01-01 2022-06-30 0001086745 AYRO:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:SupplierMember 2023-01-01 2023-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:SupplierOneMember 2023-01-01 2023-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:SupplierTwoMember 2023-01-01 2023-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:SupplierOneMember 2022-01-01 2022-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:SupplierTwoMember 2022-01-01 2022-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:OneSupplierMember 2022-04-01 2022-06-30 0001086745 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember AYRO:TwoSupplierMember 2022-04-01 2022-06-30 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2021-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2023-01-01 2023-06-30 0001086745 AYRO:DropCarOperatingIncMember 2021-12-31 0001086745 us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember AYRO:SeriesHSevenConvertiblePreferredStockMember 2023-08-07 0001086745 us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-07 2023-08-07 0001086745 us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-07 0001086745 us-gaap:SubsequentEventMember 2023-08-10 2023-08-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AYRO:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________

 

Commission file number: 001-34643

 

 

 

AYRO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   98-0204758
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

900 E. Old Settlers Boulevard, Suite 100    
Round Rock, Texas   78664
(Address of principal executive offices)   (Zip Code)

 

(512) 994-4917

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   AYRO   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer
         
Non-accelerated filer   Smaller reporting company
         
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of August 11, 2023, the registrant had 37,732,530 shares of common stock outstanding.

 

 

 

 

 

 

AYRO, Inc.

Quarter Ended June 30, 2023

 

Table of Contents

 

    PAGE
PART I FINANCIAL INFORMATION F-1
     
ITEM 1. Financial Statements (Unaudited) F-1
  Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022 F-1
  Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022 F-2
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three and Six Months Ended June 30, 2023 and 2022 F-3
  Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022 F-4
  Notes to the Condensed Consolidated Financial Statements (Unaudited) F-5
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 1
ITEM 3. Quantitative and Qualitative Disclosure About Market Risk 17
ITEM 4. Controls and Procedures 17
     
PART II OTHER INFORMATION 18
     
ITEM 1. Legal Proceedings 18
ITEM 1A. Risk Factors 18
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
ITEM 3. Defaults Upon Senior Securities 19
ITEM 4. Mine Safety Disclosures 19
ITEM 5. Other Information 19
ITEM 6. Exhibits 20
     
SIGNATURES 22

 

i

 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

 

AYRO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

   June 30,   December 31, 
   2023   2022 
ASSETS          
Current assets:          
Cash  $13,569,265   $39,096,562 
Marketable securities   19,464,015    9,848,804 
Accounts receivable, net   104,155    510,071 
Inventory   3,049,972    970,381 
Prepaid expenses and other current assets   3,269,831    1,478,845 
Total current assets   39,457,238    51,904,663 
           
Property and equipment, net   3,201,260    2,192,337 
Operating lease – right-of-use asset   750,877    819,401 
Deposits and other assets   84,595    73,683 
Total assets  $43,493,970   $54,990,084 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable   716,236    1,107,215 
Accrued expenses   910,114    964,937 
Current portion lease obligation – operating lease   178,013    165,767 
Total current liabilities   1,804,363    2,237,919 
Lease obligation – operating lease, net of current portion   601,349    693,776 
Total liabilities   2,405,712    2,931,695 
           
Stockholders’ equity:          
Preferred Stock, (authorized – 20,000,000 shares)   -    - 
Convertible Preferred Stock Series H, ($0.0001 par value; authorized – 8,500 shares; issued and outstanding – 8 shares as of June 30, 2023 and December 31, 2022, respectively)   -    - 
Convertible Preferred Stock Series H-3, ($0.0001 par value; authorized – 8,461 shares; issued and outstanding – 1,234 as of June 30, 2023 and December 31, 2022, respectively)   -    - 
Convertible Preferred Stock Series H-6, ($0.0001 par value; authorized – 50,000 shares; issued and outstanding – 50 as of June 30, 2023 and December 31, 2022, respectively)   -    - 
Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,536,101 and 37,241,642 as of June 30, 2023 and December 31, 2022, respectively)   3,753    3,724 
Additional paid-in capital   133,733,091    133,224,249 
Accumulated deficit   (92,648,586)   (81,169,584)
Total stockholders’ equity   41,088,258    52,058,389 
Total liabilities and stockholders’ equity  $43,493,970   $54,990,084 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-1

 

 

AYRO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   2023   2022   2023   2022 
   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
Revenue  $139,544   $981,560   $252,628   $2,008,405 
Cost of goods sold   332,027    2,827,512    551,820    4,004,657 
Gross loss   (192,483)   (1,845,952)   (299,192)   (1,996,252)
                     
Operating expenses:                    
Research and development   2,405,398    1,046,797    4,535,388    1,912,204 
Sales and marketing   420,861    337,226    1,138,953    1,182,042 
General and administrative   3,247,731    2,741,700    6,091,047    5,446,627 
Total operating expenses   6,073,990    4,125,723    11,765,388    8,540,873 
                     
Loss from operations   (6,266,473)   (5,971,675)   (12,064,580)   (10,537,125)
                     
Other income (expense):                    
Other income (expense), net   (9,166)   10,706    52,532    19,597 
Interest income   117,278    -    261,638    - 
Unrealized gain (loss) on marketable securities   146,935    (13,479)   198,215    (35,580)
Realized gain on marketable securities   8,193    -    73,193    - 
Other income (expense), net   263,240    (2,773)   585,578    (15,983)
                     
Net loss  $(6,003,233)  $(5,974,448)  $(11,479,002)  $(10,553,108)
                     
Net loss per share, basic and diluted  $(0.16)  $(0.16)  $(0.31)  $(0.29)
                     
Basic and diluted weighted average Common Stock outstanding   37,476,845    36,982,436    37,398,555    36,945,240 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-2

 

 

AYRO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   (Deficit)   Total 
   Three and Six Months Ended June 30, 2023 
   Series H   Series H-3   Series H-6                     
   Preferred   Preferred   Preferred           Additional         
   Stock   Stock   Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   (Deficit)   Total 
Balance, January 1, 2023   8   $-    1,234   $-    50   $-    37,241,642   $3,724   $133,224,249   $(81,169,584)  $52,058,389 
Stock Based Compensation       -         -         -         -    20,116    -    20,116 
Vesting of Restricted Stock   -    -         -         -    110,562    11    246,614    -    246,625 
Net Loss   -    -         -         -        -         (5,475,769)   (5,475,769)
Balance, March 31, 2023   8    -    1,234    -    50    -    37,352,204   3,735    133,490,979    (86,645,353)   46,849,361 
Stock Based Compensation        -         -         -         -    11,417    -    11,417 
Vesting of Restricted Stock        -         -         -    183,897    18    230,695    -    230,713 
Net Loss        -         -         -         -         (6,003,233)   (6,003,233)
Balance, June 30, 2023   8    -    1,234    -    50    -    37,536,101   $3,753   $133,733,091   $(92,648,586)  $41,088,258 

 

   Three and Six Months Ended June 30, 2022 
   Series H   Series H-3   Series H-6                     
   Preferred   Preferred   Preferred           Additional         
   Stock   Stock   Stock   Common Stock   Paid-in   Accumulated     
   Shares   Amount   Shares   Amount   Shares   Amount   Shares   Amount   Capital   (Deficit)   Total 
Balance, January 1, 2022   8   $-    1,234   $-    50   $-    36,866,956   $3,687   $131,654,776   $(58,234,231)  $73,424,232 
                                                        
Stock Based Compensation        -         -         -         -    288,110    -    288,110 
Vesting of Restricted Stock        -         -         -    43,000    4    329,377    -    329,381 
Net Loss        -         -         -         -         (4,578,660)   (4,578,660)
Balance, March 31, 2022   8    -    1,234    -    50    -    36,909,956    3,691    132,272,263    (62,812,891)   69,463,063 
Stock Based Compensation        -         -         -         -    303,553    -     303,553 
Vesting of Restricted Stock        -         -         -    110,562    11    (11)   -    - 
Net Loss        -         -         -         -         (5,974,448)   (5,974,448)
Balance, June 30, 2022   8   $-    1,234   $-    50   $-    37,020,518   $3,702   $132,575,805   $(68,787,339)  $63,792,168 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-3

 

 

AYRO, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

    1    2 
   Six Months Ended 
   June 30, 
  2023   2022 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss   $ (11,479,002)  $(10,553,108)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   452,848    257,791 
Loss on disposal of fixed asset   11,666    - 
Stock-based compensation   508,869    591,663 
Amortization of right-of-use asset   81,524    118,092 
Bad debt expense   292,010    2,069 
Unrealized (gain) loss on marketable securities   (198,215)   35,580 
Realized (gain) on marketable securities   (73,193)   - 
Impairment of inventory and prepaid   -    1,938,386 
Change in operating assets and liabilities:          
Accounts receivable   113,906    (955,609)
Inventory   (2,079,590)   325,282 
Prepaid expenses and other current assets   (1,790,987)   (785,762)
Accounts payable   (405,979)   164,809 
Accrued expenses   (234,155)   (838,304)
Lease obligations - operating leases   (93,181)   (132,403)
Net cash used in operating activities   (14,893,479)   (9,831,514)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (1,271,311)   (414,197)
Purchase of marketable securities, net   (9,343,804)   (18,006,486)
Purchase of intangible assets   (18,703)   (17,500)
Net cash used in investing activities   (10,633,818)   (18,438,183)
           
Net change in cash   (25,527,297)   (28,269,697)
           
Cash, beginning of period   39,096,562    69,160,466 
           
Cash, end of period  $13,569,265   $40,890,769 
           
Supplemental disclosure of cash and non-cash transactions:          
Accrued Fixed Assets  $194,335   $- 
Restricted Stock issued, previously accrued  $-   $329,381 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

F-4

 

 

AYRO, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1. ORGANIZATION AND NATURE OF OPERATIONS

 

AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc. (“AYRO Operating”), which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly owned subsidiaries, are principally engaged in manufacturing and sales of environmentally conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.

 

Strategic Review

 

Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, AYRO initiated a strategic review of its product development strategy, as AYRO focused on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with the strategic review by the Company, AYRO cancelled development of its planned next-generation three-wheeled high-speed vehicle.

 

For the past several years, AYRO’s primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, the Company ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus its resources on the development and launch of the new 411 fleet vehicle model year 2023 refresh (the “Vanish”).

 

In December of 2021 the Company began research and development on the Vanish, including updates on its supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.

 

F-5

 

 

NOTE 2. LIQUIDITY AND OTHER UNCERTAINTIES

 

Liquidity and Other Uncertainties

 

The unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $11,479,002 for the six months ended June 30, 2023, and negative cash flows from operations of $14,893,479 for the six months ended June 30, 2023. On June 30, 2023, the Company had cash balances totaling $13,569,265 and marketable securities of $19,464,015. In addition, overall working capital decreased by $12,013,869 during the six months ended June 30, 2023. Management believes that the existing cash as of June 30, 2023, will be sufficient to fund operations for at least the next twelve months following the issuance of these unaudited condensed consolidated financial statements. Additionally, on August 7, 2023, the Company entered into a Securities Purchase Agreement to which it agreed to sell to certain existing investors (the “Investors”) an aggregate of 22,000 shares of the Company’s newly designated Series H-7 convertible preferred stock with a stated value of $1,000 per share (“Series H-7 Preferred Stock”). The Company raised approximately $22 million from the sale, which closed on August 10, 2023.

 

The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially and negatively impact the business, prospects, financial condition, and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to Company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.

 

The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:

 

 

the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;

 

 

disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and

 

  an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.

 

Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup the increasing costs of raw materials by increasing vehicle prices.

 

We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.

 

On October 3, 2022, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Initial Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

On April 4, 2023, the Company received a letter from Nasdaq notifying the Company that the Company has been granted an additional 180-day period, or until October 2, 2023, to regain compliance with the Minimum Bid Price Requirement. The new compliance period is an extension of the Initial Compliance Period provided for in Nasdaq’s deficiency notice to the Company dated October 3, 2022. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

 

Management’s plan to regain compliance with the Minimum Bid Price Requirement is to seek stockholder approval for, and to file, an amendment to the Company’s amended and restated certificate of incorporation (“Certificate of Incorporation”) to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-2 to 1-for-10 with the exact ratio within such range to be determined by the Company’s board of directors at its discretion (the “Reverse Stock Split Amendment”). On August 8, 2023, the Company filed a preliminary proxy statement in connection with a special meeting of the Company’s stockholders to be held on September 14, 2023 for the purpose of approving, among other things, the Reverse Stock Split Amendment.

 

If compliance with the Minimum Bid Price Requirement cannot be demonstrated by October 2, 2023, Nasdaq will provide written notification that the Company’s common stock could be delisted. In such an event, Nasdaq rules permit the Company to appeal any delisting determination to a Nasdaq Hearings Panel. Accordingly, there can be no assurance that the Company will be able to regain compliance with the Nasdaq listing rules or maintain its listing on Nasdaq.

 

F-6

 

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The unaudited condensed consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and in conformity with the instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”).

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 23, 2023, as amended on May 1, 2023.

 

F-7

 

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

The Company’s most significant estimates include marketable securities, revenue recognition, and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.

 

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $19,464,015 and $9,848,804 in marketable securities as of June 30, 2023 and December 31, 2022, respectively.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $20,768 and $145,496 for the three months ended June 30, 2023, and 2022 and $41,334 and $256,045 for the six months ended June 30, 2023 and 2022 respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent, and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

F-8

 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

The Company estimates the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share is the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

F-9

 

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Options to purchase common stock   732,422    788,546    732,422    788,546 
Restricted stock unvested   1,120,502    781,686    1,120,502    781,686 
Restricted stock vested - unissued   6,269    -    6,269    - 
Warrants outstanding   5,969,595    6,106,023    5,969,595    6,106,023 
Preferred stock outstanding   2,475    2,475    2,475    2,475 
Total   7,831,263    7,678,730    7,831,263    7,678,730 

 

NOTE 4. REVENUES

 

Disaggregation of Revenue

 

Revenue by type was as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Revenue type                    
Product revenue  $127,106   $918,808   $247,388   $1,838,150 
Shipping revenue   12,438    22,752    (4,150)   130,255 
Miscellaneous income   -    40,000    9,390    40,000 
Total Revenue  $139,544   $981,560   $252,628   $2,008,405 

 

Warranty Reserve

 

The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of June 30, 2023, and December 31, 2022, warranty reserves were recorded within accrued expenses of $395,071 and $410,017, respectively.

 

NOTE 5. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net, consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   June 30,   December 31, 
   2023   2022 
Trade receivables  $104,155   $512,420 
Less: Allowance for doubtful accounts   -    (2,349)
Accounts receivable, net  $104,155   $510,071 

 

The Company reduced allowance for doubtful accounts by $2,349 for the three and six months ended June 30, 2023, and recorded $292,010 of bad debt expense due to direct write off balances due from Club Car, LLC (“Club Car”) for the six months ended June 30, 2023. The Company recorded $2,069 of bad debt expense for the three and six months ending June 30, 2022.

 

NOTE 6. INVENTORY

 

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Raw materials  $2,481,859   $330,931 
Work-in-progress   -    - 
Finished goods   568,113    639,450 
Total  $3,049,972   $970,381 

 

For the three months ended June 30, 2023 and 2022, depreciation for fleet inventory was $0 and $23,883, and for the six months ended June 30, 2023 and 2022, was $0 and $47,775 respectively.

 

F-10

 

 

NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

 SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

   June 30,   December 31, 
   2023   2022 
Prepayments for inventory  $2,603,057   $1,174,466 
Prepayments for insurance   274,724    118,434 
Prepayments on advances on design   101,815    75,000 
Prepayments on software   190,333    103,851 
Prepaid other   99,902    7,094 
Total Prepaid Expenses and Other Current Assets  $3,269,831   $1,478,845 

 

NOTE 8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 SCHEDULE OF PROPERTY AND EQUIPMENT, NET

   June 30,   December 31, 
   2023   2022 
Computer and equipment  $3,211,535   $1,970,001 
Furniture and fixtures   395,705    323,789 
Lease improvements   1,093,481    952,952 
Computer software   455,875    455,875 
Property and equipment, gross   5,156,596    3,702,617 
Less: Accumulated depreciation   (1,955,336)   (1,510,280)
Property and equipment, net  $3,201,260   $2,192,337 

 

Depreciation expense for the three months ended June 30, 2023 and 2022 was $254,160 and $98,913, and for the six months ended June 30, 2023 and 2022 was $444,966 and $183,405, respectively. The company recorded a loss on disposal for fixed assets of $11,666 for the three and six months ending June 30, 2023.

 

NOTE 9. ACCRUED EXPENSES

   June 30,   December 31, 
   2023   2022 
Accrued professional and consulting fees  $122,964   $410,711 
Accrued payroll   392,079    6,000 
Accrued warranty reserve   395,071    410,017 
Accrued expenses other   -    138,209 
Total accrued expenses  $910,114   $964,937 

 

NOTE 10. STOCKHOLDERS’ EQUITY

 

Restricted Stock

 

On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 760,668 shares of restricted stock to non-executive directors at a value of $0.75 per share. During the six months ended June 30, 2023 183,897 were vested and an equal number of shares of common stock were issued.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 442,249 shares of restricted stock to non-executive directors at a value of $1.29 per share. As of December 31, 2022, 110,562 shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2023.

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. As of December 31, 2021, 43,000 shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2022.

 

F-11

 

 

Series H Convertible Preferred Stock

 

      
Number of Series H Preferred Stock outstanding as of June 30, 2023   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   7 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $5 

 

Series H-3 Convertible Preferred Stock

 

      
Number of Series H-3 Preferred Stock outstanding as of June 30, 2023   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $699 

 

Series H-6 Convertible Preferred Stock

 

      
Number of Series H-6 Preferred Stock outstanding as of June 30, 2023   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $979 

 

Warrants

 

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

           Weighted Average 
   Shares Underlying   Weighted Average   Remaining Contractual Term 
   Warrants   Exercise Price   (in years) 
Outstanding at December 31, 2022   6,106,023   $7.30    1.32 
Granted   -    -      
Exercised   -    -      
Expired   (136,428)   9.60      
Outstanding at June 30, 2023   5,969,595   $7.25    0.84 

 

F-12

 

 

NOTE 11. STOCK-BASED COMPENSATION

 

AYRO 2020 Long Term Incentive Plan

 

The Company has reserved a total of 4,089,650 shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has 443,732 stock options, restricted stock and warrants remaining under this plan as of June 30, 2023.

 

Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Research and development  $5,034   $(6,904)  $11,798   $9,800 
Sales and marketing   (435)   870    5,489    13,815 
General and administrative   237,532    309,587    491,582    568,048 
Total  $242,131   $303,553   $508,869   $591,663 

 

Options

 

The following table reflects a summary of stock option activity:

 

      Weighted Average   Contractual Life 
   Number of Shares   Exercise Price   (Years) 
Outstanding at December 31, 2022   777,922   $6.15    7.56 
Forfeitures   (45,500)   0.97      
Outstanding at June 30, 2023   732,422   $6.47    7.10 

 

Of the outstanding options, 654,937 were vested and exercisable as of June 30, 2023. At June 30, 2023 the aggregate intrinsic value of stock options vested and exercisable was $0.

 

The Company recognized $11,417 and $(6,298) of stock option expense for the three months ended June 30, 2023 and 2022, and $31,533 and $26,078 for the six months ended June 30, 2023 and June 30, 2022, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of June 30, 2023 was $69,823 and will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.

 

Restricted Stock

 SCHEDULE OF RESTRICTED STOCK ACTIVITY

       Weighted 
   Number of   Average Grant 
   Shares   Price 
Outstanding at December 31, 2022   660,562   $1.91 
Granted   760,668    0.75 
Vested   (300,728)   0.95 
Outstanding at June 30, 2023   1,120,502   $1.38 

 

F-13

 

 

On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 760,668 shares of restricted stock to non-executive directors at a value of $0.75 per share. There are 6,269 vested and unissued shares of restricted stock awards as of June 30, 2023. As of June 30, 2023 570,502 shares of restricted stock remain unvested and unissued.

 

The Company recognized compensation expense related to all restricted stock during the three months ended June 30, 2023, and 2022 of $230,713 and $309,850 and for the six months ended June 30, 2023 and 2022 $477,335 and $565,585, respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of June 30, 2023, was $428,473.

 

NOTE 12. CONCENTRATIONS AND CREDIT RISK

 

Revenues

 

One customer accounted for approximately 46% of the Company’s revenues for the three months ended June 30, 2023 and another customer accounted for 35%. Club Car accounted for approximately 89% and another customer 10% of the Company’s revenues for the three months ended June 30, 2022. Three customers accounted for approximately 42%, 25%, and 20% of the Company’s revenues for the six months ended June 30, 2023, respectively. Club Car accounted for approximately 95% of the Company’s revenues for the six months ended June 30, 2022. We do not expect Club Car to remain a customer going forward.

 

Accounts Receivable

 

As of June 30, 2023, two customers accounted for 61% and 39%, respectively, of the Company’s net accounts receivable. As of December 31, 2022, Club Car accounted for 100% of the Company’s net accounts receivable.

 

Purchasing

 

The Company places orders with various suppliers. No suppliers accounted for more than 10% of the Company’s raw materials purchased for the three months ended June 30, 2023. During the six months ended June 30, 2023, two suppliers accounted for more than 10% of the Company’s raw materials, one supplier accounted for 15% the other 13%. During the six months ended June 30, 2022, two suppliers accounted for accounted for more than 10% of the Company’s raw materials. One supplier accounted for 61% and the other 13%. The Company’s purchases of raw materials from one supplier was approximately 43% and 9% of its total purchases of raw materials for the three months ended June 30, 2022.

 

F-14
 

 

NOTE 13. COMMITMENTS AND CONTINGENCIES

 

Manufacturing Agreements

 

On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.

 

In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.

 

Supply Chain Agreements

 

In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Cenntro was previously a significant stockholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract.

 

As of December 31, 2021, the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $602,016. As of December 31, 2022, the balance was zero. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. Additionally, all inventory associated with Cenntro’s lithium-ion line NCM line was written off to cost of goods sold for $1,317,289.

 

The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.

 

Litigation

 

The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.

 

On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (non-exempt worker whose workday is longer than ten hours must receive an extra hour of pay at the basic minimum hourly rate). Management believes the case has no merit.

 

DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $476,280 in expense for such additional sales tax and interest and paid as of December 31, 2022.

 

NOTE 14. SUBSEQUENT EVENTS

 

On June 15, 2023, a certain lease agreement commenced for the purpose of expanding AYRO operations into Florida. The agreement called for the leased premises to provide general systems and equipment to be available in working order. The said premises ultimately failed to meet the working order provision, and all parties agreed to terminate the said lease. Thus, the lease for the Florida expansion premises was terminated on July 28, 2023, amicably, by all parties. Remaining obligations for this lease are de minimis.

 

On August 7, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the Investors, pursuant to which it agreed to sell to the Investors (i) an aggregate of 22,000 shares of Series H-7 Preferred Stock, initially convertible into up to 22,000,000 shares of the Company’s common stock at a conversion price of $1.00 per share, and (ii) warrants to acquire up to an aggregate of 22,000,000 shares of common stock at an exercise price of $1.00 per share (the “Warrants, and such transactions collectively, the “Private Placement”).

 

The closing of the Private Placement occurred on August 10, 2023. The aggregate gross proceeds from the Private Placement were approximately $22 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes.

 

The Purchase Agreement contains certain representations and warranties, covenants, and indemnities customary for similar transactions. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties.

 

F-15

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following management’s discussion and analysis should be read in conjunction with our historical financial statements and the related notes thereto. This management’s discussion and analysis contains forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those under “Risk Factors” in our filings with the Securities and Exchange Commission (“SEC”) that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. See “Cautionary Note Regarding Forward-Looking Statements.”

 

References in this management’s discussion and analysis to “we,” “us,” “our,” “the Company,” “our Company,” or “AYRO” refer to AYRO, Inc. and its subsidiaries.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q (this “Form 10-Q”) contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as “anticipates,” “assumes,” “believes,” “can,” “could,” “estimates,” “expects,” “forecasts,” “guides,” “intends,” “is confident that,” “may,” “plans,” “seeks,” “projects,” “targets,” “would” and “will” or the negative of such terms or other variations on such terms or comparable terminology. Such forward-looking statements include, but are not limited to, future financial and operating results, the company’s plans, objectives, expectations and intentions, statements concerning the strategic review of our product development strategy, the development and launch of the AYRO Vanish (the “Vanish”) and other statements that are not historical facts. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, and results of operations. These forward-looking statements speak only as of the date of this Form 10-Q and are subject to a number of risks, uncertainties, and assumptions that could cause actual results to differ materially from our historical experience and our present expectations, or projections described under the sections in this Form 10-Q and our other reports filed with the SEC titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

A summary of the principal risk factors that make investing in our securities risky and might cause our actual results to differ materially from those projected in these forward-looking statements is set forth below. If any of the following risks occur, our business, financial condition, results of operations, cash flows, cash available for distribution, ability to service our debt obligations and prospects could be materially and adversely affected.

 

we may be acquired by a third party;
   
we have a history of losses and have never been profitable, and we expect to incur additional losses in the future and may never be profitable;
   
our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our common stock;
   
a significant portion of our revenues has historically been derived from Club Car pursuant to the MPA. Following our termination of the MPA, our sales could decrease significantly, and we will need to identify new strategic channel partners to support the sales of our vehicles;
   
holders of our Series H-7 convertible preferred stock with a stated value of $1,000 per share (“Series H-7 Preferred Stock”) are entitled to certain payments that may be paid in cash or in shares of common stock depending on the circumstances, if we make these payments in cash, we may be required to expend a substantial portion of our cash resources, and if we make these payments in common stock, it may result in substantial dilution to the holders of our common stock;
   
the certificate of designations for the Series H-7 Preferred Stock and the warrants issued concurrently therewith contain anti-dilution provisions that may result in the reduction of the conversion price of the Series H-7 Preferred Stock or the exercise price of such warrants in the future. These features may increase the number of shares of common stock being issuable upon conversion of the Series H-7 Preferred Stock or upon the exercise of the warrants;
   
under the Purchase Agreement (as defined below) we are subject to certain restrictive covenants that may make it difficult to procure additional financing;
   
if we do not receive approval from our stockholders, we will be unable to pay amounts due to the holders of the Series H-7 Preferred Shares in shares of common stock and we will be required to pay such amounts in cash, which may force us to divert cash from other uses;

 

1
 

 

we rely on a single third-party supplier and manufacturer located in Canada for certain sub-assembly and assembly parts for the Vanish and any disruption in the operations of this third-party supplier could adversely affect our business and results of operations;
   
if we lose our exclusive license to manufacture the AYRO 411x model in North America, Cenntro could sell identical or similar products through other companies or directly to our customers;
   
we may be unable to replace lost manufacturing capacity on a timely and cost-effective basis, which could adversely impact our operations and ability to meet delivery timelines;
   
we may experience delays in the development and introduction of new products;
   
the market for our products is developing and may not develop as expected;
   
we are currently evaluating our product development strategy, which may result in significant changes and have a material impact on our business, results of operations and financial condition;
   
our business is subject to general economic and market conditions, including trade wars and tariffs;
   
if disruptions in our transportation network continue to occur or our shipping costs continue to increase, we may be unable to sell or timely deliver our products, and our gross margin could decrease;
   
our limited operating history makes evaluating our business and future prospects difficult and may increase the risk of any investment in our securities;
   
if we are unable to effectively implement or manage our growth strategy, our operating results and financial condition could be materially and adversely affected;
   
developments in alternative technologies or improvements in the internal combustion engine may have a materially adverse effect on the demand for our electric vehicles;
   
the markets in which we operate are highly competitive, and we may not be successful in competing in these industries;
   
our future growth depends on customers’ willingness to adopt electric vehicles;
   
we may experience lower-than-anticipated market acceptance of our current models and the vehicles in development;
   
if we are unable to manage our growth and expand our operations successfully, our business and operating results will be harmed, and our reputation may be damaged;
   
if we fail to include key feature sets relative to the target markets for our electric vehicles, our business will be harmed;
   
unanticipated changes in industry standards could render our vehicles incompatible with such standards and adversely affect our business;
   
our future success depends on our ability to identify additional market opportunities and develop and successfully introduce new and enhanced products that address such markets and meet the needs of customers in such markets;
   
unforeseen or recurring operational problems at our facilities, or a catastrophic loss of our manufacturing facilities, may cause significant lost or delayed production and adversely affect our results of operations;

 

2
 

 

we may become subject to product liability claims, which could harm our financial condition and liquidity if we are not able to successfully defend or insure against such claims;
   
if our vehicles fail to perform as expected due to defects, our ability to develop, market and sell our electric vehicles could be seriously harmed;
   
we depend on key personnel to operate our business, and the loss of one or more members of our management team, or our failure to attract, integrate and retain other highly qualified personnel in the future, could harm our business;
   
transitioning from an offshoring to an onshoring business model carries risk;
   
we currently have limited electric vehicles marketing and sales experience, and if we are unable to establish sales and marketing capabilities or enter into dealer agreements to market and sell our vehicles, we may be unable to generate any revenue;
   
failure to maintain the strength and value of our brand could have a material adverse effect on our business, financial condition, and results of operations;
   
the range of our electric vehicles on a single-charge declines over time, which may negatively influence potential customers’ decisions whether to purchase our vehicles;
   
an unexpected change in failure rates of our products could have a material adverse impact on our business, financial condition, and operating results;

 

increases in costs, disruption of supply or shortage of raw materials, in particular lithium-ion battery cells, chipsets and displays, could harm our business;
   
customer financing and insuring our vehicles may prove difficult because retail lenders are unfamiliar with our vehicles and our vehicles have a limited loss history determining residual values within the insurance industry;
   
our electric vehicles make use of lithium-ion battery cells, which, if not appropriately managed and controlled, have occasionally been observed to catch fire or vent smoke and flames;
   
our business may be adversely affected by labor and union activities;
   
we rely on our dealers for the service of our vehicles and have limited experience servicing our vehicles, and if we are unable to address the service requirements of our future customers, our business will be materially and adversely affected;

 

3
 

 

   
if we fail to deliver vehicles and accessories to market as scheduled, our business will be harmed;
   
failure in our information technology and storage systems could significantly disrupt the operation of our business;
   
we may be required to raise additional capital to fund our operations, and such capital raising may be costly or difficult to obtain, and could dilute our stockholders’ ownership interests;
   
our long-term capital requirements are subject to numerous risks;
   
we may invest in or acquire other businesses, and our business may suffer if we are unable to successfully integrate acquired businesses into our company or otherwise manage the growth associated with multiple acquisitions;
   
increased safety, emissions, fuel economy or other regulations may result in higher costs, cash expenditures, and/or sales restrictions;
   
our vehicles are subject to multi-jurisdictional motor vehicle standards;
we may fail to comply with evolving environmental and safety laws and regulations;
   
changes in regulations could render our vehicles incompatible with federal, state, or local regulations, or use cases;
   
unusual or significant litigation, governmental investigations or adverse publicity arising out of alleged defects in our vehicles, or otherwise, may derail our business;
   
we are required to comply with state-specific regulations regarding the sale of vehicles by a manufacturer;
   
we have identified a material weakness in our internal control over financial reporting, and if we are unable to remediate the material weakness, or if we experience additional material weaknesses in the future, our business may be harmed;
   
if we are unable to adequately protect our proprietary designs and intellectual property rights, our competitive position could be harmed;
   
we may need to obtain rights to intellectual property from third parties in the future, and if we fail to obtain licenses or fail to comply with our obligations in existing agreements under which we have licensed intellectual property and other rights from third parties, we could lose our ability to manufacture our vehicles;
   
many of our proprietary designs are in digital form, and a breach of our computer systems could result in these designs being stolen;
   
our proprietary designs are susceptible to reverse engineering by our competitors;
   
if we are unable to protect the confidentiality of our trade secrets or know-how, such proprietary information may be used by others to compete against us;
   
legal proceedings or third-party claims of intellectual property infringement and other challenges may require us to spend substantial time and money and could harm our business;
   
we are generally obligated to indemnify our sales channel partners, customers, suppliers and contractors for certain expenses and liabilities resulting from intellectual property infringement claims regarding our products, which could force us to incur substantial costs;
   
we are subject to exposure from changes in the exchange rates of local currencies;
   
we are subject to governmental export and import controls that could impair our ability to compete in international markets due to licensing requirements and subject us to liability if we are not in compliance with applicable laws.

 

For a more detailed discussion of these and other factors that may affect our business and that could cause our actual results to differ materially from those projected in these forward-looking statements, see the risk factors and uncertainties set forth in Part II, Item 1A of this Form 10-Q and in Part I, Item 1A of our Annual Report on Form 10-K as filed with the SEC on March 23, 2023 and amended on May 1, 2023 (“Form 10-K”). Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise, except as required by law.

 

4
 

 

Overview

 

We design and manufacture compact, sustainable electric vehicles for closed campus mobility, low speed urban and community transport, local on-demand and last mile delivery and government use. Our four-wheeled purpose-built electric vehicles are geared toward commercial customers, including universities, business and medical campuses, last mile delivery services and food service providers. We are currently updating our next model year (model year 2023) vehicle lineup in support of the aforementioned markets.

 

Strategic Review

 

Following the hiring of our current Chief Executive Officer in the third quarter of 2021, we initiated a strategic review of our product development strategy, as we focus on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with our strategic review, we cancelled development of our planned next-generation three-wheeled high-speed vehicle.

 

For the past several years, our primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, we ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus our resources on the development and launch of the new 411 fleet vehicle model year 2023 refresh, the Vanish. We began design and development of the Vanish in December 2021, including updates to our supply chain, the offshoring/onshoring mix, our manufacturing strategy and our annual model year refresh program. We unveiled the first Vanish prototype in the fourth quarter of 2022. Pre-production of the Vanish was completed in December 2022.

 

Club Car MPA Termination

 

The majority of our sales have historically been comprised of sales to Club Car LLC (“Club Car”) pursuant to a master procurement agreement (the “MPA”) entered into by and among AYRO Operating Company, Inc., our subsidiary (“AYRO Operating”), and Club Car on March 5, 2019. The MPA grants Club Car the exclusive right to sell our 411 and 411x vehicles (the “AYRO 411 Fleet”) in North America, provided that Club Car orders at least 500 vehicles per year. Club Car did not meet this volume threshold for 2020, 2021 or 2022. Pursuant to the MPA, AYRO Operating granted Club Car a right of first refusal for sales of 51% or more of AYRO Operating’s assets or equity interests, which right of first refusal is exercisable for a period of 45 days following delivery of an acquisition notice to Club Car. AYRO Operating also agreed to collaborate with Club Car on new products similar to the AYRO 411 Fleet and improvements to existing products and granted Club Car a right of first refusal to purchase similar commercial utility vehicles which AYRO Operating may develop during the term of the MPA.

 

On April 4, 2023, AYRO Operating delivered notice of termination of the MPA to Club Car, and we intend to replace Club Car with new business partners for selling our products beginning with the Vanish. We do not expect Club Car to remain a customer going forward. In connection with the termination of the MPA and the forthcoming introduction of the Vanish, we are reevaluating our channel strategy with an eye towards distributing our next-generation platform and payloads in a manner that maximizes visibility, moderates channel costs, and creates value. The loss of Club Car as a customer could have a material adverse effect on our sales, financial condition, and results of operations.

 

Nasdaq Minimum Bid Price Requirement

 

As previously reported, on October 3, 2022, we received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of our common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, we did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter also indicated that the Company would be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Initial Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

On April 4, 2023, we received a letter from Nasdaq notifying us that we had been granted an additional 180-day period, or until October 2, 2023, to regain compliance with the Minimum Bid Price Requirement. The new compliance period is an extension of the Initial Compliance Period provided for in Nasdaq’s deficiency notice to the Company dated October 3, 2022. Nasdaq’s determination was based on our meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

 

5
 

 

Management’s plan to regain compliance with the Minimum Bid Price Requirement is to seek stockholder approval for, and to file, an amendment to our amended and restated certificate of incorporation (“Certificate of Incorporation”) to effect a reverse stock split of our common stock at a ratio of 1-for-2 to 1-for-10, including shares held by us as treasury shares, with the exact ratio within such range to be determined by our board of directors at its discretion (the “Reverse Stock Split Amendment”). On August 8, 2023, we filed a preliminary proxy statement in connection with a special meeting of our stockholders to be held on September 14, 2023 (the “Special Meeting”) for the purpose of approving, among other things, the Reverse Stock Split Amendment.

 

If compliance with the Minimum Bid Price Requirement cannot be demonstrated by October 2, 2023, Nasdaq will provide written notification that our common stock could be delisted. In such an event, Nasdaq rules permit us to appeal any delisting determination to a Nasdaq Hearings Panel. There can be no assurance that we will be able to regain compliance with the Nasdaq listing rules or maintain its listing on Nasdaq.

 

Products

 

Our vehicles provide the end user an environmentally friendly alternative to internal combustion engine vehicles (cars powered by gasoline or diesel oil), for light duty uses, including low-speed logistics, maintenance services, cargo services, and personal/group transport in a quiet, zero emissions vehicle with a lower total cost of ownership.

 

Manufacturing Agreement with Cenntro

 

In 2017, AYRO Operating partnered with Cenntro in a supply chain agreement to provide sub-assembly manufacturing services. Cenntro owns the design of the AYRO Club Car 411 and 411x (“AYRO 411 Fleet”) vehicles and has granted us an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America.

 

Under our Manufacturing License Agreement with Cenntro (the “Cenntro MLA”), in order for us to maintain our exclusive territorial rights pursuant to the Cenntro MLA, we must meet certain minimum purchase requirements.

 

We imported semi-knocked-down vehicle kits from Cenntro for the AYRO 411x models comprising our model year 2022 lineup. The vehicle kits were received through shipping containers at the assembly facility of Karma Automotive LLC (“Karma”), our previous manufacturing partner in southern California, as well as at our customization, service and integration facility in Round Rock, Texas. The vehicles were then assembled with tailored customization requirements per order.

 

On May 31, 2022, we received a letter from Cenntro purporting to terminate all agreements and contracts between the Company and Cenntro. Although we do not believe Cenntro’s termination of the Cenntro MLA is valid, we have determined to cease production of the AYRO 411x and focus our resources on the development and launch of the Vanish. We have canceled all purchase orders and future builds with Cenntro and currently intend to only order replacement parts for vehicles from Cenntro in the future. Cenntro inventory remaining on hand as of June 30, 2023, was valued at $109,238. We expect to lose our exclusive license under the Cenntro MLA, in which case Cenntro could sell identical or similar products through other companies or directly to our customers, which could have a material adverse effect on our results of operations and financial condition.

 

We intend for the new Vanish to utilize assemblies and products that will largely eliminate our dependency on Chinese imports and optimize the supply chain to rely primarily upon North American and European sources. Final assembly of the Vanish will occur in our Round Rock, Texas facilities.

 

6
 

 

Manufacturing Agreement with Linamar

 

On July 28, 2022, we partnered with Linamar Corporation (“Linamar”), a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, we may terminate upon written notice within three days of completion of such change in control.

 

In the event we terminate the Linamar MLA prior to its expiration, whether following a change in control or otherwise, we must purchase any remaining raw material inventory, finished goods inventory, work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. We are dependent on the Linamar MLA, and in the event of its termination our manufacturing operations and customer deliveries would be materially impacted.

 

Under the Linamar MLA, we must commit to certain minimum purchases, to be determined by AYRO on a quarterly basis.

 

We import the Products from Linamar in Canada, and we manufacture and assemble the Vanish at our customization, service, and integration facility in Round Rock, Texas. Over 98% of the vehicle assemblies, components, and products are from North American and European sources.

 

7
 

 

Supply Agreement with Gallery Carts

 

During 2020, we entered into a supply agreement with Gallery Carts (“Gallery”), a leading provider of food and beverage kiosks, carts, and mobile storefront solutions. Joint development efforts have led to the launch of the parties’ first all-electric configurable mobile hospitality vehicle for “on-the-go” venues across the United States. This innovative solution permits food, beverage, and merchandising operators to bring goods directly to consumers.

 

The configurable Powered Vendor Box, in the rear of the vehicle, features long-life lithium batteries that power the preconfigured hot/cold beverage and food equipment and is directly integrated with the AYRO 411x and will be directly integrated with the Vanish. The canopy doors, as well as the full vehicle, can be customized with end-user logos and graphics to enhance the brand experience. Gallery, with 40 years of experience delivering custom food kiosk solutions, has expanded into electric mobile delivery vehicles, as customers increasingly want food, beverages and merchandise delivered to where they are gathering. For example, a recent study conducted by Technomic found that a large majority of students, 77%, desired alternative mobile and to-go food options on campuses.

 

Gallery, a premier distributor of AYRO vehicles, has a diverse clientele throughout mobile food, beverage, and merchandise distribution markets for key customer applications such as university, corporate and government campuses, major league and amateur-level stadiums and arenas, resorts, airports, and event centers. In addition to finding innovative and safe ways to deliver food and beverages to their patrons, reducing and ultimately eliminating their carbon footprint is a top priority for many of these customers.

 

Factors Affecting Results of Operations

 

Master Procurement Agreement

 

In March 2019, we entered into the MPA with Club Car. In partnership with Club Car and in interaction with its dealer network, we directed our business development resources towards supporting Club Car’s enterprise and fleet sales function as Club Car proceeds in its new product introduction initiatives. Substantially all of our sales have historically been to Club Car pursuant to the MPA. On April 4, 2023, we delivered notice of termination of the MPA to Club Car, and we intend to replace Club Car with new business partners for selling our products beginning with the Vanish. We do not expect Club Car to remain a customer going forward.

 

Tariffs

 

Countervailing tariffs on certain goods from China continued to have an adverse impact on raw material costs throughout 2021 and 2022.

 

8
 

 

Supply Chain

 

Beginning in the second quarter of 2021, we offered a configuration of our 411x powered by lithium-ion battery technology. Additionally, our powered food box offerings are currently powered by lithium-ion battery technology. Our business depends on the continued supply of battery cells and other parts for our vehicles. During 2021 and 2022, we at times experienced supply chain shortages of both lithium-ion battery cells and other critical components used to produce our vehicles, which has slowed our planned production of vehicles. In addition, we could be impacted by shortages of other products or raw materials, including silicon chips that we or our suppliers use in the production of our vehicles or parts sourced for our vehicles.

 

We intend for the Vanish to utilize assemblies and products that will eliminate our dependency on Chinese imports and optimize the supply chain to North American and European sources.

 

Components of Results of Operations

 

Revenue

 

We derive revenue from the sale of our four-wheeled electric vehicles, and, to a lesser extent, shipping, parts, and service fees. In the past we also derived rental revenue from vehicle revenue sharing agreements with tourist destination fleet operators, and, to a lesser extent, shipping, parts, and service fees. Provided that all other revenue recognition criteria have been met, we typically recognize revenue upon shipment, as title and risk of loss are transferred to customers and channel partners at that time. Products are typically shipped to dealers or directly to end customers, or in some cases to our international distributors. These international distributors assist with import regulations, currency conversions and local language. Our vehicle product sales revenues vary from period to period based on, among other things, the customer orders received and our ability to produce and deliver the ordered products. Customers often specify requested delivery dates that coincide with their need for our vehicles.

 

Because these customers may use our products in connection with a variety of projects of different sizes and durations, a customer’s orders for one reporting period generally do not indicate a trend for future orders by that customer. Additionally, order patterns do not necessarily correlate amongst customers.

 

Cost of Goods Sold

 

Cost of goods sold primarily consists of costs of materials and personnel costs associated with manufacturing operations, and an accrual for post-sale warranty claims. Personnel costs consist of wages and associated taxes and benefits. Cost of goods sold also includes freight and changes to our warranty reserves. Allocated overhead costs consist of certain facilities and utility costs. We expect the cost of revenue to increase in absolute dollars as product revenue increases.

 

Operating Expenses

 

Our operating expenses consist of general and administrative, sales and marketing and research and development expenses. Salaries and personnel-related costs, benefits, and stock-based compensation expense are the most significant components of each category of operating expenses. Operating expenses also include allocated overhead costs for facilities and utility costs.

 

9
 

 

Stock-based compensation

 

We account for stock-based compensation expense in accordance with Accounting Standards Codification (“ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of compensation expense for share-based awards based on the estimated fair value on the date of grant.

 

The fair value of each stock option granted to employees is estimated on the date of the grant using the Black-Scholes option-pricing model and the related stock-based compensation expense is recognized over the vesting period during which an employee is required to provide service in exchange for the award. The fair value of the options granted to non-employees is measured and expensed as the options vest.

 

Restricted stock grants are stock awards that entitle the holder to receive shares of our common stock as the award vests over time. The fair value of each restricted stock grant is based on the fair market value price of common stock on the date of grant, and it is measured and expensed as the restricted stock vests.

 

We estimate the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield, and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of our publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since we do not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Research and Development Expense

 

Research and development expense consists primarily of employee compensation and related expenses, prototype expenses, depreciation associated with assets acquired for research and development, amortization of product development costs, product strategic advisory fees, third-party engineering and contractor support costs and allocated overhead. We expect our research and development expenses to increase in absolute dollars as we continue to invest in new and existing products.

 

Sales and Marketing Expense

 

Sales and marketing expenses consist primarily of employee compensation and related expenses, sales commissions, marketing programs, travel and entertainment expenses and allocated overhead. Marketing programs consist of advertising, tradeshows, events, corporate communications, and brand-building activities. We expect sales and marketing expenses to increase in absolute dollars as we expand our sales force, expand our product lines, increase marketing resources, and further develop potential sales channels.

 

General and Administrative Expense

 

General and administrative expenses consist primarily of employee compensation and related expenses for administrative functions including finance, legal, human resources and fees for third-party professional services, and allocated overhead. We expect our general and administrative expense to increase in absolute dollars as we continue to invest in growing our business.

 

Other (Expense) Income

 

Other (expense) income consists of income received or expenses incurred for activities outside of our core business. Other expense consists primarily of interest expense and unrealized gain/loss on marketable securities.

 

Provision for Income Taxes

 

Provision for income taxes consists of estimated income taxes due to the United States government and to the state tax authorities in jurisdictions in which we conduct business. In the case of a tax deferred asset, we reserve the entire value for future periods.

 

10
 

 

Results of Operations

 

Three months ended June 30, 2023 compared to three months ended June 30, 2022

 

The following table sets forth our results of operations for each of the periods set forth below:

 

    For the Three Months Ended June 30,  
    2023     2022     Change  
Revenue   $ 139,544     $ 981,560     $ (842,016 )
Cost of goods sold     332,027       2,827,512       (2,495,485 )
Gross loss     (192,483 )     (1,845,952 )     1,653,469  
Operating expenses:                        
Research and development     2,405,398       1,046,797       1,358,601  
Sales and marketing     420,861       337,226       83,635  
General and administrative     3,247,731       2,741,700       506,031  
Total operating expenses     6,073,990       4,125,723       1,948,267  
Loss from operations     (6,266,473 )     (5,971,675 )     (294,798 )
Other income (expense):                        
Other income (expense), net     (9,166 )     10,706       (19,872 )
Interest income     117,278       -       117,278  
Unrealized gain (loss) on marketable securities     146,935       (13,479 )     160,414  
Realized gain on marketable securities     8,193             8,193  
Net loss   $ (6,003,233 )   $ (5,974,448 )   $ (28,785 )

 

Revenue

 

Revenue was $0.14 million for the three months ended June 30, 2023, as compared to $0.98 million for the same period in 2022, a decrease of 85.8%, or $0.84 million. The decrease in revenue was the result of a reduction in sales to Club Car as we wind down our relationship with Club Car.

 

Cost of goods sold and gross loss

 

Cost of goods decreased by $2.5 million, or 88.3% for the three months ended June 30, 2023, as compared to the same period in 2022, corresponding with the decrease in vehicle sales and a $1.32 million write-off of NCM inventory and $0.62 million of Cenntro prepaid and accrued balances that were expensed in the same period in 2022.

 

Research and development expense

 

Research and development (“R&D”) expense was $2.41 million for the three months ended June 30, 2023, as compared to $1.05 million for the same period in 2022, an increase of $1.36 million, or 129.8%. The increase was primarily due to pre-production and low-rate initial production costs for the AYRO Vanish. We had an increase in R&D contracting for professional service and design costs of $0.41 million, an increase in design and testing material of $0.54 million, and an increase in salaries and related expenses of $0.37 million.

 

11
 

 

Sales and marketing expense

 

Sales and marketing expense was $0.42 million for the three months ended June 30, 2023, as compared to $0.34 million for the same period in 2022, an increase of $0.08 million, or 24.8%, as we increased our focus on marketing-related initiatives surrounding the AYRO Vanish. Contracting for professional marketing services increased by $0.07 million.

 

General and administrative expenses

 

The majority of our operating losses from continuing operations resulted from general and administrative expenses. General and administrative expenses consist primarily of costs associated with our overall operations and with being a public company. These costs include personnel, legal and financial professional services, insurance, investor relations, and compliance related fees. General and administrative expense was $3.25 million for the three months ended June 30, 2023, compared to $2.74 million for the same period in 2022, an increase of $0.51 million, or 18.5% primarily due to contracting and professional services for overall repositioning of engineering, design, and manufacturing partnerships. Salaries and related expenses decreased by $0.09 million, primarily due to reducing headcount. Fulfillment expense and rent expense decreased by $0.05 million and $0.04 million, respectively. Depreciation and stock-based compensation increased by $0.06 million and decreased by $0.07 million, respectively.

 

Other income and expense

 

We recorded a $0.01 million decrease of net other income from disposing a fixed asset, a $0.17 million increase in interest income on cash accounts, an increase in unrealized gains of $0.16 million on marketable securities, and an increase in realized gains of $0.01 million on marketable securities.

 

Six months ended June 30, 2023 compared to six months ended June 30, 2022

 

The following table sets forth our results of operations for each of the periods set forth below:

 

   For the Six Months Ended June 30, 
   2023   2022   Change 
Revenue  $252,628   $2,008,405   $(1,755,777)
Cost of goods sold   551,820    4,004,657    (3,452,837)
Gross loss   (299,192)   (1,996,252)   1,697,060 
Operating expenses:               
Research and development   4,535,388    1,912,204    2,623,184 
Sales and marketing   1,138,953    1,182,042    (43,089)
General and administrative   6,091,047    5,446,627    644,420 
Total operating expenses   11,765,388    8,540,873    3,224,515 
Loss from operations   (12,064,580)   (10,537,125)   (1,527,455)

Other income (expense):

               
Other income (expense), net   52,532    19,597    32,935 
Interest income   261,638    -    261,638 
Unrealized gain (loss) on marketable securities   198,215    (35,580)   233,795 
Realized loss on marketable securities   73,193    -    73,193 
Net loss  $(11,479,002)  $(10,553,108)  $(925,894)

 

Revenue

 

Revenue was $0.25 million for the six months ended June 30, 2023, as compared to $2.01 million for the same period in 2022, a decrease of 87.4%, or $1.76 million. The decrease in revenue was the result of a reduction in sales to Club Car as we wind down our relationship with Club Car.

 

Cost of goods sold and gross profit

 

Cost of goods decreased by $3.45 million, or 86.2% for the six months ended June 30, 2023, as compared to the same period in 2022, corresponding with the decrease in vehicle sales and a $1.32 million write-off of NCM inventory and $0.62 million of Cenntro prepaid and accrued balances that were expensed in the same period in 2022.

 

12
 

 

Research and development expense

 

Research and development (“R&D”) expense was $4.54 million for the six months ended June 30, 2023, as compared to $1.91 million for the same period in 2022, an increase of $2.62 million, or 137.2%. The increase was primarily due to pre-production and low-rate initial production costs for the AYRO Vanish. We had an increase in R&D contracting for professional service and design costs of $1.5 million, an increase in design and testing material of $0.66 million, and an increase in salaries and related expenses of $0.4 million.

 

Sales and marketing expense

 

Sales and marketing expense was $1.14 million for the six months ended June 30, 2023, as compared to $1.18 million for the same period in 2022, an decrease of $0.04 million, or 3.6%, as we restructured our sales and marketing staff and marketing-related initiatives surrounding the AYRO Vanish. Salaries and related expenses decreased by $0.48 million due to the reduction of our sales and marketing resources. Bad debt increased by $0.29 million due to winding down our relationship with Club Car. Contracting for professional marketing services increased by $0.16 million.

 

General and administrative expenses

 

The majority of our operating losses from continuing operations resulted from general and administrative expenses. General and administrative expenses consist primarily of costs associated with our overall operations and with being a public company. These costs include personnel, legal and financial professional services, insurance, investor relations, and compliance related fees. General and administrative expense was $6.09 million for the six months ended June 30, 2023, compared to $5.45 million for the same period in 2022, an increase of $0.64 million, or 11.8% primarily due to an overall repositioning of engineering, design, and manufacturing partnerships. Salaries and related expenses increased by $0.21 million, primarily due to expanding headcount. Fulfillment expense and rent expense decreased by $0.21 million and $0.13 million, respectively. Depreciation and stock-based compensation increased by $0.1 million and decreased by $0.08 million, respectively.

 

Other income and expense

 

We recorded a $0.5 million increase of net other income from an insurance settlement on damaged vehicles in transit and loss on disposal of a fixed asset of $0.01 million, a $0.26 million increase in interest income on cash accounts, an increase in realized gains of $0.07 million on marketable securities and an increase in unrealized gains of $0.24 million on marketable securities.

 

Liquidity and Capital Resources

 

As of June 30, 2023, we had $13.57 million in cash, $19.46 million in marketable securities and working capital of $37.65 million. As of December 31, 2022, we had $39.1 million in cash, $9.85 million in marketable securities and working capital of $49.67 million. The decrease in cash and working capital was primarily a result of our operating loss. Our sources of cash since inception have been predominately from the sale of equity and debt.

 

Our business is capital-intensive, and future capital requirements will depend on many factors, including our growth rate, the timing and extent of spending to support development efforts, the results of our strategic review, the expansion of our sales and marketing teams, the timing of new product introductions and the continuing market acceptance of our products and services. We are working to control expenses and deploy our capital in the most efficient manner.

 

13
 

 

We are evaluating other options for the strategic deployment of capital beyond our ongoing strategic initiatives, including potentially entering other segments of the electric vehicle market. We anticipate being opportunistic with our capital, and we intend to explore potential partnerships and acquisitions that could be synergistic with our competitive stance in the market.

 

We are subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, and competition from larger companies, other technology companies and other technologies. Based on the foregoing, management believes that the existing cash at June 30, 2023, will be sufficient to fund operations for at least the next twelve months following the date of this report.

 

As discussed above, in connection with our strategic review we canceled development of our planned next-generation three-wheeled vehicle. In December of 2022 we completed pre-production on the new 411 fleet vehicle model refresh, the Vanish.

 

Summary of Cash Flows

 

The following table summarizes our cash flows:

 

   For the Six Months Ended June 30, 
   2023   2022 
Cash Flows:          
Net cash used in operating activities  $(14,893,479)  $(9,831,514)
Net cash used in investing activities  $(10,633,818)  $(18,438,183)
Net cash provided by financing activities  $-   $- 

 

Operating Activities

 

During the six months ended June 30, 2023, we used $14.89 million in cash in operating activities, an increase in use of $5.06 million compared to the cash used in operating activities of $9.83 million during the same period in 2022. The increase in cash used in operating activities was primarily a result of raw materials purchased and $1.51 million of prepayments for inventory and manufacturing services, payments of accrued expenses, and an increase in our operating loss as we continue to build our core business.

 

Our ability to generate cash from operations in future periods will depend in large part on profitability, the rate and timing of collections of our accounts receivable, inventory turns and our ability to manage other areas of working capital.

 

Investing Activities

 

During the six months ended June 30, 2023, we used cash of $10.63 million from investing activities as compared to $18.44 million of cash used in investing activities during 2022, a decrease of $7.8 million. The net decrease was primarily due to our investment in marketable securities of $9.3 million for the six months ended June 30, 2023 compared to $18 million for the six months ended June 30, 2022.

 

Financing Activities

 

During the six months ended June 30, 2023, and 2022, we had no financing activities of note.

 

Critical Accounting Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates, assumptions and judgments that affect the reported amount of assets, liabilities, revenue, costs and expenses and related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our consolidated financial statements are prepared. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions.

 

Our critical accounting estimates have not changed materially from those previously reported in our Form 10-K.

 

14
 

 

Recent Developments

 

August 2023 Private Placement

 

On August 7, 2023, we entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain existing investors (the “Investors”), pursuant to which we agreed to sell to the Investors (i) an aggregate of 22,000 shares of our newly-designated Series H-7 Preferred Stock, initially convertible into up to 22,000,000 shares of our common stock at a conversion price of $1.00 per share (the “Preferred Shares”), and (ii) warrants to acquire up to an aggregate of 22,000,000 shares of common stock at an exercise price of $1.00 per share (the “Investor Warrants,” and such transactions collectively, the “Private Placement”).

 

The Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the exemption for transactions by an issuer not involving any public offering under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. Each of the Investors has represented to us that it is an accredited investor within the meaning of Rule 501(a) of Regulation D and that it is acquiring the securities for investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof. The Preferred Shares and Investor Warrants were offered without any general solicitation by us or our representatives.

The Private Placement closed on August 10, 2023. The aggregate gross proceeds from the Private Placement were approximately $22 million. We expect to use the net proceeds from the Private Placement for general corporate purposes.

 

The Purchase Agreement contains certain representations and warranties, covenants and indemnities customary for similar transactions. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties.

 

In connection with the Private Placement, pursuant to an Engagement Letter, dated August 7, 2023, between the Company and Palladium Capital Group, LLC (the “Placement Agent”), we agreed to pay the Placement Agent (i) a cash fee equal to 6% of the gross proceeds from any sale of securities in the Private Placement and (ii) warrants (“Placement Agent Warrants,” and together with the Investor Warrants, the “Warrants”) to purchase shares of common stock equal to 2% of the number of shares of common stock that the Preferred Shares are initially convertible into, with an exercise price of $1.00 per share and a five-year term.

 

Series H-7 Preferred Stock

 

The terms of the Preferred Shares are as set forth in the certificate of designations filed with the Secretary of State of the State of Delaware prior to the closing of the Private Placement (the “Certificate of Designations”). The Preferred Shares are convertible into shares of common stock (the “Conversion Shares”) at the election of the holder at any time at an initial conversion price ( “Conversion Price”) of $1.00. The Conversion Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable for common stock, at a price below the then-applicable Conversion Price (subject to certain exceptions). We are required to redeem the Preferred Shares in twelve equal monthly installments, commencing on a date between February 7, 2024 and August 7, 2025, at the election of each Investor. The amortization payments due upon such redemption are payable, at our election, in cash at 105% of the Installment Redemption Amount (as defined in the Certificate of Designations), or subject to certain limitations, in shares of common stock valued at the lower of (i) the Conversion Price then in effect and (ii) the greater of (A) 80% of the average of the three lowest closing prices of the common stock during the thirty trading day period immediately prior to the date the amortization payment is due or (B) the lower of $0.144 and 20% of the Minimum Price (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of receipt of Nasdaq Stockholder Approval (as defined below), which amortization payments are subject to certain adjustments as set forth in the Certificate of Designations.

 

15
 

 

The holders of the Preferred Shares are entitled to dividends of 8% per annum, compounded monthly, which are payable in cash or shares of common stock at our option, in accordance with the terms of the Certificate of Designations. Upon the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Preferred Shares will accrue dividends at the rate of 15% per annum. Upon conversion or redemption, the holders of the Preferred Shares are also entitled to receive a dividend make-whole payment assuming for calculation purposes that the stated value remained outstanding through and including the twelve (12) month anniversary of the first installment date as elected by an Investor. Except as required by applicable law, the holders of Preferred Shares are entitled to vote with holders of the common stock on as as-converted basis, with the number of votes to which each holder of Preferred Shares is entitled to be calculated assuming conversion at the Minimum Price (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) applicable immediately before the execution and delivery of the Purchase Agreement.

 

Notwithstanding the foregoing, our ability to settle conversions and make amortization and dividend make-whole payments using shares of common stock is subject to certain limitations set forth in the Certificate of Designations, including a limit on the number of shares that may be issued until the time, if any, that our stockholders have approved the issuance of more than 19.9% of our outstanding shares of common stock in accordance with Nasdaq listing standards (the “Nasdaq Stockholder Approval”). We have agreed to seek stockholder approval of these matters at a meeting to be held no later than November 5, 2023. We intend to obtain the Nasdaq Stockholder Approval at the Special Meeting. Our directors and officers holding approximately 1,484,458 shares of common stock, representing approximately 3.9% of our issued and outstanding Common Stock, have executed an agreement to vote their shares in favor of the Nasdaq Stockholder Approval. The Certificate of Designations also contains a certain beneficial ownership limitation after giving effect to the issuance of shares of common stock issuable upon conversion of, or as part of any amortization or dividend make-whole payment under, the Certificate of Designations or Warrants. Such amount may be lowered with the consent of the holder and the Company.

 

The Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other things, the suspension from trading or the failure of the common stock to be trading or listed (as applicable) on an eligible market for a period of five (5) consecutive trading days and our failure to pay any amounts due to the holders of the Preferred Shares when due. In connection with a Triggering Event, each holder of Preferred Shares will be able to require us to redeem in cash any or all of the holder’s Preferred Shares at a premium set forth in the Certificate of Designations.

 

We are subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, the existence of liens, investment transactions, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends pursuant to the Certificate of Designations), distributions or redemptions, the transfer of assets, and certain minimum cash requirements and establishment of a segregated deposit account for the proceeds of the offering, among other matters.

 

There is no established public trading market for the Preferred Shares and we do not intend to list the Preferred Shares on any national securities exchange or nationally recognized trading system.

 

Warrants

 

The Warrants are exercisable for shares of common stock (the “Warrant Shares”) immediately at an exercise price of $1.00 per share (the “Exercise Price”) and expire five years from the date of issuance. The Exercise Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based adjustment, on a “full ratchet” basis, in the event of any issuances of common stock, or securities convertible, exercisable or exchangeable for common stock, at a price below the then-applicable Exercise Price (subject to certain exceptions). There is no established public trading market for the Warrants and we do not intend to list the Warrants on any national securities exchange or nationally recognized trading system.

 

Registration Rights

 

The Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares have not been registered under the Securities Act. In connection with the Purchase Agreement, on August 7, 2023, the Company and the Investors entered into a Registration Rights Agreement (the “Registration Rights Agreement”), pursuant to which we are required to file a resale registration statement (the “Registration Statement”) with the SEC to register for resale 150% of the Conversion Shares and the Warrant Shares promptly following the closing date, but in no event later than 30 calendar days after the closing date, and to have such Registration Statement declared effective by the Effectiveness Date (as defined in the Registration Rights Agreement). We will be obligated to pay certain liquidated damages to the Investors if we fail to file the Registration Statement when required, fails to file or cause the Registration Statement to be declared effective by the SEC when required, or fails to maintain the effectiveness of the Registration Statement pursuant to the terms of the Registration Rights Agreement.

 

16
 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Under the supervision and with the participation of management, including our principal executive and principal financial officers, we evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Based on the evaluation of our disclosure controls and procedures as of June 30, 2023, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were ineffective due to the material weakness in internal control over financial reporting discussed below.

 

In its assessment of the effectiveness of internal control over financial reporting as of December 31, 2022, management identified a material weakness related to segregation of duties. Specifically, due to limited resources and headcount, we did not have multiple people in the accounting function for full segregation of duties.

 

Plan for Remediation of Material Weakness

 

We have engaged a third party to conduct a full assessment of our controls and procedures. In the fourth quarter of 2022 we completed our full assessment and are now in the process of testing those controls.

 

Changes in Internal Control over Financial Reporting

 

Except as described above under “Plan for Remediation of Material Weakness,” there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

17
 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

There have been no changes to the legal proceedings disclosed in our Form 10-K.

 

ITEM 1A. RISK FACTORS

 

Except as set forth below, there have been no material changes to the risk factors as identified in our Form 10-K.

 

Our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our common stock.

 

As previously reported, on October 3, 2022, we received a letter from Nasdaq indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, we did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). In order to regain compliance with Nasdaq’s minimum bid price requirement, our common stock was required to maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during the Initial Compliance Period. We did not regain compliance during the Initial Compliance Period. On April 4, 2023, we received a letter from Nasdaq notifying us that we had been granted an additional 180-day period, or until October 2, 2023, to regain compliance with the Minimum Bid Price Requirement. The new compliance period is an extension of the Initial Compliance Period provided for in Nasdaq’s deficiency notice to the Company dated October 3, 2022. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and our written notice of our intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

 

To resolve the noncompliance, we may consider available options including a reverse stock split, which may not result in a permanent increase in the market price of our common stock, which is dependent on many factors, including general economic, market and industry conditions and other factors detailed from time to time in the reports we file with the SEC. It is not uncommon for the market price of a company’s shares to decline in the period following a reverse stock split.

 

If compliance with the Minimum Bid Price Requirement cannot be demonstrated by October 2, 2023, Nasdaq will provide written notification that our common stock could be delisted. In such an event, Nasdaq rules permit the Company to appeal any delisting determination to a Nasdaq Hearings Panel. However, there can be no assurance that we will be able to regain compliance with the Nasdaq listing rules or maintain its listing on Nasdaq.

 

Although we expect to take actions intended to restore our compliance with the listing requirements, we can provide no assurance that any action taken by us would be successful, or that any such action would stabilize the market price or improve the liquidity of our common stock. Should a delisting occur, an investor would likely find it significantly more difficult to dispose of, or to obtain accurate quotations as to the value of our common stock, and our ability to raise future capital through the sale of our common stock could be severely limited.

 

A significant portion of our revenues has historically been derived from Club Car pursuant to the MPA. Following the termination of the MPA, we will need to identify new strategic channel partners to support the sales of our vehicles.

 

The majority of our sales have historically been comprised of sales to Club Car pursuant to the MPA, with revenues from Club Car constituting approximately 100% of our revenues in 2022 and 79% of our revenues in 2021. On April 4, 2023, we delivered notice of termination of the MPA to Club Car, and we do not expect them to remain a customer going forward. The loss of Club Car as a customer could have a material adverse effect on our sales, financial condition, and results of operations.

 

Following the termination of the MPA, we will need to identify new strategic channel partners to support the sales of our vehicles. It may take time to identify and add these partners and to train new personnel to market and support our vehicles. We may be unable to identify suitable partners, or such partners may not successfully market and sell our vehicles and may not devote sufficient time and resources to enable our vehicles to develop, achieve or sustain market acceptance. Failure to enter into arrangements with and retain a sufficient number of high-quality strategic channel partners could increase our marketing costs, adversely impact buying and inventory patterns, payment terms or other contractual terms, sell-through or delivery of our vehicles or curtail our routes-to-market, and could have a material adverse effect on our prospects, business, financial condition or results of operations.

 

Holders of our Series H-7 Preferred Stock are entitled to certain payments under the Certificate of Designations that may be paid in cash or in shares of common stock depending on the circumstances. If we make these payments in cash, we may be required to expend a substantial portion of our cash resources. If we make these payments in common stock, it may result in substantial dilution to the holders of our common stock.

 

Under the Certificate of Designations, we are required to redeem the Series H-7 Preferred Shares in monthly installments, commencing on a date between February 7, 2024 and August 7, 2025. Holders of the Series H-7 Preferred Shares are also entitled to receive dividends, payable in arrears monthly, and dividends payable on installment dates shall be paid as part of the applicable installment amount. Installment amounts are payable, at the company’s election, in shares of common stock or, subject to certain limitations, in cash. Installment amounts paid in cash must be paid in the amount of 105% of the applicable payment amount due. For any installment amounts paid in shares of common stock, the number of shares of common stock shall be calculated by dividing the applicable payment amount due by the “installment conversion price.” The installment conversion price shall be equal to the lower of (i) the Conversion Price (as defined in the Certificate of Designations) in effect as of the applicable payment date and (ii) the greater of (A) 80% of the average of the three lowest closing prices of our common stock during the thirty trading day period immediately prior to the date the payment is due or (B) the lower of (x) $0.144 and (y) 20% of the “Minimum Price” (as defined in Rule 5635 of the Rules of the Nasdaq Stock Market) on the date of the Nasdaq Stockholder Approval (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events) or, in any case, such lower amount as permitted, from time to time, by the Nasdaq Stock Market.

 

Our ability to make payments due to the holders of the Preferred Shares using shares of common stock is subject to certain limitations set forth in the Certificate of Designations, including a limit on the number of shares that may be issued until our receipt of the Nasdaq Stockholder Approval. If we are unable to make installment payments in shares of common stock, we may be forced to make such payments in cash. If we do not have sufficient cash resources to make these payments, we may need to raise additional equity or debt capital, and we cannot provide any assurance that we will be successful in doing so. If are unable to raise sufficient capital to meet our payment obligations, we may need to delay, reduce or eliminate certain of our operations, sell some or all of our assets or merge with another entity.

 

Our ability to make payments due to the holders of the Series H-7 Preferred Shares using cash is also limited by the amount of cash we have on hand at the time such payments are due, as well as certain provisions of the Delaware General Corporation Law. Further, we intend to make the installment payments due to holders of Series H-7 Preferred Stock in the form of common stock to the extent allowed under the Certificate of Designations and applicable law in order to preserve our cash resources. The issuance of shares of common stock to the holders of our Series H-7 Preferred Stock will increase the number of shares of common stock outstanding and could result in substantial dilution to the existing holders of our common stock.

 

18
 

 

The Certificate of Designations and the Warrants contain anti-dilution provisions that may result in the reduction of the conversion price of the Preferred Shares or the exercise price of the Warrants in the future. These features may increase the number of shares of common stock being issuable upon conversion of the Preferred Shares or upon the exercise of the warrants.

 

The Certificate of Designations and the Warrants contain anti-dilution provisions, which provisions require the lowering of the applicable conversion price or exercise, as then in effect, to the purchase price of equity or equity-linked securities issued in any subsequent offerings. If in the future, while any shares of the Series H-7 Preferred Shares or Warrants are outstanding, we issue securities for a consideration per share of common stock (the “New Issuance Price”) that is less than the Conversion Price of the Series H-7 Preferred Shares or the Exercise Price of the Warrants, as then in effect, we will be required, subject to certain limitations and adjustments as provided in the Certificate of Designations or the Warrants, to reduce the Conversion Price or the Exercise Price to be equal to the New Issuance Price, which will result in a greater number of shares of common stock being issuable upon conversion of the Preferred Shares and the exercise of the Warrants, which in turn will increase the dilutive effect of such conversions or exercises on existing holders of our common stock. It is possible that we will not have a sufficient number of shares available to satisfy the conversion of the Preferred Shares or the exercise of the Warrants if we enter into a future transaction that reduces the applicable Conversion Price or Exercise Price. If we do not have a sufficient number of available shares for any Preferred Share conversions or Warrant exercises, we may need to seek stockholder approval to increase the number of authorized shares of our common stock, which may not be possible and will be time consuming and expensive. The potential for such additional issuances may depress the price of our common stock regardless of our business performance and may make it difficult for us to raise additional equity capital while any of the Preferred Shares or Warrants are outstanding.

 

Under the Purchase Agreement we are subject to certain restrictive covenants that may make it difficult to procure additional financing.

 

The Purchase Agreement contains the following restrictive covenants: (i) until Preferred Shares are no longer outstanding, we agreed not to enter into any variable rate transactions; (ii) we agreed to offer to the Investors, until the later of (x) the date on which no Preferred Shares no longer outstanding and (y) the maturity date of the Preferred Shares, the opportunity to participate in any subsequent securities offerings by us; and (iii) we agreed to use our reasonable best efforts to hold a stockholder meeting, at which we would solicit our stockholders’ affirmative vote for approval of our issuance of the maximum Conversion Shares upon conversion of the Preferred Shares and the maximum Warrant Shares upon exercise of the Warrants, each in accordance with the applicable law and rules and regulations of Nasdaq, no later than November 5, 2023. If we require additional funding while these restrictive covenants remain in effect, we may be unable to effect a financing transaction while remaining in compliance with the terms of the Purchase Agreement, or we may be forced to seek a waiver from the investors party to the Purchase Agreement.

 

If we do not receive approval from our stockholders, we will be unable to pay amounts due to the holders of the Series H-7 Preferred Shares in shares of common stock and we will be required to pay such amounts in cash, which may force us to divert cash from other uses.

 

Under the Purchase Agreement, we are required to hold a meeting of our stockholders to seek approval under Rule 5635(d) of the Nasdaq Stock Market for the sale, issuance or potential issuance by us of our common stock (or securities convertible into or exercisable for our common stock) in excess of 7,554,727 shares, which is 19.99% of the shares of common stock outstanding immediately prior to the execution of the Purchase Agreement. Our directors and officers, who held approximately 3.9% of our issued and outstanding common stock as of the date of the Purchase Agreement, are party to a voting agreement pursuant to which, among other things, each such stockholder agreed, solely in their capacity as a stockholder, to vote all of their shares of common stock in favor of the approval. If an insufficient number of our remaining stockholders vote in favor of the proposal we will be unable to issue shares of common stock in order to pay amounts due under the Certificate of Designations to holders of the Series H-7 Preferred Shares in shares of common stock. If we are unable to pay such amounts when due in shares of common stock, we will have to satisfy our payment obligations by means of cash payments. If we do not have sufficient cash resources to make these payments, we may need to delay, reduce or eliminate certain of our operations, sell some or all of our assets or merge with another entity.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

19
 

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of , or incorporated by reference into, this Quarterly Report on Form 10-Q

 

3.1 Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
   
3.2 Certificate of Amendment to Amended and Restated Certificate of Incorporation, effective May 28, 2020 (incorporated by reference to Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
   
3.3 Amended and Restated Bylaws, effective May 28, 2020 (incorporated by reference to Exhibit 3.4 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 29, 2020)
   
3.4 First Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on July 8, 2020)
   
3.5 Second Amendment to the Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 19, 2021)
   
3.6 Form of Certificate of Designations of Series H-7 Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023)
   
4.1 Form of Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023)
   
10.1 Form of Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023)
   
10.2 Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 8, 2023)

 

20
 

 

Exhibit

No.

  Description
     
31.1**   Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2**   Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1***   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101 INS**   Inline XBRL Instance Document
101 SCH**   Inline XBRL Taxonomy Extension Schema Document
101 CAL**   Inline XBRL Taxonomy Calculation Linkbase Document
101 DEF**   Inline XBRL Taxonomy Extension Definition Linkbase Document
101 LAB**   Inline XBRL Taxonomy Labels Linkbase Document

101 PRE**

104

 

Inline XBRL Taxonomy Presentation Linkbase Document

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

** Filed herewith.
   
*** Furnished herewith

 

21
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AYRO, INC.
     
Dated: August 14, 2023 By: /s/ Thomas M. Wittenschlaeger
    Thomas M. Wittenschlaeger
   

President and Chief Executive Officer

(Principal Executive Officer)

     
Dated: August 14, 2023 By: /s/ David E. Hollingsworth
    David E. Hollingsworth
   

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

22

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATIONS UNDER SECTION 302

 

I, Thomas M. Wittenschlaeger, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of AYRO, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: August 14, 2023  
   
/s/ Thomas M. Wittenschlaeger  
Thomas M. Wittenschlaeger  

President and Chief Executive Officer

(Principal Executive Officer)

 

 

   

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATIONS UNDER SECTION 302

 

I, David E Hollingsworth, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of AYRO, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: August 14, 2023  
   
/s/ David E. Hollingsworth  
David E. Hollingsworth  
Chief Financial Officer  
(Principal Financial Officer and Principal Accounting Officer)  

 

   

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATIONS UNDER SECTION 906

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of AYRO, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge and in the capacity of an officer, that:

 

The Quarterly Report for the quarter ended June 30, 2023 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

 

Dated: August 14, 2023 By: /s/ Thomas M. Wittenschlaeger
    Thomas M. Wittenschlaeger
   

President and Chief Executive Officer

(Principal Executive Officer)

     
Dated: August 14, 2023 By: /s/ David E. Hollingsworth
    David E. Hollingsworth

 

 

 

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

   

 

EX-101.SCH 5 ayro-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - REVENUES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - REVENUES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SCHEDULE OF INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - INVENTORY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ayro-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 ayro-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ayro-20230630_lab.xml XBRL LABEL FILE Class of Stock [Axis] Convertible Preferred Stock Series H [Member] Convertible Preferred Stock Series H-3 [Member] Convertible Preferred Stock Series H-6 [Member] Series H Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series H-3 Preferred Stock [Member] Series H-6 Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Title of Individual [Axis] Investor [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Product and Service [Axis] Shipping and Handling [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Restricted Stock [Member] Restricted Stock Unissued [Member] Warrant [Member] Product [Member] Miscellaneous Income [Member] Inventory [Axis] Fleet Inventory [Member] Long-Lived Tangible Asset [Axis] Computer and Equipment [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Computer Software [Member] Non-Executive Directors [Member] Award Type [Axis] Plan Name [Axis] 2020 Long-Term Incentive Plan [Member] 2020 Long Term Incentive Plan [Member] Income Statement Location [Axis] Research and Development [Member] Sales and Marketing [Member] General and Administrative [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer One [Member] Customer [Member] Customer Two [Member] Customer Three [Member] Accounts Receivable [Member] Cost of Goods and Service, Product and Service Benchmark [Member] Supplier Concentration Risk [Member] Supplier [Member] Supplier one [Member] Supplier Two [Member] Supplier One [Member] Two Supplier [Member] Legal Entity [Axis] Cenntro Automotive Group Ltd [Member] DropCar Operating, Inc. [Member] Series H 7 Convertible Preferred Stock [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Marketable securities Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Property and equipment, net Operating lease – right-of-use asset Deposits and other assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable Accrued expenses Current portion lease obligation – operating lease Total current liabilities Lease obligation – operating lease, net of current portion Total liabilities Stockholders’ equity: Preferred stock, value Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,536,101 and 37,241,642 as of June 30, 2023 and December 31, 2022, respectively) Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, shares authorized Preferred stock, par value Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of goods sold Gross loss Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Loss from operations Other income (expense): Other income (expense), net Interest income Unrealized gain (loss) on marketable securities Realized gain on marketable securities Other income (expense), net Net loss Net loss per share, basic Net loss per share, diluted Basic weighted average Common Stock outstanding Diluted weighted average Common Stock outstanding Balance, value Balance, shares Stock Based Compensation Vesting of Restricted Stock Vesting of restricted stock , shares Net Loss Balance, value Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Loss on disposal of fixed asset Stock-based compensation Amortization of right-of-use asset Bad debt expense Unrealized (gain) loss on marketable securities Realized (gain) on marketable securities Impairment of inventory and prepaid Change in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable Accrued expenses Lease obligations - operating leases Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Purchase of marketable securities, net Purchase of intangible assets Net cash used in investing activities Net change in cash Cash, beginning of period Cash, end of period Supplemental disclosure of cash and non-cash transactions: Accrued Fixed Assets Restricted Stock issued, previously accrued Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND NATURE OF OPERATIONS Liquidity And Other Uncertainties LIQUIDITY AND OTHER UNCERTAINTIES Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Revenue from Contract with Customer [Abstract] REVENUES Credit Loss [Abstract] ACCOUNTS RECEIVABLE, NET Inventory Disclosure [Abstract] INVENTORY Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] PREPAID EXPENSES AND OTHER CURRENT ASSETS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Payables and Accruals [Abstract] ACCRUED EXPENSES Equity [Abstract] STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Risks and Uncertainties [Abstract] CONCENTRATIONS AND CREDIT RISK Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation and Principles of Consolidation Use of Estimates Marketable Securities Revenue Recognition Stock-Based Compensation Basic and Diluted Loss Per Share SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORY SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT, NET SCHEDULE OF ACCRUED EXPENSES Schedule of Stock by Class [Table] Class of Stock [Line Items] SCHEDULE OF PAYMENT OF PREFERRED STOCK SCHEDULE OF WARRANT ACTIVITY SCHEDULE OF STOCK-BASED COMPENSATION SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY SCHEDULE OF RESTRICTED STOCK ACTIVITY Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Net losses Net cash provided by (used in) operating activities Cash and cash equivalents, at carrying value Marketable securities, current Working capital Stock Issued During Period, Shares, New Issues Stock Issued During Period, Value, New Issues Proceeds from Issuance of Common Stock Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Schedule of Product Information [Table] Product Information [Line Items] General and administrative expense Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Total Revenue Warranty reserves Trade receivables Less: Allowance for doubtful accounts Accounts receivable, net Changes in allowance for doubtful accounts receivable Bed debt expense Raw materials Work-in-progress Finished goods Total Inventory, Current [Table] Inventory [Line Items] Depreciation for fleet inventory Prepayments for inventory Prepayments for insurance Prepayments on advances on design Prepayments on software Prepaid other Total Prepaid Expenses and Other Current Assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Less: Accumulated depreciation Property and equipment, net Depreciation expense Loss on disposal fixed assets Accrued professional and consulting fees Accrued payroll Accrued warranty reserve Accrued expenses other Total accrued expenses Number of Series H Preferred Stock outstanding as of June 30, 2023 Multiplied by the stated value Equals the gross stated value Divided by the conversion price Equals the convertible shares of Company Common Stock Multiplied by the fair market value of Company Common Stock as of June 30, 2023 Equals the payment Equals the payment Shares underlying warrants outstanding Weighted average exercise price outstanding Weighted average remaining contractual life Shares underlying warrants granted Weighted average exercise price granted Shares underlying warrants exercised Weighted average exercise price exercised Shares underlying warrants expired Weighted average exercise price expired Shares underlying warrants outstanding Weighted average exercise price outstanding Weighted average remaining contractual life Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of restricted stock units Share price Common stock issued and vested Common stock unissued Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Total Number of stock options outstanding, beginning balance Weighted average exercise price outstanding, beginning balance Weighted average remaining contractual life (years) Number of stock options, forfeitures Weighted average exercise price, forfeitures Number of stock options outstanding, ending balance Weighted average exercise price outstanding, ending balance Number of shares, outstanding, beginning balance Weighted average grant price, outstanding, beginning balance Number of shares, granted Weighted average grant price, granted Number of shares, vested Weighted average grant price, vested Number of shares, outstanding, ending balance Weighted average grant price, outstanding, ending balance Number of shares reserved Number of shares available for grants Number of stock options vested Number of stock options exercisable Aggregate intrinsic value of stock options vested Aggregate intrinsic value of stock options exercisable Share-based Compensation Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount Number of shares granted Stock compensation expense Unrecognized compensation expense Concentration Risk [Table] Concentration Risk [Line Items] Concentration risk percentage Termination fee Prepaid expenses Inventory written-off Accrued expense Subsequent Event [Table] Subsequent Event [Line Items] Preferred Stock, Shares Authorized Stock Issued During Period, Shares, Conversion of Convertible Securities Preferred Stock, Convertible, Conversion Price Class of Warrant or Right, Outstanding Class of Warrant or Right, Exercise Price of Warrants or Rights Gross proceeds from the private placement Convertible Preferred Stock Series H [Member] Convertible Preferred Stock Series H-3 [Member] Warranty reserves. Convertible Preferred Stock Series H-6 [Member] Fleet Inventory [Member] Prepayments for inventory. Prepayments on advances on design. Prepayments on software. Series H-3 Preferred Stock [Member] Series H-6 Preferred Stock [Member] 2020 Long-Term Incentive Plan [Member] Multiplied by the stated value. Equals the gross stated value. Number of warrants or rights granted. Number of warrants or rights exercised. Class of warrant or right expired. Exercise price per share or per unit of warrants or rights granted. Exercise price per share or per unit of warrants or rights exercised. Class of warrant or right expired erercise price expired. Weighted Average Remaining Contractual Life, Beginning. Weighted Average Remaining Contractual Life, Ending. 2020 Long Term Incentive Plan [Member] Accrued fixed assets. Supplemental cash amounts arising from obtaining right of use assets. Liquidity and other uncertainities [Text block] Working capital. Supplier One [Member] Termination fee. Cenntro Automotive Group Ltd [Member] DropCar Operating, Inc. [Member] Customer [Member] Supplier one [Member] Supplier Two [Member] Customer One [Member] Customer Two [Member] Miscellaneous Income [Member] Computer and Equipment [Member] Computer Software [Member] Research and Development [Member] Sales and Marketing [Member] General and Administrative [Member] Non-Executive Directors [Member] Incremental borrowing rate for the lease. New Lease Agreement [Member] Schedule of operating leases right of use assets and liabilities [Table Text Block]. Amount of lessee's right to use underlying asset under operating lease. Schedule of weighted average remaining lease term and discount rate [Table Text Block]. Two Supplier [Member] Operating lease right of use asset non current. Operating lease liability current and non current. Restricted Stock Unissued [Member] Customer Three [Member] Supplier [Member] Accrued purchases current. Securities Purchase Agreement [Member] Series H 7 Convertible Preferred Stock [Member] Gross proceeds from sale of available for sale securities debt percentage. Warrants purchase shares percentage. Purchase Agreement [Member] Preferred stock accrue dividend rate percentage. Directors And Officers [Member] Common stock issued and outstanding percentage. Common stock outstanding shares percentage. Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Nonoperating Income (Expense) Shares, Outstanding Gain (Loss) on Disposition of Property Plant Equipment Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Marketable Securities Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Accounts Receivable, Allowance for Credit Loss, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Preferred Stock, Liquidation Preference, Value Weighted Average Remaining Contractual Life, Ending Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period EX-101.PRE 9 ayro-20230630_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 11, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 001-34643  
Entity Registrant Name AYRO, INC.  
Entity Central Index Key 0001086745  
Entity Tax Identification Number 98-0204758  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 900 E. Old Settlers Boulevard  
Entity Address, Address Line Two Suite 100  
Entity Address, City or Town Round Rock  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78664  
City Area Code (512)  
Local Phone Number 994-4917  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol AYRO  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   37,732,530
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash $ 13,569,265 $ 39,096,562
Marketable securities 19,464,015 9,848,804
Accounts receivable, net 104,155 510,071
Inventory 3,049,972 970,381
Prepaid expenses and other current assets 3,269,831 1,478,845
Total current assets 39,457,238 51,904,663
Property and equipment, net 3,201,260 2,192,337
Operating lease – right-of-use asset 750,877 819,401
Deposits and other assets 84,595 73,683
Total assets 43,493,970 54,990,084
Current liabilities:    
Accounts payable 716,236 1,107,215
Accrued expenses 910,114 964,937
Current portion lease obligation – operating lease 178,013 165,767
Total current liabilities 1,804,363 2,237,919
Lease obligation – operating lease, net of current portion 601,349 693,776
Total liabilities 2,405,712 2,931,695
Stockholders’ equity:    
Preferred stock, value
Common Stock, ($0.0001 par value; authorized – 100,000,000 shares; issued and outstanding – 37,536,101 and 37,241,642 as of June 30, 2023 and December 31, 2022, respectively) 3,753 3,724
Additional paid-in capital 133,733,091 133,224,249
Accumulated deficit (92,648,586) (81,169,584)
Total stockholders’ equity 41,088,258 52,058,389
Total liabilities and stockholders’ equity 43,493,970 54,990,084
Convertible Preferred Stock Series H [Member]    
Stockholders’ equity:    
Preferred stock, value
Convertible Preferred Stock Series H-3 [Member]    
Stockholders’ equity:    
Preferred stock, value
Convertible Preferred Stock Series H-6 [Member]    
Stockholders’ equity:    
Preferred stock, value
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Preferred stock, shares authorized 20,000,000 20,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 37,536,101 37,241,642
Common stock, shares outstanding 37,536,101 37,241,642
Convertible Preferred Stock Series H [Member]    
Preferred stock, shares authorized 8,500 8,500
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 8 8
Preferred stock, shares outstanding 8 8
Convertible Preferred Stock Series H-3 [Member]    
Preferred stock, shares authorized 8,461 8,461
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares issued 1,234 1,234
Preferred stock, shares outstanding 1,234 1,234
Convertible Preferred Stock Series H-6 [Member]    
Preferred stock, shares authorized   50,000
Preferred stock, par value   $ 0.0001
Preferred stock, shares outstanding 50 50
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenue $ 139,544 $ 981,560 $ 252,628 $ 2,008,405
Cost of goods sold 332,027 2,827,512 551,820 4,004,657
Gross loss (192,483) (1,845,952) (299,192) (1,996,252)
Operating expenses:        
Research and development 2,405,398 1,046,797 4,535,388 1,912,204
Sales and marketing 420,861 337,226 1,138,953 1,182,042
General and administrative 3,247,731 2,741,700 6,091,047 5,446,627
Total operating expenses 6,073,990 4,125,723 11,765,388 8,540,873
Loss from operations (6,266,473) (5,971,675) (12,064,580) (10,537,125)
Other income (expense):        
Other income (expense), net (9,166) 10,706 52,532 19,597
Interest income 117,278 261,638
Unrealized gain (loss) on marketable securities 146,935 (13,479) 198,215 (35,580)
Realized gain on marketable securities 8,193 73,193
Other income (expense), net 263,240 (2,773) 585,578 (15,983)
Net loss $ (6,003,233) $ (5,974,448) $ (11,479,002) $ (10,553,108)
Net loss per share, basic $ (0.16) $ (0.16) $ (0.31) $ (0.29)
Net loss per share, diluted $ (0.16) $ (0.16) $ (0.31) $ (0.29)
Basic weighted average Common Stock outstanding 37,476,845 36,982,436 37,398,555 36,945,240
Diluted weighted average Common Stock outstanding 37,476,845 36,982,436 37,398,555 36,945,240
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance, value at Dec. 31, 2021 $ 3,687 $ 131,654,776 $ (58,234,231) $ 73,424,232
Balance, shares at Dec. 31, 2021 8 1,234 50 36,866,956      
Stock Based Compensation 288,110 288,110
Vesting of Restricted Stock $ 4 329,377 329,381
Vesting of restricted stock , shares       43,000      
Net Loss   (4,578,660) (4,578,660)
Balance, value at Mar. 31, 2022 $ 3,691 132,272,263 (62,812,891) 69,463,063
Balance, shares at Mar. 31, 2022 8 1,234 50 36,909,956      
Balance, value at Dec. 31, 2021 $ 3,687 131,654,776 (58,234,231) 73,424,232
Balance, shares at Dec. 31, 2021 8 1,234 50 36,866,956      
Net Loss             (10,553,108)
Balance, value at Jun. 30, 2022 $ 3,702 132,575,805 (68,787,339) 63,792,168
Balance, shares at Jun. 30, 2022 8 1,234 50 37,020,518      
Balance, value at Mar. 31, 2022 $ 3,691 132,272,263 (62,812,891) 69,463,063
Balance, shares at Mar. 31, 2022 8 1,234 50 36,909,956      
Stock Based Compensation 303,553 303,553
Vesting of Restricted Stock $ 11 (11)
Vesting of restricted stock , shares       110,562      
Net Loss   (5,974,448) (5,974,448)
Balance, value at Jun. 30, 2022 $ 3,702 132,575,805 (68,787,339) 63,792,168
Balance, shares at Jun. 30, 2022 8 1,234 50 37,020,518      
Balance, value at Dec. 31, 2022 $ 3,724 133,224,249 (81,169,584) 52,058,389
Balance, shares at Dec. 31, 2022 8 1,234 50 37,241,642      
Stock Based Compensation 20,116 20,116
Vesting of Restricted Stock $ 11 246,614 246,625
Vesting of restricted stock , shares       110,562      
Net Loss   (5,475,769) (5,475,769)
Balance, value at Mar. 31, 2023 $ 3,735 133,490,979 (86,645,353) 46,849,361
Balance, shares at Mar. 31, 2023 8 1,234 50 37,352,204      
Balance, value at Dec. 31, 2022 $ 3,724 133,224,249 (81,169,584) 52,058,389
Balance, shares at Dec. 31, 2022 8 1,234 50 37,241,642      
Net Loss             (11,479,002)
Balance, value at Jun. 30, 2023 $ 3,753 133,733,091 (92,648,586) 41,088,258
Balance, shares at Jun. 30, 2023 8 1,234 50 37,536,101      
Balance, value at Mar. 31, 2023 $ 3,735 133,490,979 (86,645,353) 46,849,361
Balance, shares at Mar. 31, 2023 8 1,234 50 37,352,204      
Stock Based Compensation 11,417 11,417
Vesting of Restricted Stock $ 18 230,695 230,713
Vesting of restricted stock , shares       183,897      
Net Loss   (6,003,233) (6,003,233)
Balance, value at Jun. 30, 2023 $ 3,753 $ 133,733,091 $ (92,648,586) $ 41,088,258
Balance, shares at Jun. 30, 2023 8 1,234 50 37,536,101      
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (11,479,002) $ (10,553,108)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 452,848 257,791
Loss on disposal of fixed asset 11,666
Stock-based compensation 508,869 591,663
Amortization of right-of-use asset 81,524 118,092
Bad debt expense 292,010 2,069
Unrealized (gain) loss on marketable securities (198,215) 35,580
Realized (gain) on marketable securities (73,193)
Impairment of inventory and prepaid 1,938,386
Change in operating assets and liabilities:    
Accounts receivable 113,906 (955,609)
Inventory (2,079,590) 325,282
Prepaid expenses and other current assets (1,790,987) (785,762)
Accounts payable (405,979) 164,809
Accrued expenses (234,155) (838,304)
Lease obligations - operating leases (93,181) (132,403)
Net cash used in operating activities (14,893,479) (9,831,514)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (1,271,311) (414,197)
Purchase of marketable securities, net (9,343,804) (18,006,486)
Purchase of intangible assets (18,703) (17,500)
Net cash used in investing activities (10,633,818) (18,438,183)
Net change in cash (25,527,297) (28,269,697)
Cash, beginning of period 39,096,562 69,160,466
Cash, end of period 13,569,265 40,890,769
Supplemental disclosure of cash and non-cash transactions:    
Accrued Fixed Assets 194,335
Restricted Stock issued, previously accrued $ 329,381
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
ORGANIZATION AND NATURE OF OPERATIONS
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND NATURE OF OPERATIONS

NOTE 1. ORGANIZATION AND NATURE OF OPERATIONS

 

AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc. (“AYRO Operating”), which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly owned subsidiaries, are principally engaged in manufacturing and sales of environmentally conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.

 

Strategic Review

 

Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, AYRO initiated a strategic review of its product development strategy, as AYRO focused on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with the strategic review by the Company, AYRO cancelled development of its planned next-generation three-wheeled high-speed vehicle.

 

For the past several years, AYRO’s primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, the Company ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus its resources on the development and launch of the new 411 fleet vehicle model year 2023 refresh (the “Vanish”).

 

In December of 2021 the Company began research and development on the Vanish, including updates on its supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.

 

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.2
LIQUIDITY AND OTHER UNCERTAINTIES
6 Months Ended
Jun. 30, 2023
Liquidity And Other Uncertainties  
LIQUIDITY AND OTHER UNCERTAINTIES

NOTE 2. LIQUIDITY AND OTHER UNCERTAINTIES

 

Liquidity and Other Uncertainties

 

The unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $11,479,002 for the six months ended June 30, 2023, and negative cash flows from operations of $14,893,479 for the six months ended June 30, 2023. On June 30, 2023, the Company had cash balances totaling $13,569,265 and marketable securities of $19,464,015. In addition, overall working capital decreased by $12,013,869 during the six months ended June 30, 2023. Management believes that the existing cash as of June 30, 2023, will be sufficient to fund operations for at least the next twelve months following the issuance of these unaudited condensed consolidated financial statements. Additionally, on August 7, 2023, the Company entered into a Securities Purchase Agreement to which it agreed to sell to certain existing investors (the “Investors”) an aggregate of 22,000 shares of the Company’s newly designated Series H-7 convertible preferred stock with a stated value of $1,000 per share (“Series H-7 Preferred Stock”). The Company raised approximately $22 million from the sale, which closed on August 10, 2023.

 

The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially and negatively impact the business, prospects, financial condition, and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to Company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.

 

The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:

 

 

the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;

 

 

disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and

 

  an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.

 

Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup the increasing costs of raw materials by increasing vehicle prices.

 

We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.

 

On October 3, 2022, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Initial Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).

 

On April 4, 2023, the Company received a letter from Nasdaq notifying the Company that the Company has been granted an additional 180-day period, or until October 2, 2023, to regain compliance with the Minimum Bid Price Requirement. The new compliance period is an extension of the Initial Compliance Period provided for in Nasdaq’s deficiency notice to the Company dated October 3, 2022. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

 

Management’s plan to regain compliance with the Minimum Bid Price Requirement is to seek stockholder approval for, and to file, an amendment to the Company’s amended and restated certificate of incorporation (“Certificate of Incorporation”) to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-2 to 1-for-10 with the exact ratio within such range to be determined by the Company’s board of directors at its discretion (the “Reverse Stock Split Amendment”). On August 8, 2023, the Company filed a preliminary proxy statement in connection with a special meeting of the Company’s stockholders to be held on September 14, 2023 for the purpose of approving, among other things, the Reverse Stock Split Amendment.

 

If compliance with the Minimum Bid Price Requirement cannot be demonstrated by October 2, 2023, Nasdaq will provide written notification that the Company’s common stock could be delisted. In such an event, Nasdaq rules permit the Company to appeal any delisting determination to a Nasdaq Hearings Panel. Accordingly, there can be no assurance that the Company will be able to regain compliance with the Nasdaq listing rules or maintain its listing on Nasdaq.

 

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The unaudited condensed consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and in conformity with the instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”).

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 23, 2023, as amended on May 1, 2023.

 

 

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

The Company’s most significant estimates include marketable securities, revenue recognition, and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.

 

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $19,464,015 and $9,848,804 in marketable securities as of June 30, 2023 and December 31, 2022, respectively.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $20,768 and $145,496 for the three months ended June 30, 2023, and 2022 and $41,334 and $256,045 for the six months ended June 30, 2023 and 2022 respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent, and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

 

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

The Company estimates the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share is the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Options to purchase common stock   732,422    788,546    732,422    788,546 
Restricted stock unvested   1,120,502    781,686    1,120,502    781,686 
Restricted stock vested - unissued   6,269    -    6,269    - 
Warrants outstanding   5,969,595    6,106,023    5,969,595    6,106,023 
Preferred stock outstanding   2,475    2,475    2,475    2,475 
Total   7,831,263    7,678,730    7,831,263    7,678,730 

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
REVENUES

NOTE 4. REVENUES

 

Disaggregation of Revenue

 

Revenue by type was as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Revenue type                    
Product revenue  $127,106   $918,808   $247,388   $1,838,150 
Shipping revenue   12,438    22,752    (4,150)   130,255 
Miscellaneous income   -    40,000    9,390    40,000 
Total Revenue  $139,544   $981,560   $252,628   $2,008,405 

 

Warranty Reserve

 

The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of June 30, 2023, and December 31, 2022, warranty reserves were recorded within accrued expenses of $395,071 and $410,017, respectively.

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.2
ACCOUNTS RECEIVABLE, NET
6 Months Ended
Jun. 30, 2023
Credit Loss [Abstract]  
ACCOUNTS RECEIVABLE, NET

NOTE 5. ACCOUNTS RECEIVABLE, NET

 

Accounts receivable, net, consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   June 30,   December 31, 
   2023   2022 
Trade receivables  $104,155   $512,420 
Less: Allowance for doubtful accounts   -    (2,349)
Accounts receivable, net  $104,155   $510,071 

 

The Company reduced allowance for doubtful accounts by $2,349 for the three and six months ended June 30, 2023, and recorded $292,010 of bad debt expense due to direct write off balances due from Club Car, LLC (“Club Car”) for the six months ended June 30, 2023. The Company recorded $2,069 of bad debt expense for the three and six months ending June 30, 2022.

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.2
INVENTORY
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 6. INVENTORY

 

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Raw materials  $2,481,859   $330,931 
Work-in-progress   -    - 
Finished goods   568,113    639,450 
Total  $3,049,972   $970,381 

 

For the three months ended June 30, 2023 and 2022, depreciation for fleet inventory was $0 and $23,883, and for the six months ended June 30, 2023 and 2022, was $0 and $47,775 respectively.

 

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.2
PREPAID EXPENSES AND OTHER CURRENT ASSETS
6 Months Ended
Jun. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
PREPAID EXPENSES AND OTHER CURRENT ASSETS

NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

 SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

   June 30,   December 31, 
   2023   2022 
Prepayments for inventory  $2,603,057   $1,174,466 
Prepayments for insurance   274,724    118,434 
Prepayments on advances on design   101,815    75,000 
Prepayments on software   190,333    103,851 
Prepaid other   99,902    7,094 
Total Prepaid Expenses and Other Current Assets  $3,269,831   $1,478,845 

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.2
PROPERTY AND EQUIPMENT, NET
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

NOTE 8. PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 SCHEDULE OF PROPERTY AND EQUIPMENT, NET

   June 30,   December 31, 
   2023   2022 
Computer and equipment  $3,211,535   $1,970,001 
Furniture and fixtures   395,705    323,789 
Lease improvements   1,093,481    952,952 
Computer software   455,875    455,875 
Property and equipment, gross   5,156,596    3,702,617 
Less: Accumulated depreciation   (1,955,336)   (1,510,280)
Property and equipment, net  $3,201,260   $2,192,337 

 

Depreciation expense for the three months ended June 30, 2023 and 2022 was $254,160 and $98,913, and for the six months ended June 30, 2023 and 2022 was $444,966 and $183,405, respectively. The company recorded a loss on disposal for fixed assets of $11,666 for the three and six months ending June 30, 2023.

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.2
ACCRUED EXPENSES
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
ACCRUED EXPENSES

NOTE 9. ACCRUED EXPENSES

   June 30,   December 31, 
   2023   2022 
Accrued professional and consulting fees  $122,964   $410,711 
Accrued payroll   392,079    6,000 
Accrued warranty reserve   395,071    410,017 
Accrued expenses other   -    138,209 
Total accrued expenses  $910,114   $964,937 

 

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 10. STOCKHOLDERS’ EQUITY

 

Restricted Stock

 

On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 760,668 shares of restricted stock to non-executive directors at a value of $0.75 per share. During the six months ended June 30, 2023 183,897 were vested and an equal number of shares of common stock were issued.

 

On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 442,249 shares of restricted stock to non-executive directors at a value of $1.29 per share. As of December 31, 2022, 110,562 shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2023.

 

On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued 172,000 shares of restricted stock to non-executive directors at a value of $7.66 per share. As of December 31, 2021, 43,000 shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2022.

 

 

Series H Convertible Preferred Stock

 

      
Number of Series H Preferred Stock outstanding as of June 30, 2023   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   7 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $5 

 

Series H-3 Convertible Preferred Stock

 

      
Number of Series H-3 Preferred Stock outstanding as of June 30, 2023   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $699 

 

Series H-6 Convertible Preferred Stock

 

      
Number of Series H-6 Preferred Stock outstanding as of June 30, 2023   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $979 

 

Warrants

 

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

           Weighted Average 
   Shares Underlying   Weighted Average   Remaining Contractual Term 
   Warrants   Exercise Price   (in years) 
Outstanding at December 31, 2022   6,106,023   $7.30    1.32 
Granted   -    -      
Exercised   -    -      
Expired   (136,428)   9.60      
Outstanding at June 30, 2023   5,969,595   $7.25    0.84 

 

 

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

NOTE 11. STOCK-BASED COMPENSATION

 

AYRO 2020 Long Term Incentive Plan

 

The Company has reserved a total of 4,089,650 shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has 443,732 stock options, restricted stock and warrants remaining under this plan as of June 30, 2023.

 

Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Research and development  $5,034   $(6,904)  $11,798   $9,800 
Sales and marketing   (435)   870    5,489    13,815 
General and administrative   237,532    309,587    491,582    568,048 
Total  $242,131   $303,553   $508,869   $591,663 

 

Options

 

The following table reflects a summary of stock option activity:

 

      Weighted Average   Contractual Life 
   Number of Shares   Exercise Price   (Years) 
Outstanding at December 31, 2022   777,922   $6.15    7.56 
Forfeitures   (45,500)   0.97      
Outstanding at June 30, 2023   732,422   $6.47    7.10 

 

Of the outstanding options, 654,937 were vested and exercisable as of June 30, 2023. At June 30, 2023 the aggregate intrinsic value of stock options vested and exercisable was $0.

 

The Company recognized $11,417 and $(6,298) of stock option expense for the three months ended June 30, 2023 and 2022, and $31,533 and $26,078 for the six months ended June 30, 2023 and June 30, 2022, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of June 30, 2023 was $69,823 and will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.

 

Restricted Stock

 SCHEDULE OF RESTRICTED STOCK ACTIVITY

       Weighted 
   Number of   Average Grant 
   Shares   Price 
Outstanding at December 31, 2022   660,562   $1.91 
Granted   760,668    0.75 
Vested   (300,728)   0.95 
Outstanding at June 30, 2023   1,120,502   $1.38 

 

 

On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted 760,668 shares of restricted stock to non-executive directors at a value of $0.75 per share. There are 6,269 vested and unissued shares of restricted stock awards as of June 30, 2023. As of June 30, 2023 570,502 shares of restricted stock remain unvested and unissued.

 

The Company recognized compensation expense related to all restricted stock during the three months ended June 30, 2023, and 2022 of $230,713 and $309,850 and for the six months ended June 30, 2023 and 2022 $477,335 and $565,585, respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of June 30, 2023, was $428,473.

 

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS AND CREDIT RISK
6 Months Ended
Jun. 30, 2023
Risks and Uncertainties [Abstract]  
CONCENTRATIONS AND CREDIT RISK

NOTE 12. CONCENTRATIONS AND CREDIT RISK

 

Revenues

 

One customer accounted for approximately 46% of the Company’s revenues for the three months ended June 30, 2023 and another customer accounted for 35%. Club Car accounted for approximately 89% and another customer 10% of the Company’s revenues for the three months ended June 30, 2022. Three customers accounted for approximately 42%, 25%, and 20% of the Company’s revenues for the six months ended June 30, 2023, respectively. Club Car accounted for approximately 95% of the Company’s revenues for the six months ended June 30, 2022. We do not expect Club Car to remain a customer going forward.

 

Accounts Receivable

 

As of June 30, 2023, two customers accounted for 61% and 39%, respectively, of the Company’s net accounts receivable. As of December 31, 2022, Club Car accounted for 100% of the Company’s net accounts receivable.

 

Purchasing

 

The Company places orders with various suppliers. No suppliers accounted for more than 10% of the Company’s raw materials purchased for the three months ended June 30, 2023. During the six months ended June 30, 2023, two suppliers accounted for more than 10% of the Company’s raw materials, one supplier accounted for 15% the other 13%. During the six months ended June 30, 2022, two suppliers accounted for accounted for more than 10% of the Company’s raw materials. One supplier accounted for 61% and the other 13%. The Company’s purchases of raw materials from one supplier was approximately 43% and 9% of its total purchases of raw materials for the three months ended June 30, 2022.

 

 

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 13. COMMITMENTS AND CONTINGENCIES

 

Manufacturing Agreements

 

On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.

 

In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $750,000, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.

 

Supply Chain Agreements

 

In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Cenntro was previously a significant stockholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract.

 

As of December 31, 2021, the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $602,016. As of December 31, 2022, the balance was zero. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $621,097. Additionally, all inventory associated with Cenntro’s lithium-ion line NCM line was written off to cost of goods sold for $1,317,289.

 

The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.

 

Litigation

 

The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.

 

On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (non-exempt worker whose workday is longer than ten hours must receive an extra hour of pay at the basic minimum hourly rate). Management believes the case has no merit.

 

DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $476,280 in expense for such additional sales tax and interest and paid as of December 31, 2022.

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 14. SUBSEQUENT EVENTS

 

On June 15, 2023, a certain lease agreement commenced for the purpose of expanding AYRO operations into Florida. The agreement called for the leased premises to provide general systems and equipment to be available in working order. The said premises ultimately failed to meet the working order provision, and all parties agreed to terminate the said lease. Thus, the lease for the Florida expansion premises was terminated on July 28, 2023, amicably, by all parties. Remaining obligations for this lease are de minimis.

 

On August 7, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the Investors, pursuant to which it agreed to sell to the Investors (i) an aggregate of 22,000 shares of Series H-7 Preferred Stock, initially convertible into up to 22,000,000 shares of the Company’s common stock at a conversion price of $1.00 per share, and (ii) warrants to acquire up to an aggregate of 22,000,000 shares of common stock at an exercise price of $1.00 per share (the “Warrants, and such transactions collectively, the “Private Placement”).

 

The closing of the Private Placement occurred on August 10, 2023. The aggregate gross proceeds from the Private Placement were approximately $22 million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes.

 

The Purchase Agreement contains certain representations and warranties, covenants, and indemnities customary for similar transactions. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties.

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

The unaudited condensed consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and in conformity with the instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”).

 

The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 23, 2023, as amended on May 1, 2023.

 

 

Use of Estimates

Use of Estimates

 

The preparation of the unaudited condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.

 

The Company’s most significant estimates include marketable securities, revenue recognition, and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.

 

Marketable Securities

Marketable Securities

 

Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $19,464,015 and $9,848,804 in marketable securities as of June 30, 2023 and December 31, 2022, respectively.

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.

 

To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.

 

Nature of goods and services

 

The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:

 

Product revenue

 

Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.

 

Shipping revenue

 

Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $20,768 and $145,496 for the three months ended June 30, 2023, and 2022 and $41,334 and $256,045 for the six months ended June 30, 2023 and 2022 respectively, included in General and Administrative Expenses.

 

Services and other revenue

 

Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.

 

Miscellaneous income

 

Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent, and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.

 

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.

 

The Company estimates the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.

 

Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.

 

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share

 

Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share is the same for periods with a net loss.

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

 

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Options to purchase common stock   732,422    788,546    732,422    788,546 
Restricted stock unvested   1,120,502    781,686    1,120,502    781,686 
Restricted stock vested - unissued   6,269    -    6,269    - 
Warrants outstanding   5,969,595    6,106,023    5,969,595    6,106,023 
Preferred stock outstanding   2,475    2,475    2,475    2,475 
Total   7,831,263    7,678,730    7,831,263    7,678,730 

 

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Options to purchase common stock   732,422    788,546    732,422    788,546 
Restricted stock unvested   1,120,502    781,686    1,120,502    781,686 
Restricted stock vested - unissued   6,269    -    6,269    - 
Warrants outstanding   5,969,595    6,106,023    5,969,595    6,106,023 
Preferred stock outstanding   2,475    2,475    2,475    2,475 
Total   7,831,263    7,678,730    7,831,263    7,678,730 
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES (Tables)
6 Months Ended
Jun. 30, 2023
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

Revenue by type was as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Revenue type                    
Product revenue  $127,106   $918,808   $247,388   $1,838,150 
Shipping revenue   12,438    22,752    (4,150)   130,255 
Miscellaneous income   -    40,000    9,390    40,000 
Total Revenue  $139,544   $981,560   $252,628   $2,008,405 
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.2
ACCOUNTS RECEIVABLE, NET (Tables)
6 Months Ended
Jun. 30, 2023
Credit Loss [Abstract]  
SCHEDULE OF ACCOUNTS RECEIVABLE

Accounts receivable, net, consists of amounts due from invoiced customers and product deliveries and were as follows:

 

   June 30,   December 31, 
   2023   2022 
Trade receivables  $104,155   $512,420 
Less: Allowance for doubtful accounts   -    (2,349)
Accounts receivable, net  $104,155   $510,071 
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.2
INVENTORY (Tables)
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

Inventory consisted of the following:

 

   June 30,   December 31, 
   2023   2022 
Raw materials  $2,481,859   $330,931 
Work-in-progress   -    - 
Finished goods   568,113    639,450 
Total  $3,049,972   $970,381 
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.2
PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)
6 Months Ended
Jun. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

 SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

   June 30,   December 31, 
   2023   2022 
Prepayments for inventory  $2,603,057   $1,174,466 
Prepayments for insurance   274,724    118,434 
Prepayments on advances on design   101,815    75,000 
Prepayments on software   190,333    103,851 
Prepaid other   99,902    7,094 
Total Prepaid Expenses and Other Current Assets  $3,269,831   $1,478,845 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.2
PROPERTY AND EQUIPMENT, NET (Tables)
6 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT, NET

Property and equipment consisted of the following:

 SCHEDULE OF PROPERTY AND EQUIPMENT, NET

   June 30,   December 31, 
   2023   2022 
Computer and equipment  $3,211,535   $1,970,001 
Furniture and fixtures   395,705    323,789 
Lease improvements   1,093,481    952,952 
Computer software   455,875    455,875 
Property and equipment, gross   5,156,596    3,702,617 
Less: Accumulated depreciation   (1,955,336)   (1,510,280)
Property and equipment, net  $3,201,260   $2,192,337 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.2
ACCRUED EXPENSES (Tables)
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
SCHEDULE OF ACCRUED EXPENSES

   June 30,   December 31, 
   2023   2022 
Accrued professional and consulting fees  $122,964   $410,711 
Accrued payroll   392,079    6,000 
Accrued warranty reserve   395,071    410,017 
Accrued expenses other   -    138,209 
Total accrued expenses  $910,114   $964,937 
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
Class of Stock [Line Items]  
SCHEDULE OF WARRANT ACTIVITY

A summary of the Company’s warrants to purchase common stock activity is as follows:

 

           Weighted Average 
   Shares Underlying   Weighted Average   Remaining Contractual Term 
   Warrants   Exercise Price   (in years) 
Outstanding at December 31, 2022   6,106,023   $7.30    1.32 
Granted   -    -      
Exercised   -    -      
Expired   (136,428)   9.60      
Outstanding at June 30, 2023   5,969,595   $7.25    0.84 
Convertible Preferred Stock Series H [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK

 

      
Number of Series H Preferred Stock outstanding as of June 30, 2023   8 
Multiplied by the stated value  $154 
Equals the gross stated value  $1,232 
Divided by the conversion price  $184.8 
Equals the convertible shares of Company Common Stock   7 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $5 
Convertible Preferred Stock Series H-3 [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK

 

      
Number of Series H-3 Preferred Stock outstanding as of June 30, 2023   1,234 
Multiplied by the stated value  $138 
Equals the gross stated value  $170,292 
Divided by the conversion price  $165.6 
Equals the convertible shares of Company Common Stock   1,028 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $699 
Convertible Preferred Stock Series H-6 [Member]  
Class of Stock [Line Items]  
SCHEDULE OF PAYMENT OF PREFERRED STOCK

 

      
Number of Series H-6 Preferred Stock outstanding as of June 30, 2023   50 
Multiplied by the stated value  $72 
Equals the gross stated value  $3,600 
Divided by the conversion price  $2.5 
Equals the convertible shares of Company Common Stock   1,440 
Multiplied by the fair market value of Company Common Stock as of June 30, 2023  $0.68 
Equals the payment  $979 
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK-BASED COMPENSATION

Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Research and development  $5,034   $(6,904)  $11,798   $9,800 
Sales and marketing   (435)   870    5,489    13,815 
General and administrative   237,532    309,587    491,582    568,048 
Total  $242,131   $303,553   $508,869   $591,663 
SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY

The following table reflects a summary of stock option activity:

 

      Weighted Average   Contractual Life 
   Number of Shares   Exercise Price   (Years) 
Outstanding at December 31, 2022   777,922   $6.15    7.56 
Forfeitures   (45,500)   0.97      
Outstanding at June 30, 2023   732,422   $6.47    7.10 
SCHEDULE OF RESTRICTED STOCK ACTIVITY

 SCHEDULE OF RESTRICTED STOCK ACTIVITY

       Weighted 
   Number of   Average Grant 
   Shares   Price 
Outstanding at December 31, 2022   660,562   $1.91 
Granted   760,668    0.75 
Vested   (300,728)   0.95 
Outstanding at June 30, 2023   1,120,502   $1.38 
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.2
LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 10, 2023
Aug. 07, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Net losses     $ 6,003,233 $ 5,475,769 $ 5,974,448 $ 4,578,660 $ 11,479,002 $ 10,553,108  
Net cash provided by (used in) operating activities             14,893,479 $ 9,831,514  
Cash and cash equivalents, at carrying value     13,569,265       13,569,265   $ 39,096,562
Marketable securities, current     19,464,015       19,464,015   $ 9,848,804
Working capital     $ 12,013,869       $ 12,013,869    
Securities Purchase Agreement [Member] | Investor [Member] | Subsequent Event [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Stock Issued During Period, Shares, New Issues   22,000              
Stock Issued During Period, Value, New Issues   $ 1,000              
Proceeds from Issuance of Common Stock $ 22,000,000                
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 7,831,263 7,678,730 7,831,263 7,678,730
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 732,422 788,546 732,422 788,546
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 1,120,502 781,686 1,120,502 781,686
Restricted Stock Unissued [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 6,269 6,269
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 5,969,595 6,106,023 5,969,595 6,106,023
Preferred Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 2,475 2,475 2,475 2,475
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Product Information [Line Items]          
Marketable securities $ 19,464,015   $ 19,464,015   $ 9,848,804
General and administrative expense 3,247,731 $ 2,741,700 6,091,047 $ 5,446,627  
Shipping and Handling [Member]          
Product Information [Line Items]          
General and administrative expense $ 20,768 $ 145,496 $ 41,334 $ 256,045  
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Total Revenue $ 139,544 $ 981,560 $ 252,628 $ 2,008,405
Product [Member]        
Disaggregation of Revenue [Line Items]        
Total Revenue 127,106 918,808 247,388 1,838,150
Shipping and Handling [Member]        
Disaggregation of Revenue [Line Items]        
Total Revenue 12,438 22,752 (4,150) 130,255
Miscellaneous Income [Member]        
Disaggregation of Revenue [Line Items]        
Total Revenue $ 40,000 $ 9,390 $ 40,000
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES (Details Narrative) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]    
Warranty reserves $ 395,071 $ 410,017
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Credit Loss [Abstract]    
Trade receivables $ 104,155 $ 512,420
Less: Allowance for doubtful accounts (2,349)
Accounts receivable, net $ 104,155 $ 510,071
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.2
ACCOUNTS RECEIVABLE, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Credit Loss [Abstract]      
Changes in allowance for doubtful accounts receivable   $ 2,349  
Bad debt expense   $ 292,010 $ 2,069
Bed debt expense $ 2,069   $ 2,069
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF INVENTORY (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 2,481,859 $ 330,931
Work-in-progress
Finished goods 568,113 639,450
Total $ 3,049,972 $ 970,381
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.2
INVENTORY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Inventory [Line Items]        
Depreciation for fleet inventory $ 254,160 $ 98,913 $ 444,966 $ 183,405
Fleet Inventory [Member]        
Inventory [Line Items]        
Depreciation for fleet inventory $ 0 $ 23,883 $ 0 $ 47,775
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepayments for inventory $ 2,603,057 $ 1,174,466
Prepayments for insurance 274,724 118,434
Prepayments on advances on design 101,815 75,000
Prepayments on software 190,333 103,851
Prepaid other 99,902 7,094
Total Prepaid Expenses and Other Current Assets $ 3,269,831 $ 1,478,845
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 5,156,596 $ 3,702,617
Less: Accumulated depreciation (1,955,336) (1,510,280)
Property and equipment, net 3,201,260 2,192,337
Computer and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 3,211,535 1,970,001
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 395,705 323,789
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 1,093,481 952,952
Computer Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 455,875 $ 455,875
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.2
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 254,160 $ 98,913 $ 444,966 $ 183,405
Loss on disposal fixed assets $ 11,666   $ 11,666  
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued professional and consulting fees $ 122,964 $ 410,711
Accrued payroll 392,079 6,000
Accrued warranty reserve 395,071 410,017
Accrued expenses other 138,209
Total accrued expenses $ 910,114 $ 964,937
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Convertible Preferred Stock Series H [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of June 30, 2023 8 8
Multiplied by the stated value $ 154  
Equals the gross stated value $ 1,232  
Divided by the conversion price $ 184.8  
Equals the convertible shares of Company Common Stock 7  
Multiplied by the fair market value of Company Common Stock as of June 30, 2023 $ 0.68  
Equals the payment $ 5  
Convertible Preferred Stock Series H-3 [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of June 30, 2023 1,234 1,234
Multiplied by the stated value $ 138  
Equals the gross stated value $ 170,292  
Divided by the conversion price $ 165.6  
Equals the convertible shares of Company Common Stock 1,028  
Multiplied by the fair market value of Company Common Stock as of June 30, 2023 $ 0.68  
Equals the payment $ 699  
Convertible Preferred Stock Series H-6 [Member]    
Class of Stock [Line Items]    
Number of Series H Preferred Stock outstanding as of June 30, 2023 50 50
Multiplied by the stated value $ 72  
Equals the gross stated value $ 3,600  
Divided by the conversion price $ 2.5  
Equals the convertible shares of Company Common Stock 1,440  
Multiplied by the fair market value of Company Common Stock as of June 30, 2023 $ 0.68  
Equals the payment $ 979  
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF WARRANT ACTIVITY (Details)
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Equity [Abstract]  
Shares underlying warrants outstanding | shares 6,106,023
Weighted average exercise price outstanding | $ / shares $ 7.30
Weighted average remaining contractual life 1 year 3 months 25 days
Shares underlying warrants granted | shares
Weighted average exercise price granted | $ / shares
Shares underlying warrants exercised | shares
Weighted average exercise price exercised | $ / shares
Shares underlying warrants expired | shares (136,428)
Weighted average exercise price expired | $ / shares $ 9.60
Shares underlying warrants outstanding | shares 5,969,595
Weighted average exercise price outstanding | $ / shares $ 7.25
Weighted average remaining contractual life 10 months 2 days
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.2
STOCKHOLDERS’ EQUITY (Details Narrative) - Non-Executive Directors [Member] - Restricted Stock [Member] - $ / shares
6 Months Ended
Feb. 01, 2023
Feb. 01, 2022
Feb. 24, 2021
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Share price $ 0.75          
Common stock unissued       6,269    
2020 Long-Term Incentive Plan [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Number of restricted stock units 760,668 442,249 172,000      
Share price $ 0.75 $ 1.29 $ 7.66      
Common stock issued and vested       183,897    
Common stock unissued         110,562 43,000
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF STOCK-BASED COMPENSATION (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total $ 242,131 $ 303,553 $ 508,869 $ 591,663
Research and Development [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total 5,034 (6,904) 11,798 9,800
Sales and Marketing [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total (435) 870 5,489 13,815
General and Administrative [Member]        
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]        
Total $ 237,532 $ 309,587 $ 491,582 $ 568,048
XML 57 R48.htm IDEA: XBRL DOCUMENT v3.23.2
SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) - Common Stock [Member] - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Number of stock options outstanding, beginning balance 777,922  
Weighted average exercise price outstanding, beginning balance $ 6.15  
Weighted average remaining contractual life (years) 7 years 1 month 6 days 7 years 6 months 21 days
Number of stock options, forfeitures (45,500)  
Weighted average exercise price, forfeitures $ 0.97  
Number of stock options outstanding, ending balance 732,422 777,922
Weighted average exercise price outstanding, ending balance $ 6.47 $ 6.15
XML 58 R49.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) - Restricted Stock [Member]
6 Months Ended
Jun. 30, 2023
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of shares, outstanding, beginning balance | shares 660,562
Weighted average grant price, outstanding, beginning balance | $ / shares $ 1.91
Number of shares, granted | shares 760,668
Weighted average grant price, granted | $ / shares $ 0.75
Number of shares, vested | shares (300,728)
Weighted average grant price, vested | $ / shares $ 0.95
Number of shares, outstanding, ending balance | shares 1,120,502
Weighted average grant price, outstanding, ending balance | $ / shares $ 1.38
XML 59 R50.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Feb. 01, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Share-based Compensation   $ 242,131 $ 303,553 $ 508,869 $ 591,663
Stock compensation expense       $ 508,869 591,663
Share-Based Payment Arrangement, Option [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of stock options vested       654,937  
Number of stock options exercisable   654,937   654,937  
Aggregate intrinsic value of stock options vested       $ 0  
Aggregate intrinsic value of stock options exercisable   $ 0   0  
Share-based Compensation   11,417 (6,298) 31,533 26,078
Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount   69,823   $ 69,823  
Restricted Stock [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares granted       760,668  
Stock compensation expense   230,713 $ 309,850 $ 477,335 $ 565,585
Unrecognized compensation expense   $ 428,473   $ 428,473  
Restricted Stock [Member] | Non-Executive Directors [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares granted 760,668        
Share price $ 0.75        
Common stock unissued   6,269   6,269  
Restricted Stock [Member] | Non-Executive Directors [Member] | Common Stock [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Common stock unissued   570,502   570,502  
2020 Long Term Incentive Plan [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares reserved   4,089,650   4,089,650  
2020 Long Term Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares available for grants   443,732   443,732  
2020 Long Term Incentive Plan [Member] | Restricted Stock [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares available for grants   443,732   443,732  
2020 Long Term Incentive Plan [Member] | Warrant [Member]          
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]          
Number of shares available for grants   443,732   443,732  
XML 60 R51.htm IDEA: XBRL DOCUMENT v3.23.2
CONCENTRATIONS AND CREDIT RISK (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 46.00% 89.00% 42.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage 35.00%     95.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage   10.00% 25.00%    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Three [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     20.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     61.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage         100.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     39.00%    
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     10.00%    
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier one [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     15.00% 61.00%  
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier Two [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage     13.00% 13.00%  
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Supplier One [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage   43.00%      
Cost of Goods and Service, Product and Service Benchmark [Member] | Supplier Concentration Risk [Member] | Two Supplier [Member]          
Concentration Risk [Line Items]          
Concentration risk percentage   9.00%      
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.23.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Termination fee     $ 750,000      
Accrued expenses $ 910,114   910,114   $ 964,937  
Cost of goods sold $ 332,027 $ 2,827,512 551,820 $ 4,004,657    
Cenntro Automotive Group Ltd [Member]            
Prepaid expenses         0 $ 602,016
Accrued expenses         $ 0 602,016
Cost of goods sold     621,097      
Inventory written-off     $ 1,317,289      
DropCar Operating, Inc. [Member]            
Accrued expense           $ 476,280
XML 62 R53.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
Aug. 10, 2023
Aug. 07, 2023
Jun. 30, 2023
Dec. 31, 2022
Subsequent Event [Line Items]        
Preferred Stock, Shares Authorized     20,000,000 20,000,000
Class of Warrant or Right, Outstanding     5,969,595 6,106,023
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 7.25 $ 7.30
Subsequent Event [Member]        
Subsequent Event [Line Items]        
Gross proceeds from the private placement $ 22      
Subsequent Event [Member] | Securities Purchase Agreement [Member]        
Subsequent Event [Line Items]        
Stock Issued During Period, Shares, Conversion of Convertible Securities   22,000,000    
Preferred Stock, Convertible, Conversion Price   $ 1.00    
Class of Warrant or Right, Outstanding   22,000,000    
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 1.00    
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Series H 7 Convertible Preferred Stock [Member]        
Subsequent Event [Line Items]        
Preferred Stock, Shares Authorized   22,000    
XML 63 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001086745 2023-01-01 2023-06-30 0001086745 2023-08-11 0001086745 2023-06-30 0001086745 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2022-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2022-12-31 0001086745 2023-04-01 2023-06-30 0001086745 2022-04-01 2022-06-30 0001086745 2022-01-01 2022-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001086745 us-gaap:CommonStockMember 2022-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001086745 us-gaap:RetainedEarningsMember 2022-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-03-31 0001086745 us-gaap:CommonStockMember 2023-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001086745 us-gaap:RetainedEarningsMember 2023-03-31 0001086745 2023-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001086745 us-gaap:CommonStockMember 2021-12-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001086745 us-gaap:RetainedEarningsMember 2021-12-31 0001086745 2021-12-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-03-31 0001086745 us-gaap:CommonStockMember 2022-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001086745 us-gaap:RetainedEarningsMember 2022-03-31 0001086745 2022-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001086745 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001086745 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001086745 2023-01-01 2023-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001086745 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001086745 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001086745 2022-01-01 2022-03-31 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001086745 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2023-06-30 0001086745 us-gaap:CommonStockMember 2023-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001086745 us-gaap:RetainedEarningsMember 2023-06-30 0001086745 us-gaap:SeriesHPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 AYRO:SeriesHThreePreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 AYRO:SeriesHSixPreferredStockMember us-gaap:PreferredStockMember 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-06-30 0001086745 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001086745 us-gaap:RetainedEarningsMember 2022-06-30 0001086745 2022-06-30 0001086745 us-gaap:InvestorMember us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-06 2023-08-07 0001086745 us-gaap:InvestorMember us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-09 2023-08-10 0001086745 us-gaap:ShippingAndHandlingMember 2023-04-01 2023-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2022-04-01 2022-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-06-30 0001086745 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2023-04-01 2023-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2022-04-01 2022-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2023-01-01 2023-06-30 0001086745 AYRO:RestrictedStockUnissuedMember 2022-01-01 2022-06-30 0001086745 us-gaap:WarrantMember 2023-04-01 2023-06-30 0001086745 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001086745 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001086745 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001086745 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:PreferredStockMember 2022-01-01 2022-06-30 0001086745 us-gaap:ProductMember 2023-04-01 2023-06-30 0001086745 us-gaap:ProductMember 2022-04-01 2022-06-30 0001086745 us-gaap:ProductMember 2023-01-01 2023-06-30 0001086745 us-gaap:ProductMember 2022-01-01 2022-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2023-04-01 2023-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2022-04-01 2022-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2023-01-01 2023-06-30 0001086745 AYRO:MiscellaneousIncomeMember 2022-01-01 2022-06-30 0001086745 AYRO:FleetInventoryMember 2023-04-01 2023-06-30 0001086745 AYRO:FleetInventoryMember 2022-04-01 2022-06-30 0001086745 AYRO:FleetInventoryMember 2023-01-01 2023-06-30 0001086745 AYRO:FleetInventoryMember 2022-01-01 2022-06-30 0001086745 AYRO:ComputerAndEquipmentMember 2023-06-30 0001086745 AYRO:ComputerAndEquipmentMember 2022-12-31 0001086745 us-gaap:FurnitureAndFixturesMember 2023-06-30 0001086745 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001086745 us-gaap:LeaseholdImprovementsMember 2023-06-30 0001086745 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001086745 AYRO:ComputerSoftwareMember 2023-06-30 0001086745 AYRO:ComputerSoftwareMember 2022-12-31 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-01-30 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2023-01-01 2023-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-01-30 2022-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2022-12-31 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-23 2021-02-24 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-02-24 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember AYRO:TwoThousandAndTwentyLongTermIncentivePlanMember 2021-12-31 0001086745 AYRO:ConvertiblePreferredStockSeriesHMember 2023-01-01 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHThreeMember 2023-01-01 2023-06-30 0001086745 AYRO:ConvertiblePreferredStockSeriesHSixMember 2023-01-01 2023-06-30 0001086745 AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2023-06-30 0001086745 us-gaap:RestrictedStockMember AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2023-06-30 0001086745 us-gaap:WarrantMember AYRO:TwoThousandTwentyLongTermIncentivePlanMember 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001086745 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-01-30 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-02-01 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember 2023-06-30 0001086745 AYRO:NonExecutiveDirectorsMember us-gaap:RestrictedStockMember us-gaap:CommonStockMember 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0001086745 us-gaap:RestrictedStockMember 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2023-04-01 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2022-04-01 2022-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2023-01-01 2023-06-30 0001086745 AYRO:ResearchAndDevelopmentMember 2022-01-01 2022-06-30 0001086745 AYRO:SalesAndMarketingMember 2023-04-01 2023-06-30 0001086745 AYRO:SalesAndMarketingMember 2022-04-01 2022-06-30 0001086745 AYRO:SalesAndMarketingMember 2023-01-01 2023-06-30 0001086745 AYRO:SalesAndMarketingMember 2022-01-01 2022-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2023-04-01 2023-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2022-04-01 2022-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2023-01-01 2023-06-30 0001086745 AYRO:GeneralAndAdministrativeMember 2022-01-01 2022-06-30 0001086745 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001086745 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001086745 us-gaap:RestrictedStockMember 2022-12-31 0001086745 AYRO:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001086745 AYRO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001086745 AYRO:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 AYRO:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 AYRO:CustomerOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-06-30 0001086745 AYRO:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001086745 AYRO:SupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:SupplierOneMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:SupplierTwoMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2023-01-01 2023-06-30 0001086745 AYRO:SupplierOneMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001086745 AYRO:SupplierTwoMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001086745 AYRO:OneSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 AYRO:TwoSupplierMember us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2021-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2022-12-31 0001086745 AYRO:CenntroAutomotiveGroupLtdMember 2023-01-01 2023-06-30 0001086745 AYRO:DropCarOperatingIncMember 2021-12-31 0001086745 AYRO:SeriesHSevenConvertiblePreferredStockMember us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-07 0001086745 us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-07 2023-08-07 0001086745 us-gaap:SubsequentEventMember AYRO:SecuritiesPurchaseAgreementMember 2023-08-07 0001086745 us-gaap:SubsequentEventMember 2023-08-10 2023-08-10 iso4217:USD shares iso4217:USD shares pure AYRO:Integer 0001086745 false Q2 --12-31 10-Q true 2023-06-30 2023 false 001-34643 AYRO, INC. DE 98-0204758 900 E. Old Settlers Boulevard Suite 100 Round Rock TX 78664 (512) 994-4917 Common Stock, par value $0.0001 per share AYRO NASDAQ Yes Yes Non-accelerated Filer true false false 37732530 13569265 39096562 19464015 9848804 104155 510071 3049972 970381 3269831 1478845 39457238 51904663 3201260 2192337 750877 819401 84595 73683 43493970 54990084 716236 1107215 910114 964937 178013 165767 1804363 2237919 601349 693776 2405712 2931695 20000000 20000000 0.0001 0.0001 8500 8500 8 8 8 8 0.0001 0.0001 8461 8461 1234 1234 1234 1234 0.0001 50000 50 0.0001 0.0001 100000000 100000000 37536101 37536101 37241642 37241642 3753 3724 133733091 133224249 -92648586 -81169584 41088258 52058389 43493970 54990084 139544 981560 252628 2008405 332027 2827512 551820 4004657 -192483 -1845952 -299192 -1996252 2405398 1046797 4535388 1912204 420861 337226 1138953 1182042 3247731 2741700 6091047 5446627 6073990 4125723 11765388 8540873 -6266473 -5971675 -12064580 -10537125 -9166 10706 52532 19597 117278 261638 146935 -13479 198215 -35580 8193 73193 263240 -2773 585578 -15983 -6003233 -5974448 -11479002 -10553108 -0.16 -0.16 -0.16 -0.16 -0.31 -0.31 -0.29 -0.29 -0.16 -0.16 -0.16 -0.16 -0.31 -0.31 -0.29 -0.29 37476845 37476845 36982436 36982436 37398555 37398555 36945240 36945240 37476845 37476845 36982436 36982436 37398555 37398555 36945240 36945240 8 1234 50 37241642 3724 133224249 -81169584 52058389 20116 20116 110562 11 246614 246625 -5475769 -5475769 8 1234 50 37352204 3735 133490979 -86645353 46849361 11417 11417 183897 18 230695 230713 -6003233 -6003233 8 1234 50 37536101 3753 133733091 -92648586 41088258 8 1234 50 36866956 3687 131654776 -58234231 73424232 8 1234 50 36866956 3687 131654776 -58234231 73424232 288110 288110 43000 4 329377 329381 -4578660 -4578660 8 1234 50 36909956 3691 132272263 -62812891 69463063 8 1234 50 36909956 3691 132272263 -62812891 69463063 303553 303553 110562 11 -11 110562 11 -11 -5974448 -5974448 8 1234 50 37020518 3702 132575805 -68787339 63792168 8 1234 50 37020518 3702 132575805 -68787339 63792168 -11479002 -10553108 452848 257791 -11666 508869 591663 81524 118092 292010 2069 198215 -35580 73193 1938386 -113906 955609 2079590 -325282 1790987 785762 -405979 164809 -234155 -838304 -93181 -132403 -14893479 -9831514 1271311 414197 9343804 18006486 18703 17500 -10633818 -18438183 -25527297 -28269697 39096562 69160466 13569265 40890769 194335 329381 <p id="xdx_804_eus-gaap--NatureOfOperations_z5dcXVW6wCu2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_828_zppICfbn2e5i">ORGANIZATION AND NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AYRO, Inc. (“AYRO” or the “Company”), a Delaware corporation formerly known as DropCar, Inc. (“DropCar”), a corporation headquartered outside Austin, Texas, is the merger successor discussed below of AYRO Operating Company, Inc. (“AYRO Operating”), which was formed under the laws of the State of Texas on May 17, 2016 as Austin PRT Vehicle, Inc. and subsequently changed its name to Austin EV, Inc. under an Amended and Restated Certificate of Formation filed with the State of Texas on March 9, 2017. On July 24, 2019, the Company changed its name to AYRO, Inc. and converted its corporate domicile to Delaware. The Company was founded on the basis of promoting resource sustainability. The Company, and its wholly owned subsidiaries, are principally engaged in manufacturing and sales of environmentally conscious, minimal-footprint electric vehicles. The all-electric vehicles are typically sold both directly to customers and to dealers in the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i>Strategic Review</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the hiring of the Company’s current Chief Executive Officer in the third quarter of 2021, AYRO initiated a strategic review of its product development strategy, as AYRO focused on creating value within the electric vehicle, last-mile delivery, smart payload and enabling infrastructure markets. In connection with the strategic review by the Company, AYRO cancelled development of its planned next-generation three-wheeled high-speed vehicle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the past several years, AYRO’s primary supplier has been Cenntro Automotive Group, Ltd. (“Cenntro”), which operates a large electric vehicle factory in the automotive district in Hangzhou, China. As a result of rising shipping costs, quality issues with certain components and persistent delays, the Company ceased production of the AYRO 411x from Cenntro in September 2022 in order to focus its resources on the development and launch of the new 411 fleet vehicle model year 2023 refresh (the “Vanish”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December of 2021 the Company began research and development on the Vanish, including updates on its supply chain evolution, offshoring/onshoring mix, manufacturing strategy, and annual model year refresh program.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_806_ecustom--LiquidityAndOtherUncertainitiesTextBlock_zajuw0a3MbFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2. <span id="xdx_824_zHO9Ylt6IPNi">LIQUIDITY AND OTHER UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity and Other Uncertainties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”), which contemplates continuation of the Company as a going concern. The Company is subject to a number of risks similar to those of earlier stage commercial companies, including dependence on key individuals and products, the difficulties inherent in the development of a commercial market, the potential need to obtain additional capital, competition from larger companies, other technology companies and other technologies. The Company has a limited operating history and the sales and income potential of its business and market are unproven. The Company incurred net losses of $<span id="xdx_901_eus-gaap--NetIncomeLoss_iN_di_c20230101__20230630_z7Z58guryca3" title="Net losses">11,479,002</span> for the six months ended June 30, 2023, and negative cash flows from operations of $<span id="xdx_90D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20230101__20230630_zGBwbklrn4nj" title="Net cash provided by (used in) operating activities">14,893,479</span> for the six months ended June 30, 2023. On June 30, 2023, the Company had cash balances totaling $<span id="xdx_901_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20230630_zy0gaFSbEoX5" title="Cash and cash equivalents, at carrying value">13,569,265</span> and marketable securities of $<span id="xdx_907_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630_z5jBbEWMGiXk" title="Marketable securities, current">19,464,015</span>. In addition, overall working capital decreased by $<span id="xdx_903_ecustom--WorkingCapital_iI_c20230630_zrycEYSfjHGi" title="Working capital">12,013,869</span> during the six months ended June 30, 2023. Management believes that the existing cash as of June 30, 2023, will be sufficient to fund operations for at least the next twelve months following the issuance of these unaudited condensed consolidated financial statements. Additionally, on August 7, 2023, the Company entered into a Securities Purchase Agreement to which it agreed to sell to certain existing investors (the “Investors”) an aggregate of <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230806__20230807__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zvmpUUl4Pzkd">22,000</span> shares of the Company’s newly designated Series H-7 convertible preferred stock with a stated value of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230806__20230807__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUmtBumzjeaj">1,000</span> per share (“Series H-7 Preferred Stock”). The Company raised approximately $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfCommonStock_pn6n6_c20230809__20230810__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--TitleOfIndividualAxis__us-gaap--InvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUpRXdR1W6vh">22</span> million from the sale, which closed on August 10, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may experience increases in the cost or a sustained interruption in the supply or shortage of raw materials, including lithium-ion battery cells, semiconductors, and integrated circuits. Any such increase or supply interruption could materially and negatively impact the business, prospects, financial condition, and operating results. Currently, the Company is experiencing supply chain shortages, including with respect to lithium-ion battery cells, integrated circuits, vehicle control chips, and displays. Certain production-ready components may be delayed in shipment to Company facilities which has and may continue to cause delays in validation and testing for these components, which would in turn create a delay in the availability of saleable vehicles.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various raw materials, including aluminum, steel, carbon fiber, non-ferrous metals (such as copper), and cobalt. The prices for these raw materials fluctuate depending on market conditions, and global demand and could adversely affect business and operating results. For instance, the Company is exposed to multiple risks relating to price fluctuations for lithium-ion cells. These risks include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the inability or unwillingness of current battery manufacturers to build or operate battery cell manufacturing plants to supply the numbers of lithium-ion cells required to support the growth of the electric vehicle industry as demand for such cells increases;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption in the supply of cells due to quality issues or recalls by the battery cell manufacturers; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an increase in the cost of raw materials, such as cobalt, used in lithium-ion cells.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any disruption in the supply of lithium-ion battery cells, semiconductors, or integrated circuits could temporarily disrupt production of the Company’s vehicles until a different supplier is fully qualified. Moreover, battery cell manufacturers may refuse to supply electric vehicle manufacturers if they determine that the vehicles are not sufficiently safe. Furthermore, fluctuations or shortages in petroleum and other economic conditions may cause the Company to experience significant increases in freight charges and raw material costs. Substantial increases in the prices for our raw materials would increase operating costs and could reduce our margins if the increased costs cannot be recouped through increased electric vehicle prices. There can be no assurance that the Company will be able to recoup the increasing costs of raw materials by increasing vehicle prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have made certain indemnities, under which we may be required to make payments to an indemnified party, in relation to certain transactions. We indemnify our directors and officers to the maximum extent permitted under the laws of the State of Delaware. In connection with our facility leases, we have indemnified our lessors for certain claims arising from the use of the facilities. The duration of the indemnities vary and, in many cases, are indefinite. These indemnities do not provide for any limitation of the maximum potential future payments we could be obligated to make. Historically, we have not been obligated to make any payments for these obligations and no liabilities have been recorded for these indemnities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 3, 2022, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30 consecutive business day period between August 19, 2022 and September 30, 2022, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The letter also indicated that the Company will be provided with a compliance period of 180 calendar days, or until April 3, 2023 (the “Initial Compliance Period”), in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 4, 2023, the Company received a letter from Nasdaq notifying the Company that the Company has been granted an additional 180-day period, or until October 2, 2023, to regain compliance with the Minimum Bid Price Requirement. The new compliance period is an extension of the Initial Compliance Period provided for in Nasdaq’s deficiency notice to the Company dated October 3, 2022. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Management’s plan to regain compliance with the Minimum Bid Price Requirement is to seek stockholder approval for, and to file, an amendment to the Company’s amended and restated certificate of incorporation (“Certificate of Incorporation”) to effect a reverse stock split of the Company’s common stock at a ratio of 1-for-2 to 1-for-10 with the exact ratio within such range to be determined by the Company’s board of directors at its discretion (the “Reverse Stock Split Amendment”). On August 8, 2023, the Company filed a preliminary proxy statement in connection with a special meeting of the Company’s stockholders to be held on September 14, 2023 for the purpose of approving, among other things, the Reverse Stock Split Amendment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If compliance with the Minimum Bid Price Requirement cannot be demonstrated by October 2, 2023, Nasdaq will provide written notification that the Company’s common stock could be delisted. In such an event, Nasdaq rules permit the Company to appeal any delisting determination to a Nasdaq Hearings Panel. Accordingly, there can be no assurance that the Company will be able to regain compliance with the Nasdaq listing rules or maintain its listing on Nasdaq.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -11479002 -14893479 13569265 19464015 12013869 22000 1000 22000000 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zJB43Cz9iRjf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3. <span id="xdx_82A_z6D3l7zO6x4b">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_z1dSgurHNBmi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zmLHLyvA6iMd">Basis of Presentation and Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and in conformity with the instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 23, 2023, as amended on May 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--UseOfEstimates_zoAAwz5rdXL3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zMqeVMkZtfR9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s most significant estimates include marketable securities, revenue recognition, and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zaP62YLOOubb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z6vHUtsVk0Vh">Marketable Securities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $<span id="xdx_900_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630_z4LeRWImFRK2" title="Marketable securities">19,464,015</span> and $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zf1H5F3EgSP9" title="Marketable securities">9,848,804</span> in marketable securities as of June 30, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zCE6mLgHvgX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zEy35kTLfRkf">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, <i>Revenue from Contracts with Customers</i>, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of goods and services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $<span id="xdx_90D_eus-gaap--GeneralAndAdministrativeExpense_c20230401__20230630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zXBTlI0M2hPh" title="Shipping expenses">20,768</span> and $<span id="xdx_90B_eus-gaap--GeneralAndAdministrativeExpense_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zQgtw9kxFmX8" title="Shipping expenses">145,496</span> for the three months ended June 30, 2023, and 2022 and $<span id="xdx_908_eus-gaap--GeneralAndAdministrativeExpense_c20230101__20230630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zkZCighR9LKf" title="Shipping expenses">41,334</span> and $<span id="xdx_90A_eus-gaap--GeneralAndAdministrativeExpense_c20220101__20220630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zOsihfI2yv32" title="General and administrative expense">256,045</span> for the six months ended June 30, 2023 and 2022 respectively, included in General and Administrative Expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services and other revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Miscellaneous income</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent, and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYgVtKSHWss5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_863_zdiMplrRgYog">Stock-Based Compensation</span></i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zdPnlz5LMiM6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z5pY25jBAfWg">Basic and Diluted Loss Per Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zG6ksFVOW0Oi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zRWGagGWv7X4" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230401__20230630_zRpK3AoCknO6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20220401__20220630_zJqZuaCol3vk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20230101__20230630_zcZNUXyTYu3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zmIRv7w4cnZb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zpX3n6HIrtIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zQw8VGvHtVQk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted stock unvested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnissuedMember_zIF3EfacFO9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock vested - unissued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9US9gq2x6Cb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zbp92pmVNvee" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Preferred stock outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1OPbssJdzl4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_z8U8VKs0FHuh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_z1dSgurHNBmi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zmLHLyvA6iMd">Basis of Presentation and Principles of Consolidation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and in conformity with the instructions on Form 10-Q and Rule 8-03 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements reflect all adjustments consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of such statements. The results of operations for the three and six months ended June 30, 2023, are not necessarily indicative of the results that may be expected for the entire year. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the accompanying notes for the fiscal year ended December 31, 2022, which are included in the Company’s Annual Report on Form 10-K, filed with the SEC on March 23, 2023, as amended on May 1, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--UseOfEstimates_zoAAwz5rdXL3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zMqeVMkZtfR9">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements, in conformity with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s most significant estimates include marketable securities, revenue recognition, and the measurement of stock-based compensation expenses. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--MarketableSecuritiesPolicy_zaP62YLOOubb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_z6vHUtsVk0Vh">Marketable Securities</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities include investment in fixed income bonds and U.S. Treasury securities that are considered to be highly liquid and easily tradeable. The marketable securities are considered trading securities and are measured at fair value and are accounted for in accordance with ASC 320. The marketable securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company held $<span id="xdx_900_eus-gaap--MarketableSecuritiesCurrent_iI_c20230630_z4LeRWImFRK2" title="Marketable securities">19,464,015</span> and $<span id="xdx_90C_eus-gaap--MarketableSecuritiesCurrent_iI_c20221231_zf1H5F3EgSP9" title="Marketable securities">9,848,804</span> in marketable securities as of June 30, 2023 and December 31, 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 19464015 9848804 <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_zCE6mLgHvgX9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_zEy35kTLfRkf">Revenue Recognition</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC 606, <i>Revenue from Contracts with Customers</i>, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To achieve this core principle, five basic criteria must be met before revenue can be recognized: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to performance obligations in the contract; and (5) recognize revenue when or as the Company satisfies a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of goods and services</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a description of the Company’s products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Product revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product revenue from customer contracts is recognized on the sale of each electric vehicle as vehicles are shipped to customers. The majority of the Company’s vehicle sales orders generally have only one performance obligation: sale and delivery of complete vehicles. Ownership and risk of loss transfers to the customer based on FOB shipping point and freight charges are the responsibility of the customer. Revenue is typically recognized at the point control transfers or in accordance with payment terms customary to the business. The Company provides product warranties to assure that the product assembly complies with agreed upon specifications. The Company’s product warranty is similar in all material respects to the product warranties provided by the Company’s suppliers, therefore minimizing the warranty liability to the standard labor rates associated with the defective part replacement. Customers do not have the option to purchase a warranty separately; as such, warranty is not accounted for as a separate performance obligation. The Company’s policy is to exclude taxes collected from a customer from the transaction price of automotive contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shipping revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts billed to customers related to shipping and handling are classified as shipping revenue. The Company has elected to recognize the cost for freight and shipping when control over vehicles has transferred to the customer as an operating expense. The Company has reported shipping expenses of $<span id="xdx_90D_eus-gaap--GeneralAndAdministrativeExpense_c20230401__20230630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zXBTlI0M2hPh" title="Shipping expenses">20,768</span> and $<span id="xdx_90B_eus-gaap--GeneralAndAdministrativeExpense_c20220401__20220630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zQgtw9kxFmX8" title="Shipping expenses">145,496</span> for the three months ended June 30, 2023, and 2022 and $<span id="xdx_908_eus-gaap--GeneralAndAdministrativeExpense_c20230101__20230630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zkZCighR9LKf" title="Shipping expenses">41,334</span> and $<span id="xdx_90A_eus-gaap--GeneralAndAdministrativeExpense_c20220101__20220630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zOsihfI2yv32" title="General and administrative expense">256,045</span> for the six months ended June 30, 2023 and 2022 respectively, included in General and Administrative Expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Services and other revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services and other revenue consist of non-warranty after-sales vehicle services. Revenue is typically recognized at a point in time when services and replacement parts are provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Miscellaneous income</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Miscellaneous income consists of late fees charged for receivables not paid within the terms of the customer agreement based upon the outstanding customer receivable balance. This revenue is earned when a customer’s receivable balance becomes delinquent, and its collection is reasonably assured and is calculated using a stated late fee rate multiplied by the outstanding balance that is subject to a late fee charge.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 20768 145496 41334 256045 <p id="xdx_843_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zYgVtKSHWss5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><i><span id="xdx_863_zdiMplrRgYog">Stock-Based Compensation</span></i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock-based compensation in accordance with ASC 718, Compensation-Stock Compensation. The Company recognizes all employee and non-employee share-based compensation as an expense in the financial statements on a straight-line basis over the requisite service period, based on the terms of the awards. Equity-classified awards principally related to stock options, restricted stock awards (“RSAs”) and equity-based compensation, are measured at the grant date fair value of the award. The Company determines grant date fair value of stock option awards using the Black-Scholes option-pricing model. The fair value of RSAs is determined using the closing price of the Company’s common stock on the grant date. For service based vesting grants, expense is recognized ratably over the requisite service period based on the number of options or shares. For value-based vesting grants, expense is recognized via straight line expense over the expected period per grant as determined by outside valuation experts. Stock-based compensation is reversed for forfeitures in the period of forfeiture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates the fair value of stock-based and cash unit awards containing a market condition using a Monte Carlo simulation model. Key inputs and assumptions used in the Monte Carlo simulation model include the stock price of the award on the grant date, the expected term, the risk-free interest rate over the expected term, the expected annual dividend yield and the expected stock price volatility. The expected volatility is based on a combination of the historical and implied volatility of the Company’s publicly traded, near-the-money stock options, and the valuation period is based on the vesting period of the awards. The risk-free interest rate is derived from the U.S. Treasury yield curve in effect at the time of grant and, since the Company does not currently pay or plan to pay a dividend on its common stock, the expected dividend yield was zero.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock options and warrants issued as compensation for services provided to the Company are accounted for based upon the fair value of the underlying equity instrument. The attribution of the fair value of the equity instrument is charged directly to compensation expense over the period during which services are rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--EarningsPerSharePolicyTextBlock_zdPnlz5LMiM6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_z5pY25jBAfWg">Basic and Diluted Loss Per Share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net loss per share is determined by dividing net loss by the weighted average ordinary shares outstanding during the period. For all periods presented with a net loss, the shares underlying the ordinary share options and warrants have been excluded from the calculation because their effect would be anti-dilutive. Therefore, the weighted-average shares outstanding used to calculate both basic and diluted loss per share is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zG6ksFVOW0Oi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zRWGagGWv7X4" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230401__20230630_zRpK3AoCknO6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20220401__20220630_zJqZuaCol3vk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20230101__20230630_zcZNUXyTYu3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zmIRv7w4cnZb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zpX3n6HIrtIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zQw8VGvHtVQk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted stock unvested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnissuedMember_zIF3EfacFO9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock vested - unissued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9US9gq2x6Cb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zbp92pmVNvee" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Preferred stock outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1OPbssJdzl4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_z8U8VKs0FHuh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zG6ksFVOW0Oi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zRWGagGWv7X4" style="display: none">SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230401__20230630_zRpK3AoCknO6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49C_20220401__20220630_zJqZuaCol3vk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20230101__20230630_zcZNUXyTYu3j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20220101__20220630_zmIRv7w4cnZb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zpX3n6HIrtIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Options to purchase common stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">732,422</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">788,546</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zQw8VGvHtVQk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Restricted stock unvested</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,120,502</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">781,686</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--RestrictedStockUnissuedMember_zIF3EfacFO9h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Restricted stock vested - unissued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,269</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z9US9gq2x6Cb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,969,595</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,106,023</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zbp92pmVNvee" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Preferred stock outstanding</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,475</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1OPbssJdzl4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,831,263</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,678,730</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 732422 788546 732422 788546 1120502 781686 1120502 781686 6269 6269 5969595 6106023 5969595 6106023 2475 2475 2475 2475 7831263 7678730 7831263 7678730 <p id="xdx_805_eus-gaap--RevenueFromContractWithCustomerTextBlock_z6BHeG7N2zgc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4. <span id="xdx_82B_zg3uCV1etJdk">REVENUES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disaggregation of Revenue</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zzcW2svhHPii" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zi7seBMB1IH1" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_498_20230401__20230630_zO9yvDPe0mh1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20220401__20220630_zX3UwCRjN2yg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230101__20230630_zqpe4Kx6Kn63" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20220101__20220630_zizPSGtEwmC5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenue type</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zG4PerYcqNV2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 36%; text-align: left">Product revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">127,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">918,808</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">247,388</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,838,150</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zBnyyNfBiL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Shipping revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,438</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,752</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,150</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,255</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousIncomeMember_zHQhdE9aWEO2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left">Miscellaneous income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zPtXjRmpXch8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">139,544</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">981,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">252,628</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,008,405</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_znfahZAPqbo1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warranty Reserve</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records a reserve for warranty repairs upon the initial delivery of vehicles to its dealer network. The Company provides a product warranty on each vehicle including powertrain, battery pack and electronics package. Such warranty matches the product warranty provided by its supply chain for warranty parts for all unaltered vehicles and is not considered a separate performance obligation. The supply chain warranty does not cover warranty-based labor needed to replace a part under warranty. Warranty reserves include management’s best estimate of the projected cost of labor to repair/replace all items under warranty. The Company reserves a percentage of all dealer-based sales to cover an industry-standard warranty fund to support dealer labor warranty repairs. Such percentage is recorded as a component of cost of revenues in the statement of operations. As of June 30, 2023, and December 31, 2022, warranty reserves were recorded within accrued expenses of $<span id="xdx_90F_ecustom--WarrantyReserves_iI_pp0p0_c20230630_zVSnngio2ms2" title="Warranty reserves">395,071</span> and $<span id="xdx_904_ecustom--WarrantyReserves_iI_pp0p0_c20221231_zaksMN5SzDLe" title="Warranty reserves">410,017</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--DisaggregationOfRevenueTableTextBlock_zzcW2svhHPii" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue by type was as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zi7seBMB1IH1" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_498_20230401__20230630_zO9yvDPe0mh1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20220401__20220630_zX3UwCRjN2yg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20230101__20230630_zqpe4Kx6Kn63" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20220101__20220630_zizPSGtEwmC5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenue type</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ProductMember_zG4PerYcqNV2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 36%; text-align: left">Product revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">127,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">918,808</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">247,388</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,838,150</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zBnyyNfBiL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Shipping revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,438</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,752</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,150</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130,255</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--MiscellaneousIncomeMember_zHQhdE9aWEO2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; text-align: left">Miscellaneous income</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0757">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,390</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">40,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zPtXjRmpXch8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Total Revenue</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">139,544</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">981,560</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">252,628</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,008,405</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 127106 918808 247388 1838150 12438 22752 -4150 130255 40000 9390 40000 139544 981560 252628 2008405 395071 410017 <p id="xdx_808_eus-gaap--AccountsAndNontradeReceivableTextBlock_zi1j35lnQdEj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5. <span id="xdx_828_zZSFjP3ZuU35">ACCOUNTS RECEIVABLE, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zNWCQ011DAG4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net, consists of amounts due from invoiced customers and product deliveries and were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zpjiOGkBJZ6j" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20230630_zuZj1xetpQWf" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20221231_zMscuJN6UES8" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNzKXJ_znVrAumFGD6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Trade receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">104,155</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">512,420</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNzKXJ_z9nasYgcgT29" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,349</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNzKXJ_zV8mWAkfbon3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">104,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">510,071</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zCx2OQnc2tw2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reduced allowance for doubtful accounts by $<span id="xdx_906_eus-gaap--AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_pp0p0_c20230101__20230630_zBWZBiQjSnz" title="Changes in allowance for doubtful accounts receivable">2,349</span> for the three and six months ended June 30, 2023, and recorded $<span id="xdx_909_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20230101__20230630_z8kpde9NEjkh" title="Bad debt expense">292,010</span> of bad debt expense due to direct write off balances due from Club Car, LLC (“Club Car”) for the six months ended June 30, 2023. The Company recorded $<span id="xdx_906_eus-gaap--InterestAndDebtExpense_c20220101__20220630_z1edvMXPdAJi" title="Bed debt expense"><span id="xdx_90B_eus-gaap--InterestAndDebtExpense_c20220401__20220630_zEmG4RmbR528" title="Bed debt expense">2,069</span></span> of bad debt expense for the three and six months ending June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zNWCQ011DAG4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net, consists of amounts due from invoiced customers and product deliveries and were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zpjiOGkBJZ6j" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20230630_zuZj1xetpQWf" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20221231_zMscuJN6UES8" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNzKXJ_znVrAumFGD6h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Trade receivables</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">104,155</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">512,420</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNzKXJ_z9nasYgcgT29" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0778">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,349</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNzKXJ_zV8mWAkfbon3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable, net</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">104,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">510,071</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 104155 512420 2349 104155 510071 2349 292010 2069 2069 <p id="xdx_807_eus-gaap--InventoryDisclosureTextBlock_zGC8TMLJhmwf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6. <span id="xdx_82F_z5psvSvNPZBi">INVENTORY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ziIhVDFubkJe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zEkmrhoRW6O1" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230630_zedVNwibI5Dl" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zoFUJpZtei7f" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzu39_zQY1juQYmjy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,481,859</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">330,931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_maINzu39_zM9AZhWsnB79" style="vertical-align: bottom; background-color: White"> <td>Work-in-progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0800">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryFinishedGoods_iI_maINzu39_zJw7lmcUaoBk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">568,113</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">639,450</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_mtINzu39_zivlIGPGYK12" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,049,972</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">970,381</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zwCO34Vnr53" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended June 30, 2023 and 2022, depreciation for fleet inventory was $<span id="xdx_909_eus-gaap--Depreciation_c20230401__20230630__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zfy3pLuZ9r2d" title="Depreciation for fleet inventory">0</span> and $<span id="xdx_909_eus-gaap--Depreciation_c20220401__20220630__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zNBU3LA8vrO3" title="Depreciation for fleet inventory">23,883</span>, and for the six months ended June 30, 2023 and 2022, was $<span id="xdx_90D_eus-gaap--Depreciation_c20230101__20230630__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zM1UvPVq0Co5" title="Depreciation for fleet inventory">0</span> and $<span id="xdx_90B_eus-gaap--Depreciation_c20220101__20220630__us-gaap--PublicUtilitiesInventoryAxis__custom--FleetInventoryMember_zG3UXbTSJKy" title="Depreciation for fleet inventory">47,775</span> respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p id="xdx_899_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ziIhVDFubkJe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zEkmrhoRW6O1" style="display: none">SCHEDULE OF INVENTORY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20230630_zedVNwibI5Dl" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_497_20221231_zoFUJpZtei7f" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzu39_zQY1juQYmjy1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,481,859</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">330,931</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryWorkInProcess_iI_maINzu39_zM9AZhWsnB79" style="vertical-align: bottom; background-color: White"> <td>Work-in-progress</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0799">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0800">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--InventoryFinishedGoods_iI_maINzu39_zJw7lmcUaoBk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Finished goods</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">568,113</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">639,450</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InventoryNet_iTI_mtINzu39_zivlIGPGYK12" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,049,972</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">970,381</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2481859 330931 568113 639450 3049972 970381 0 23883 0 47775 <p id="xdx_803_eus-gaap--OtherCurrentAssetsTextBlock_zY7lRLLWDgm9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7. <span id="xdx_82F_zDYu6x3N1UD3">PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></b></span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zAWHFZ4hKKOd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B6_zyHLkriool7b">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20230630_zEi2JzZiSBK6" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20221231_zqtMuIlxwaji" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--PrepaymentsForInventory_iI_maPEAOAzMVY_zNsbeRN84xpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Prepayments for inventory</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,603,057</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,174,466</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_maPEAOAzMVY_zHofHnPChGkk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepayments for insurance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">274,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,434</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PrepaymentsOnAdvancesOnDesign_iI_maPEAOAzMVY_zjnmc7vYnNcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepayments on advances on design</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">101,815</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--PrepaymentsOnSoftware_iI_maPEAOAzMVY_z4sGAfyHP2Ih" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepayments on software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,851</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzMVY_zpqu69WqALC7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Prepaid other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">99,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,094</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzMVY_zc9Qh0LqC0kb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Total Prepaid Expenses and Other Current Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,269,831</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,478,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zFWpMrG08Omd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfOtherCurrentAssetsTableTextBlock_zAWHFZ4hKKOd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8B6_zyHLkriool7b">SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20230630_zEi2JzZiSBK6" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_495_20221231_zqtMuIlxwaji" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_409_ecustom--PrepaymentsForInventory_iI_maPEAOAzMVY_zNsbeRN84xpa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Prepayments for inventory</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,603,057</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,174,466</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidInsurance_iI_maPEAOAzMVY_zHofHnPChGkk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepayments for insurance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">274,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118,434</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--PrepaymentsOnAdvancesOnDesign_iI_maPEAOAzMVY_zjnmc7vYnNcg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Prepayments on advances on design</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">101,815</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--PrepaymentsOnSoftware_iI_maPEAOAzMVY_z4sGAfyHP2Ih" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepayments on software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">190,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,851</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzMVY_zpqu69WqALC7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Prepaid other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">99,902</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,094</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzMVY_zc9Qh0LqC0kb" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-align: left">Total Prepaid Expenses and Other Current Assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,269,831</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,478,845</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2603057 1174466 274724 118434 101815 75000 190333 103851 99902 7094 3269831 1478845 <p id="xdx_806_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zEPRcaGRqM9j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8. <span id="xdx_823_zcjdJBtiK1qg">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zUJEe3QXlYgh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8BF_zKeukh8nM4aj">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center"><b> </b></td> <td colspan="2" id="xdx_49F_20230630_zkaG3y4HXkhi" style="text-align: center"><b>June 30,</b></td><td style="text-align: center"><b> </b></td><td style="text-align: center; font-weight: bold"><b> </b></td> <td colspan="2" id="xdx_495_20221231_zCkud6NNdCne" style="text-align: center; font-weight: bold"><b>December 31,</b></td><td style="text-align: center; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b> </b></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndEquipmentMember_zAz1wZXW5kEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Computer and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,211,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,970,001</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0rnlWTil81" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,789</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKnsSFDrzDMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,093,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">952,952</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_z4dqsaKDwbmi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Computer software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">455,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">455,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzjOM_zdxTi7wTDhLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment, gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,156,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,702,617</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzjOM_zP7VYE5kVv7a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,955,336</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,510,280</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzjOM_zpGuqsmyHoYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,201,260</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,192,337</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_z5km0wS5A4aj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended June 30, 2023 and 2022 was $<span id="xdx_905_eus-gaap--Depreciation_c20230401__20230630_z2Lkk9Vy1tm5" title="Depreciation expense">254,160</span> and $<span id="xdx_907_eus-gaap--Depreciation_c20220401__20220630_zdTcO24nVnwa" title="Depreciation expense">98,913</span>, and for the six months ended June 30, 2023 and 2022 was $<span id="xdx_905_eus-gaap--Depreciation_c20230101__20230630_zkiAY9GPVU3" title="Depreciation expense">444,966</span> and $<span id="xdx_905_eus-gaap--Depreciation_c20220101__20220630_zrDiTGChq7Ka" title="Depreciation expense">183,405</span>, respectively. The company recorded a loss on disposal for fixed assets of $<span id="xdx_903_eus-gaap--GainLossOnDispositionOfAssets1_c20230101__20230630_zJ7743SE6vzf" title="Loss on disposal fixed assets"><span id="xdx_90D_eus-gaap--GainLossOnDispositionOfAssets1_c20230401__20230630_zRMhehVtWIW5" title="Loss on disposal fixed assets">11,666</span></span> for the three and six months ending June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--PropertyPlantAndEquipmentTextBlock_zUJEe3QXlYgh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8BF_zKeukh8nM4aj">SCHEDULE OF PROPERTY AND EQUIPMENT, NET</span></span></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><b> </b></td><td style="text-align: center"><b> </b></td> <td colspan="2" id="xdx_49F_20230630_zkaG3y4HXkhi" style="text-align: center"><b>June 30,</b></td><td style="text-align: center"><b> </b></td><td style="text-align: center; font-weight: bold"><b> </b></td> <td colspan="2" id="xdx_495_20221231_zCkud6NNdCne" style="text-align: center; font-weight: bold"><b>December 31,</b></td><td style="text-align: center; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b> </b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b> </b></td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndEquipmentMember_zAz1wZXW5kEc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Computer and equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,211,535</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,970,001</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zG0rnlWTil81" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,705</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">323,789</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKnsSFDrzDMc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Lease improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,093,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">952,952</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerSoftwareMember_z4dqsaKDwbmi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Computer software</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">455,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">455,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzjOM_zdxTi7wTDhLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment, gross</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,156,596</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,702,617</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzjOM_zP7VYE5kVv7a" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Less: Accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,955,336</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,510,280</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzjOM_zpGuqsmyHoYk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,201,260</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,192,337</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3211535 1970001 395705 323789 1093481 952952 455875 455875 5156596 3702617 1955336 1510280 3201260 2192337 254160 98913 444966 183405 11666 11666 <p id="xdx_80C_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z3FskYht5Gg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9. <span id="xdx_82F_zR1qujaODMj8">ACCRUED EXPENSES</span></b></span></p> <p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z5sT2AVTzoVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z9YNPQKFgCsc" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20230630_zD8IfKpRcOZf" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20221231_zOgfPea9CTt2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--AccruedProfessionalAndConsultingFees_iI_maALCzZt7_z4efkmLYGizj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued professional and consulting fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">122,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">410,711</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzZt7_zJu1ILwNpsab" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payroll</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">392,079</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maALCzZt7_zBViijUWOVY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranty reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,017</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedPurchasesCurrent_iI_maALCzZt7_za0dR7NbvZo" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">138,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzZt7_zS18C0cc9M6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">910,114</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">964,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zCHzf8JjCU78" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p id="xdx_893_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_z5sT2AVTzoVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_z9YNPQKFgCsc" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20230630_zD8IfKpRcOZf" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_492_20221231_zOgfPea9CTt2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_ecustom--AccruedProfessionalAndConsultingFees_iI_maALCzZt7_z4efkmLYGizj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued professional and consulting fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">122,964</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">410,711</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--AccruedPayrollTaxesCurrent_iI_maALCzZt7_zJu1ILwNpsab" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued payroll</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">392,079</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_maALCzZt7_zBViijUWOVY3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued warranty reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">395,071</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,017</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedPurchasesCurrent_iI_maALCzZt7_za0dR7NbvZo" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0888">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">138,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccruedLiabilitiesCurrent_iTI_mtALCzZt7_zS18C0cc9M6b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total accrued expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">910,114</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">964,937</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 122964 410711 392079 6000 395071 410017 138209 910114 964937 <p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z91v1p4WDrr4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10. <span id="xdx_821_zdgBJiobR7Be">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230130__20230201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_ztMSqWiPnAla" title="Number of restricted stock units">760,668</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20230201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zRteMBc1giv4" title="Share price">0.75</span> per share. During the six months ended June 30, 2023 <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20230101__20230630__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zbGbTTDIw1lg" title="Common stock issued and vested">183,897</span> were vested and an equal number of shares of common stock were issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2022, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20220130__20220201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zjpdqn7CSov" title="Number of restricted stock units">442,249</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20220201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zRenD79Ws8X5" title="Share price">1.29</span> per share. As of December 31, 2022, <span id="xdx_900_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20221231__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_z8owpxmWEoai" title="Common stock unissued">110,562</span> shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 24, 2021, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20210223__20210224__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zd3IizycNdy5" title="Number of restricted stock units">172,000</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20210224__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zP8pjM0qmV3" title="Share price">7.66</span> per share. As of December 31, 2021, <span id="xdx_909_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20211231__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyLongTermIncentivePlanMember_zJzUtkBisNE9" title="Common stock unissued">43,000</span> shares of common stock remained unissued; these shares were issued during the six months ended June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H Convertible Preferred Stock</i></span></p> <p id="xdx_899_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_zdcCdJjP6TBd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zuwhnuNQiBMb" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_zOEH0bKgWRil" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zRRGUTPbdyBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">8</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--StatedValueOfPreferredStockSeries_iI_zlUPbUS0Zxl3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">154</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--GrossStateValueOfPreferredStock_iI_z5lXTcv9LD6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,232</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zXLkxEJ84VEa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">184.8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zv7ZmFKre3E9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SharesIssuedPricePerShare_iI_zRlBbJxr9Yjc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PreferredStockLiquidationPreference_iI_zRyvJNW2GaQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zmYtPhR3BgEa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-3 Convertible Preferred Stock</i></span></p> <p id="xdx_890_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_z4p8TNHpwbG1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zV5zQ0hQOfWl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_zeGFxJn9blyb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_zS1Lrj2AEJOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H-3 Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,234</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--StatedValueOfPreferredStockSeries_iI_zTir0aVQmIr8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">138</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--GrossStateValueOfPreferredStock_iI_zXPCGWovV18i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">170,292</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zECITO3s1h66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">165.6</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zmYM5Ninvvuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,028</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SharesIssuedPricePerShare_iI_zHHni6KFTUPh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zGV87EwdodM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">699</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A8_z7YjJK7gAkle" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series H-6 Convertible Preferred Stock</i></span></p> <p id="xdx_899_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zaOl2tDLOuAd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zBmY9294rgZh" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zgOVJenAfkOf" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zUlgNzWYQAOg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H-6 Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">50</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PreferredStockSharesOutstanding_iI_zEpaUN1ZrCZj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Number of Series H Preferred Stock outstanding as of June 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--StatedValueOfPreferredStockSeries_iI_zp9CVbfs3SIk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--GrossStateValueOfPreferredStock_iI_zqIJCNCuBpj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,600</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockConvertibleConversionPrice_iI_ztPrFWVgIdJ8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.5</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zeBGIjsg5uY2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,440</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SharesIssuedPricePerShare_iI_zgGMUStW2Ffc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zrSVE7JqeZ5a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">979</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AF_zYU7IfjYH8Z3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Warrants</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zCWK1ij4304k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrants to purchase common stock activity is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zY7sqQTab6ag" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td><b> </b></td> <td colspan="2"><b> </b></td><td><b> </b></td><td><b> </b></td> <td colspan="2"><b> </b></td><td><b> </b></td><td style="font-weight: bold"><b> </b></td> <td colspan="2" style="text-align: center; font-weight: bold"><b>Weighted Average</b></td><td style="font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td><b> </b></td> <td colspan="2" style="text-align: center"><b>Shares Underlying</b></td><td><b> </b></td><td><b> </b></td> <td colspan="2" style="text-align: center"><b>Weighted Average</b></td><td><b> </b></td><td style="font-weight: bold"><b> </b></td> <td colspan="2" style="text-align: center; font-weight: bold"><b>Remaining Contractual Term</b></td><td style="font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Warrants</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Exercise Price</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>(in years)</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 40%; text-align: left">Outstanding at December 31, 2022</td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20230630_z44qotWLhPO6" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Shares underlying warrants outstanding">6,106,023</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230630_zUGlkvjrH8Qe" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price outstanding">7.30</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630_zFcQLUhr5jL4" title="Weighted average remaining contractual life">1.32</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_c20230101__20230630_z49AT7lRVOfa" style="text-align: right" title="Shares underlying warrants granted"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted_c20230101__20230630_zTIwYwEe0uOi" style="text-align: right" title="Weighted average exercise price granted"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercised</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230630_znPiYqdRWGOl" style="text-align: right" title="Shares underlying warrants exercised"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised_c20230101__20230630_zQlALUZktFW7" style="text-align: right" title="Weighted average exercise price exercised"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Expired</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_c20230101__20230630_zAEegGMl8TFl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares underlying warrants expired">(136,428</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20230101__20230630_zgDZyZIbBAxa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">9.60</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20230630_zh9vemTRUVH4" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares underlying warrants outstanding">5,969,595</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230630_zpe6fmsJLIF6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding">7.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630_z6Z6Q3R6ElD8" title="Weighted average remaining contractual life">0.84</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zqjC9xg1z8Nj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 760668 0.75 183897 442249 1.29 110562 172000 7.66 43000 <p id="xdx_899_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_zdcCdJjP6TBd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zuwhnuNQiBMb" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHMember_zOEH0bKgWRil" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zRRGUTPbdyBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">8</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--StatedValueOfPreferredStockSeries_iI_zlUPbUS0Zxl3" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">154</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--GrossStateValueOfPreferredStock_iI_z5lXTcv9LD6j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,232</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zXLkxEJ84VEa" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">184.8</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zv7ZmFKre3E9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--SharesIssuedPricePerShare_iI_zRlBbJxr9Yjc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PreferredStockLiquidationPreference_iI_zRyvJNW2GaQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5</td><td style="text-align: left"> </td></tr> </table> 8 154 1232 184.8 7 0.68 5 <p id="xdx_890_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_z4p8TNHpwbG1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zV5zQ0hQOfWl" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHThreeMember_zeGFxJn9blyb" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PreferredStockSharesOutstanding_iI_zS1Lrj2AEJOf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H-3 Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">1,234</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--StatedValueOfPreferredStockSeries_iI_zTir0aVQmIr8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">138</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--GrossStateValueOfPreferredStock_iI_zXPCGWovV18i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">170,292</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockConvertibleConversionPrice_iI_zECITO3s1h66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">165.6</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zmYM5Ninvvuj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,028</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SharesIssuedPricePerShare_iI_zHHni6KFTUPh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zGV87EwdodM9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">699</td><td style="text-align: left"> </td></tr> </table> 1234 138 170292 165.6 1028 0.68 699 <p id="xdx_899_eus-gaap--ScheduleOfStockByClassTextBlock_hus-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zaOl2tDLOuAd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zBmY9294rgZh" style="display: none">SCHEDULE OF PAYMENT OF PREFERRED STOCK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20230630__us-gaap--StatementClassOfStockAxis__custom--ConvertiblePreferredStockSeriesHSixMember_zgOVJenAfkOf" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--PreferredStockSharesOutstanding_iI_zUlgNzWYQAOg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Number of Series H-6 Preferred Stock outstanding as of June 30, 2023</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">50</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PreferredStockSharesOutstanding_iI_zEpaUN1ZrCZj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Number of Series H Preferred Stock outstanding as of June 30, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--StatedValueOfPreferredStockSeries_iI_zp9CVbfs3SIk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the stated value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--GrossStateValueOfPreferredStock_iI_zqIJCNCuBpj6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the gross stated value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,600</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PreferredStockConvertibleConversionPrice_iI_ztPrFWVgIdJ8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Divided by the conversion price</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.5</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_zeBGIjsg5uY2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Equals the convertible shares of Company Common Stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,440</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--SharesIssuedPricePerShare_iI_zgGMUStW2Ffc" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Multiplied by the fair market value of Company Common Stock as of June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.68</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_zrSVE7JqeZ5a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Equals the payment</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">979</td><td style="text-align: left"> </td></tr> </table> 50 50 72 3600 2.5 1440 0.68 979 <p id="xdx_89E_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zCWK1ij4304k" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the Company’s warrants to purchase common stock activity is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zY7sqQTab6ag" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td><b> </b></td> <td colspan="2"><b> </b></td><td><b> </b></td><td><b> </b></td> <td colspan="2"><b> </b></td><td><b> </b></td><td style="font-weight: bold"><b> </b></td> <td colspan="2" style="text-align: center; font-weight: bold"><b>Weighted Average</b></td><td style="font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><b> </b></td><td><b> </b></td> <td colspan="2" style="text-align: center"><b>Shares Underlying</b></td><td><b> </b></td><td><b> </b></td> <td colspan="2" style="text-align: center"><b>Weighted Average</b></td><td><b> </b></td><td style="font-weight: bold"><b> </b></td> <td colspan="2" style="text-align: center; font-weight: bold"><b>Remaining Contractual Term</b></td><td style="font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Warrants</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Exercise Price</b></td><td style="padding-bottom: 1.5pt"><b> </b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>(in years)</b></td><td style="padding-bottom: 1.5pt; font-weight: bold"><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 40%; text-align: left">Outstanding at December 31, 2022</td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20230630_z44qotWLhPO6" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Shares underlying warrants outstanding">6,106,023</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20230630_zUGlkvjrH8Qe" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price outstanding">7.30</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630_zFcQLUhr5jL4" title="Weighted average remaining contractual life">1.32</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Granted</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--ClassOfWarrantOrRightGranted_c20230101__20230630_z49AT7lRVOfa" style="text-align: right" title="Shares underlying warrants granted"><span style="-sec-ix-hidden: xdx2ixbrl0972">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted_c20230101__20230630_zTIwYwEe0uOi" style="text-align: right" title="Weighted average exercise price granted"><span style="-sec-ix-hidden: xdx2ixbrl0974">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Exercised</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightExercised_c20230101__20230630_znPiYqdRWGOl" style="text-align: right" title="Shares underlying warrants exercised"><span style="-sec-ix-hidden: xdx2ixbrl0976">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised_c20230101__20230630_zQlALUZktFW7" style="text-align: right" title="Weighted average exercise price exercised"><span style="-sec-ix-hidden: xdx2ixbrl0978">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Expired</td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightExpired_c20230101__20230630_zAEegGMl8TFl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares underlying warrants expired">(136,428</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired_c20230101__20230630_zgDZyZIbBAxa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price expired">9.60</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left">Outstanding at June 30, 2023</td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20230630_zh9vemTRUVH4" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares underlying warrants outstanding">5,969,595</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20230630_zpe6fmsJLIF6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price outstanding">7.25</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230630_z6Z6Q3R6ElD8" title="Weighted average remaining contractual life">0.84</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6106023 7.30 P1Y3M25D -136428 9.60 5969595 7.25 P0Y10M2D <p id="xdx_80E_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zafZXny65o2j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11. <span id="xdx_82E_zAoYeFPNBko6">STOCK-BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>AYRO 2020 Long Term Incentive Plan</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reserved a total of <span id="xdx_90F_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember_zCsptKwm6rp2" title="Number of shares reserved">4,089,650</span> shares of its common stock pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, including shares of restricted stock that have been issued. The Company has <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zGTdKEdY0Me8" title="Number of shares available for grants"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_znVigpDV9uz2" title="Number of shares available for grants"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230630__us-gaap--PlanNameAxis__custom--TwoThousandTwentyLongTermIncentivePlanMember__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zwlYKGzF2Vga" title="Number of shares available for grants">443,732</span></span></span> stock options, restricted stock and warrants remaining under this plan as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zgBF4lJvzde8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zY24vTjh62Ya" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20230401__20230630_zZH5GAxtpMt1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20220401__20220630_zv1k4xt0E7sa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230101__20230630_znL48F3Nu0X5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zrCLSreJezd2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ResearchAndDevelopmentMember_zfWfD6U0cE0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Research and development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,034</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(6,904</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">11,798</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--SalesAndMarketingMember_zj8gVarHqpml" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(435</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,815</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--GeneralAndAdministrativeMember_zFq6ihPOjp1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">237,532</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,587</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">491,582</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">568,048</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_zRPt9MkVcHQ8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">242,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">303,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">508,869</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">591,663</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zLJWvzBhXkEd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zY7Kt4kX14i3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table reflects a summary of stock option activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B4_zuvRVij3gnae" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual Life</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Number of Shares</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2CSdRAPN21e" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of stock options outstanding, beginning balance">777,922</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOGHDehUZ7p9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price outstanding, beginning balance">6.15</td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLISa09jk5O6" title="Weighted average remaining contractual life">7.56</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeitures</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjWR4wogKtCf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, forfeitures">(45,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh2tbnSCjLOl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, forfeitures">0.97</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaItCxZOb8na" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options outstanding, ending balance">732,422</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZiGGKvVmcW1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price outstanding, ending balance">6.47</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9QTa45VqMrg" title="Weighted average remaining contractual life (years)">7.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zTENZFbIKMFd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of the outstanding options, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zve0cXHdepHk" title="Number of stock options vested"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zXOSeLCrQvef" title="Number of stock options exercisable">654,937</span></span> were vested and exercisable as of June 30, 2023. At June 30, 2023 the aggregate intrinsic value of stock options vested and exercisable was $<span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zn2FO9W1spk5" title="Aggregate intrinsic value of stock options vested"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_c20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zti7pZghVdL6" title="Aggregate intrinsic value of stock options exercisable">0</span></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20230401__20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zpVmeBecaaU6" title="Share-based Compensation">11,417</span> and $<span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20220401__20220630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zMr3bhHlKgdh" title="Share-based Compensation">(6,298)</span> of stock option expense for the three months ended June 30, 2023 and 2022, and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zzaaKvjkjBjd" title="Share-based Compensation">31,533</span> and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z4aKmkTjFIc2" title="Share-based Compensation">26,078</span> for the six months ended June 30, 2023 and June 30, 2022, respectively. Total compensation cost related to non-vested stock option awards not yet recognized as of June 30, 2023 was $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20230630__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbKavnYjL3K" title="Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount">69,823</span> <span style="background-color: white">a</span>nd will be recognized on a straight-line basis through the end of the vesting periods through April 2025. The amount of future stock option compensation expense could be affected by any future option grants or by any forfeitures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock</i></span></p> <p id="xdx_89A_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zSPzCGqfXsSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8BE_zYsgHRWHPFJj">SCHEDULE OF RESTRICTED STOCK ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average Grant</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zlqlyLJAP8Qc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of shares, outstanding, beginning balance">660,562</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zuujozrnPkQf" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average grant price, outstanding, beginning balance">1.91</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRXLRG88dPxi" style="text-align: right" title="Number of shares, granted">760,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp8ATa2wX2O4" style="text-align: right" title="Weighted average grant price, granted">0.75</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z2X0FhM8uxyf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, vested">(300,728</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPqkIARxggya" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant price, vested">0.95</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoeAkuTpTrj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding, ending balance">1,120,502</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBUv1is8P0vh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant price, outstanding, ending balance">1.38</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zQg8faPhHBw8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2023, pursuant to the AYRO, Inc. 2020 Long-Term Incentive Plan, the Company granted <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230130__20230201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSbTQJDcJj0e" title="Number of shares granted">760,668</span> shares of restricted stock to non-executive directors at a value of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20230201__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zDqsoBnwmaR4" title="Share price">0.75</span> per share. There are <span id="xdx_902_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20230630__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z1MqkW216Wj1" title="Common stock unissued">6,269</span> vested and unissued shares of restricted stock awards as of June 30, 2023. As of June 30, 2023 <span id="xdx_909_eus-gaap--CommonStockSharesSubscribedButUnissued_iI_c20230630__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW6Vs8MKNcUe" title="Common stock unissued">570,502</span> shares of restricted stock remain unvested and unissued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognized compensation expense related to all restricted stock during the three months ended June 30, 2023, and 2022 of $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20230401__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zltWz1jZyVHi" title="Stock compensation expense">230,713</span> and $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20220401__20220630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zwlYf8iccomd" title="Stock compensation expense">309,850</span> and for the six months ended June 30, 2023 and 2022 $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zuzv2wN8DJpd" title="Stock compensation expense">477,335</span> and $<span id="xdx_906_eus-gaap--ShareBasedCompensation_c20220101__20220630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9eW2xEYteg3" title="Stock compensation expense">565,585</span>, respectively. Total compensation cost related to non-vested restricted stock not yet recognized as of June 30, 2023, was $<span id="xdx_90D_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_c20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXzoP4udv2Z3" title="Unrecognized compensation expense">428,473</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4089650 443732 443732 443732 <p id="xdx_89F_eus-gaap--ScheduleOfShareBasedCompensationActivityTableTextBlock_zgBF4lJvzde8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation, including restricted stock awards and stock options is included in the unaudited condensed consolidated statement of operations as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zY24vTjh62Ya" style="display: none">SCHEDULE OF STOCK-BASED COMPENSATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20230401__20230630_zZH5GAxtpMt1" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20220401__20220630_zv1k4xt0E7sa" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_49A_20230101__20230630_znL48F3Nu0X5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zrCLSreJezd2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--ResearchAndDevelopmentMember_zfWfD6U0cE0i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-align: left">Research and development</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">5,034</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(6,904</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">11,798</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">9,800</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--SalesAndMarketingMember_zj8gVarHqpml" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Sales and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(435</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">870</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,489</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,815</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AllocatedShareBasedCompensationExpense_hus-gaap--IncomeStatementLocationAxis__custom--GeneralAndAdministrativeMember_zFq6ihPOjp1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">General and administrative</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">237,532</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,587</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">491,582</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">568,048</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AllocatedShareBasedCompensationExpense_zRPt9MkVcHQ8" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">242,131</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">303,553</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">508,869</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">591,663</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 5034 -6904 11798 9800 -435 870 5489 13815 237532 309587 491582 568048 242131 303553 508869 591663 <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zY7Kt4kX14i3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table reflects a summary of stock option activity:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span id="xdx_8B4_zuvRVij3gnae" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center"></td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted Average</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Contractual Life</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>Number of Shares</b></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2CSdRAPN21e" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of stock options outstanding, beginning balance">777,922</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOGHDehUZ7p9" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average exercise price outstanding, beginning balance">6.15</td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLISa09jk5O6" title="Weighted average remaining contractual life">7.56</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeitures</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjWR4wogKtCf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, forfeitures">(45,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zh2tbnSCjLOl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, forfeitures">0.97</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaItCxZOb8na" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options outstanding, ending balance">732,422</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZiGGKvVmcW1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price outstanding, ending balance">6.47</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9QTa45VqMrg" title="Weighted average remaining contractual life (years)">7.10</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 777922 6.15 P7Y6M21D -45500 0.97 732422 6.47 P7Y1M6D 654937 654937 0 0 11417 -6298 31533 26078 69823 <p id="xdx_89A_eus-gaap--ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_zSPzCGqfXsSb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span style="display: none"><span id="xdx_8BE_zYsgHRWHPFJj">SCHEDULE OF RESTRICTED STOCK ACTIVITY</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Weighted</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Average Grant</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at December 31, 2022</span></td><td style="padding-bottom: 1.5pt; width: 2%; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right; width: 1%"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zlqlyLJAP8Qc" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Number of shares, outstanding, beginning balance">660,562</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zuujozrnPkQf" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted average grant price, outstanding, beginning balance">1.91</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRXLRG88dPxi" style="text-align: right" title="Number of shares, granted">760,668</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zp8ATa2wX2O4" style="text-align: right" title="Weighted average grant price, granted">0.75</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_iN_di_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z2X0FhM8uxyf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, vested">(300,728</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPqkIARxggya" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant price, vested">0.95</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zQoeAkuTpTrj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of shares, outstanding, ending balance">1,120,502</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_c20230101__20230630__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBUv1is8P0vh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average grant price, outstanding, ending balance">1.38</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 660562 1.91 760668 0.75 300728 0.95 1120502 1.38 760668 0.75 6269 570502 230713 309850 477335 565585 428473 <p id="xdx_808_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4I7YcU0wN97" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12. <span id="xdx_82D_zhUNiITFBue4">CONCENTRATIONS AND CREDIT RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One customer accounted for approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zfNtAv2EmFxg" title="Concentration risk percentage">46</span>% of the Company’s revenues for the three months ended June 30, 2023 and another customer accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230401__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zPy7g5aBJEcl" title="Concentration risk percentage">35</span>%. Club Car accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFRuWRYXG3vk" title="Concentration risk percentage">89</span>% and another customer <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOB7flmfWgM6" title="Concentration risk percentage">10</span>% of the Company’s revenues for the three months ended June 30, 2022. Three customers accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zfDfKRa8X9G3" title="Concentration risk percentage">42</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zKanueFLMRQ" title="Concentration risk percentage">25</span>%, and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zMPvE4XW7Qoc" title="Concentration risk percentage">20</span>% of the Company’s revenues for the six months ended June 30, 2023, respectively. Club Car accounted for approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zWfpicOCQ6Jk" title="Concentration risk percentage">95</span>% of the Company’s revenues for the six months ended June 30, 2022. We do not expect Club Car to remain a customer going forward.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Receivable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, two customers accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoKkK00YGHpg" title="Concentration risk percentage">61</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z1M583kFJer1" title="Concentration risk percentage">39</span>%, respectively, of the Company’s net accounts receivable. As of December 31, 2022, Club Car accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zIfdpxEQUQkg" title="Concentration risk percentage">100</span>% of the Company’s net accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchasing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company places orders with various suppliers. No suppliers accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierMember_zkgcGbit06h5">10</span>% of the Company’s raw materials purchased for the three months ended June 30, 2023. During the six months ended June 30, 2023, two suppliers accounted for more than 10% of the Company’s raw materials, one supplier accounted for <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zIkAFYm7f7j3">15</span>% the other <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_zJ8rn7Ue9VFh">13</span>%. During the six months ended June 30, 2022, two suppliers accounted for accounted for more than 10% of the Company’s raw materials. One supplier accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierOneMember_zs7qr7y5kjch">61</span>% and the other <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierTwoMember_znHgbuWw18a1">13</span>%. The Company’s purchases of raw materials from one supplier was approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneSupplierMember_zGZIQnsS1qWj">43</span>% and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsProductLineMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoSupplierMember_z8khPVJa6Wej">9</span>% of its total purchases of raw materials for the three months ended June 30, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.46 0.35 0.89 0.10 0.42 0.25 0.20 0.95 0.61 0.39 1 0.10 0.15 0.13 0.61 0.13 0.43 0.09 <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zuE4kGeojt5i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13. <span id="xdx_82E_zWjiSUQfCo45">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Manufacturing Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 28, 2022, the Company partnered with Linamar Corporation (“Linamar”) a Canadian manufacturer, in a manufacturing agreement (the “Linamar MLA”) to provide certain sub assembly and assembly parts, including the cabin frame and skate for the Vanish (collectively, the “Products”). During the term of the Linamar MLA, Linamar has the exclusive right to supply the Products to the Company, subject to certain exceptions. The Linamar MLA has an initial term of three years and will automatically renew for successive two-year terms unless either party has given at least 12 months’ written notice of nonrenewal. Either party may terminate the Linamar MLA at any time upon 12 months’ written notice, and in the event of a change in control of the Company prior to the end of the initial term, the Company may terminate upon written notice within three days of completion of such change in control.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event the Company terminates the Linamar MLA prior to its expiration, whether following a change in control or otherwise, the Company must purchase any remaining raw material inventory, finished goods inventory and work in progress and any unamortized capital equipment used in production and testing of the Products and pay a termination fee of $<span id="xdx_90D_ecustom--TerminationFee_c20230101__20230630_z5dVGSxl4kz3" title="Termination fee">750,000</span>, subject to certain adjustments. The Company is dependent on the Linamar MLA, and in the event of its termination the Company’s manufacturing operations and customer deliveries would be materially impacted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Supply Chain Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2017, the Company executed a supply chain contract with Cenntro, which has historically been the Company’s primary supplier. Cenntro was previously a significant stockholder in AYRO Operating. Cenntro owns the design of the AYRO 411 Fleet vehicles and has granted the Company an exclusive license to purchase the AYRO 411 Fleet vehicles for sale in North America. The Company purchased 100% of its vehicle chassis, cabs and wheels for AYRO 411 Fleet Vehicles through this supply chain relationship with Cenntro. The Company must sell a minimum number of units in order to maintain its exclusive supply chain contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the net balance between prepaid expenses and accrued expenses with Cenntro was a prepaid balance of $<span id="xdx_907_eus-gaap--PrepaidExpenseCurrent_iI_c20211231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_ze6JYNeKqDTh" title="Prepaid expenses"><span id="xdx_90F_eus-gaap--AccruedLiabilitiesCurrent_iI_c20211231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zkwdoFcQJxf2" title="Accrued expenses">602,016</span></span>. As of December 31, 2022, the balance was <span id="xdx_90B_eus-gaap--PrepaidExpenseCurrent_iI_dc_c20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_ziiXYH5Vj3m5" title="Prepaid expenses"><span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrent_iI_dc_c20221231__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zIGWJyQXUQbc" title="Accrued expenses">zero</span></span>. Impairments of prepaid expenses led to a write-down, netted with the balance in accrued expenses. The remainder of the balance was expensed through cost of goods sold for $<span id="xdx_90E_eus-gaap--CostOfGoodsAndServicesSold_c20230101__20230630__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zIcKzLQkMEze" title="Cost of goods sold">621,097</span>. Additionally, all inventory associated with Cenntro’s lithium-ion line NCM line was written off to cost of goods sold for $<span id="xdx_908_eus-gaap--InventoryWriteDown_c20230101__20230630__dei--LegalEntityAxis__custom--CenntroAutomotiveGroupLtdMember_zjSoFn5cggj3" title="Inventory written-off">1,317,289</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has canceled all purchase orders and future builds with Cenntro and currently intends to only order replacement parts from Cenntro in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, that it believes are incidental to the operation of its business. While the outcome of these claims cannot be predicted with certainty, management does not believe that the outcome of any of these legal matters will have a material adverse effect on its results of operations, financial positions or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 23, 2018, DropCar was made aware of an audit being conducted by the New York State Department of Labor (“DOL”) regarding a claim filed by an employee. The DOL is investigating whether DropCar properly paid overtime for which DropCar has raised several defenses. In addition, the DOL is conducting its audit to determine whether the Company owes spread of hours pay (non-exempt worker whose workday is longer than ten hours must receive an extra hour of pay at the basic minimum hourly rate). Management believes the case has no merit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DropCar was audited by the New York State Department of Taxation and Finance (“DOTF”) for its sales tax paid over the period of 2017 – 2020. The DOTF believes DropCar owes additional sales tax plus interest. Management is investigating the details this audit. As of December 31, 2021, the Company has accrued $<span id="xdx_907_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20211231__dei--LegalEntityAxis__custom--DropCarOperatingIncMember_zRzhMM5Ce0Ve" title="Accrued expense">476,280</span> in expense for such additional sales tax and interest and paid as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> 750000 602016 602016 0 0 621097 1317289 476280 <p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zXhTIyjpc80a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 14. <span id="xdx_823_ztEuJeqxBu5">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On June 15, 2023, a certain lease agreement commenced for the purpose of expanding AYRO operations into Florida. The agreement called for the leased premises to provide general systems and equipment to be available in working order. The said premises ultimately failed to meet the working order provision, and all parties agreed to terminate the said lease. Thus, the lease for the Florida expansion premises was terminated on July 28, 2023, amicably, by all parties. Remaining obligations for this lease are de minimis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">On August 7, 2023, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the Investors, pursuant to which it agreed to sell to the Investors (i) an aggregate of <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesHSevenConvertiblePreferredStockMember_zbtD6Kz5m45a">22,000 </span>shares of Series H-7 Preferred Stock, initially convertible into up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20230807__20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zb3Yg75xIP59">22,000,000 </span>shares of the Company’s common stock at a conversion price of $<span id="xdx_902_eus-gaap--PreferredStockConvertibleConversionPrice_iI_c20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zMrUsef0f9Pd">1.00 </span>per share, and (ii) warrants to acquire up to an aggregate of <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zduwuGco40re">22,000,000 </span>shares of common stock at an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230807__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgAceiQqkXsd">1.00 </span>per share (the “Warrants, and such transactions collectively, the “Private Placement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing of the Private Placement occurred on August 10, 2023. The aggregate gross proceeds from the Private Placement were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_pn6n6_c20230810__20230810__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zwx94aoSa4R" title="Gross proceeds from the private placement">22</span> million. The Company expects to use the net proceeds from the Private Placement for general corporate purposes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Purchase Agreement contains certain representations and warranties, covenants, and indemnities customary for similar transactions. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> 22000 22000000 1.00 22000000 1.00 22000000 EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R M:V)O;VLN>&UL+G)E;'-02P$"% ,4 " 6B Y7*F32ILH! ";'P $P M @ &1' $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 /0 ] + *(0 ",'@$ ! end XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 196 207 1 false 52 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://ayro.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://ayro.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://ayro.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://ayro.com/role/StatementsOfOperations Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://ayro.com/role/StatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://ayro.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS Sheet http://ayro.com/role/OrganizationAndNatureOfOperations ORGANIZATION AND NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES Sheet http://ayro.com/role/LiquidityAndOtherUncertainties LIQUIDITY AND OTHER UNCERTAINTIES Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://ayro.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - REVENUES Sheet http://ayro.com/role/Revenues REVENUES Notes 10 false false R11.htm 00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET Sheet http://ayro.com/role/AccountsReceivableNet ACCOUNTS RECEIVABLE, NET Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORY Sheet http://ayro.com/role/Inventory INVENTORY Notes 12 false false R13.htm 00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS Sheet http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets PREPAID EXPENSES AND OTHER CURRENT ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://ayro.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 14 false false R15.htm 00000015 - Disclosure - ACCRUED EXPENSES Sheet http://ayro.com/role/AccruedExpenses ACCRUED EXPENSES Notes 15 false false R16.htm 00000016 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://ayro.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 00000017 - Disclosure - STOCK-BASED COMPENSATION Sheet http://ayro.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 17 false false R18.htm 00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK Sheet http://ayro.com/role/ConcentrationsAndCreditRisk CONCENTRATIONS AND CREDIT RISK Notes 18 false false R19.htm 00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://ayro.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 00000020 - Disclosure - SUBSEQUENT EVENTS Sheet http://ayro.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 20 false false R21.htm 00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://ayro.com/role/SummaryOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - REVENUES (Tables) Sheet http://ayro.com/role/RevenuesTables REVENUES (Tables) Tables http://ayro.com/role/Revenues 23 false false R24.htm 00000024 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables) Sheet http://ayro.com/role/AccountsReceivableNetTables ACCOUNTS RECEIVABLE, NET (Tables) Tables http://ayro.com/role/AccountsReceivableNet 24 false false R25.htm 00000025 - Disclosure - INVENTORY (Tables) Sheet http://ayro.com/role/InventoryTables INVENTORY (Tables) Tables http://ayro.com/role/Inventory 25 false false R26.htm 00000026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) Sheet http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) Tables http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets 26 false false R27.htm 00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://ayro.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://ayro.com/role/PropertyAndEquipmentNet 27 false false R28.htm 00000028 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://ayro.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://ayro.com/role/AccruedExpenses 28 false false R29.htm 00000029 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://ayro.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://ayro.com/role/StockholdersEquity 29 false false R30.htm 00000030 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://ayro.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://ayro.com/role/Stock-basedCompensation 30 false false R31.htm 00000031 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) Sheet http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative) Details http://ayro.com/role/LiquidityAndOtherUncertainties 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Sheet http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) Details 32 false false R33.htm 00000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables 33 false false R34.htm 00000034 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 34 false false R35.htm 00000035 - Disclosure - REVENUES (Details Narrative) Sheet http://ayro.com/role/RevenuesDetailsNarrative REVENUES (Details Narrative) Details http://ayro.com/role/RevenuesTables 35 false false R36.htm 00000036 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://ayro.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 36 false false R37.htm 00000037 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative) Sheet http://ayro.com/role/AccountsReceivableNetDetailsNarrative ACCOUNTS RECEIVABLE, NET (Details Narrative) Details http://ayro.com/role/AccountsReceivableNetTables 37 false false R38.htm 00000038 - Disclosure - SCHEDULE OF INVENTORY (Details) Sheet http://ayro.com/role/ScheduleOfInventoryDetails SCHEDULE OF INVENTORY (Details) Details 38 false false R39.htm 00000039 - Disclosure - INVENTORY (Details Narrative) Sheet http://ayro.com/role/InventoryDetailsNarrative INVENTORY (Details Narrative) Details http://ayro.com/role/InventoryTables 39 false false R40.htm 00000040 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Sheet http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details) Details 40 false false R41.htm 00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Sheet http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details) Details 41 false false R42.htm 00000042 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://ayro.com/role/PropertyAndEquipmentNetTables 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) Sheet http://ayro.com/role/ScheduleOfAccruedExpensesDetails SCHEDULE OF ACCRUED EXPENSES (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) Sheet http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details) Details 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) Sheet http://ayro.com/role/ScheduleOfWarrantActivityDetails SCHEDULE OF WARRANT ACTIVITY (Details) Details 45 false false R46.htm 00000046 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://ayro.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://ayro.com/role/StockholdersEquityTables 46 false false R47.htm 00000047 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details) Sheet http://ayro.com/role/ScheduleOfStock-basedCompensationDetails SCHEDULE OF STOCK-BASED COMPENSATION (Details) Details 47 false false R48.htm 00000048 - Disclosure - SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) Sheet http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details) Details 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) Sheet http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details) Details 49 false false R50.htm 00000050 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://ayro.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://ayro.com/role/Stock-basedCompensationTables 50 false false R51.htm 00000051 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative) Sheet http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative CONCENTRATIONS AND CREDIT RISK (Details Narrative) Details http://ayro.com/role/ConcentrationsAndCreditRisk 51 false false R52.htm 00000052 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://ayro.com/role/CommitmentsAndContingencies 52 false false R53.htm 00000053 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://ayro.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://ayro.com/role/SubsequentEvents 53 false false All Reports Book All Reports form10-q.htm ayro-20230630.xsd ayro-20230630_cal.xml ayro-20230630_def.xml ayro-20230630_lab.xml ayro-20230630_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 69 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 16, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 660, "http://xbrl.sec.gov/dei/2023": 30 }, "contextCount": 196, "dts": { "calculationLink": { "local": [ "ayro-20230630_cal.xml" ] }, "definitionLink": { "local": [ "ayro-20230630_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "ayro-20230630_lab.xml" ] }, "presentationLink": { "local": [ "ayro-20230630_pre.xml" ] }, "schema": { "local": [ "ayro-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 370, "entityCount": 1, "hidden": { "http://ayro.com/20230630": 6, "http://fasb.org/us-gaap/2023": 109, "http://xbrl.sec.gov/dei/2023": 4, "total": 119 }, "keyCustom": 21, "keyStandard": 186, "memberCustom": 29, "memberStandard": 19, "nsprefix": "AYRO", "nsuri": "http://ayro.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://ayro.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - REVENUES", "menuCat": "Notes", "order": "10", "role": "http://ayro.com/role/Revenues", "shortName": "REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE, NET", "menuCat": "Notes", "order": "11", "role": "http://ayro.com/role/AccountsReceivableNet", "shortName": "ACCOUNTS RECEIVABLE, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORY", "menuCat": "Notes", "order": "12", "role": "http://ayro.com/role/Inventory", "shortName": "INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS", "menuCat": "Notes", "order": "13", "role": "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - PROPERTY AND EQUIPMENT, NET", "menuCat": "Notes", "order": "14", "role": "http://ayro.com/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - ACCRUED EXPENSES", "menuCat": "Notes", "order": "15", "role": "http://ayro.com/role/AccruedExpenses", "shortName": "ACCRUED EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "16", "role": "http://ayro.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "17", "role": "http://ayro.com/role/Stock-basedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - CONCENTRATIONS AND CREDIT RISK", "menuCat": "Notes", "order": "18", "role": "http://ayro.com/role/ConcentrationsAndCreditRisk", "shortName": "CONCENTRATIONS AND CREDIT RISK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "19", "role": "http://ayro.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://ayro.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "20", "role": "http://ayro.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "21", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "22", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - REVENUES (Tables)", "menuCat": "Tables", "order": "23", "role": "http://ayro.com/role/RevenuesTables", "shortName": "REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - ACCOUNTS RECEIVABLE, NET (Tables)", "menuCat": "Tables", "order": "24", "role": "http://ayro.com/role/AccountsReceivableNetTables", "shortName": "ACCOUNTS RECEIVABLE, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - INVENTORY (Tables)", "menuCat": "Tables", "order": "25", "role": "http://ayro.com/role/InventoryTables", "shortName": "INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)", "menuCat": "Tables", "order": "26", "role": "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables", "shortName": "PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "menuCat": "Tables", "order": "27", "role": "http://ayro.com/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - ACCRUED EXPENSES (Tables)", "menuCat": "Tables", "order": "28", "role": "http://ayro.com/role/AccruedExpensesTables", "shortName": "ACCRUED EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "29", "role": "http://ayro.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://ayro.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "30", "role": "http://ayro.com/role/Stock-basedCompensationTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "shortName": "LIQUIDITY AND OTHER UNCERTAINTIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-08-062023-08-07_custom_SecuritiesPurchaseAgreementMember_us-gaap_InvestorMember_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "menuCat": "Details", "order": "32", "role": "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "shortName": "SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "33", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_us-gaap_ShippingAndHandlingMember", "decimals": "0", "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "menuCat": "Details", "order": "34", "role": "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_us-gaap_ProductMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:WarrantyReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - REVENUES (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://ayro.com/role/RevenuesDetailsNarrative", "shortName": "REVENUES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:WarrantyReserves", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "menuCat": "Details", "order": "36", "role": "http://ayro.com/role/ScheduleOfAccountsReceivableDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - ACCOUNTS RECEIVABLE, NET (Details Narrative)", "menuCat": "Details", "order": "37", "role": "http://ayro.com/role/AccountsReceivableNetDetailsNarrative", "shortName": "ACCOUNTS RECEIVABLE, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:AccountsAndNontradeReceivableTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - SCHEDULE OF INVENTORY (Details)", "menuCat": "Details", "order": "38", "role": "http://ayro.com/role/ScheduleOfInventoryDetails", "shortName": "SCHEDULE OF INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - INVENTORY (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://ayro.com/role/InventoryDetailsNarrative", "shortName": "INVENTORY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_FleetInventoryMember", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://ayro.com/role/StatementsOfOperations", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:PrepaymentsForInventory", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "menuCat": "Details", "order": "40", "role": "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails", "shortName": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock", "us-gaap:OtherCurrentAssetsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:PrepaymentsForInventory", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "menuCat": "Details", "order": "41", "role": "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:GainLossOnDispositionOfAssets1", "span", "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:GainLossOnDispositionOfAssets1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:AccruedProfessionalAndConsultingFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)", "menuCat": "Details", "order": "43", "role": "http://ayro.com/role/ScheduleOfAccruedExpensesDetails", "shortName": "SCHEDULE OF ACCRUED EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:AccruedProfessionalAndConsultingFees", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ConvertiblePreferredStockSeriesHMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details)", "menuCat": "Details", "order": "44", "role": "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "shortName": "SCHEDULE OF PAYMENT OF PREFERRED STOCK (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30_custom_ConvertiblePreferredStockSeriesHMember", "decimals": "INF", "lang": null, "name": "AYRO:StatedValueOfPreferredStockSeries", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)", "menuCat": "Details", "order": "45", "role": "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "shortName": "SCHEDULE OF WARRANT ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "lang": "en-US", "name": "AYRO:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-02-01_custom_NonExecutiveDirectorsMember_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesIssuedPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://ayro.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-302023-02-01_custom_NonExecutiveDirectorsMember_us-gaap_RestrictedStockMember_custom_TwoThousandAndTwentyLongTermIncentivePlanMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SCHEDULE OF STOCK-BASED COMPENSATION (Details)", "menuCat": "Details", "order": "47", "role": "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails", "shortName": "SCHEDULE OF STOCK-BASED COMPENSATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_custom_ResearchAndDevelopmentMember", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details)", "menuCat": "Details", "order": "48", "role": "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails", "shortName": "SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_us-gaap_CommonStockMember", "decimals": null, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details)", "menuCat": "Details", "order": "49", "role": "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "shortName": "SCHEDULE OF RESTRICTED STOCK ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_RestrictedStockMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "0", "lang": null, "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-06-30_us-gaap_EmployeeStockOptionMember24633500", "decimals": "INF", "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative", "shortName": "CONCENTRATIONS AND CREDIT RISK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-04-012023-06-30_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerOneMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:TerminationFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "52", "role": "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "AYRO:TerminationFee", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://ayro.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-08-102023-08-10_us-gaap_SubsequentEventMember", "decimals": "-6", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfPrivatePlacement", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://ayro.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND NATURE OF OPERATIONS", "menuCat": "Notes", "order": "7", "role": "http://ayro.com/role/OrganizationAndNatureOfOperations", "shortName": "ORGANIZATION AND NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - LIQUIDITY AND OTHER UNCERTAINTIES", "menuCat": "Notes", "order": "8", "role": "http://ayro.com/role/LiquidityAndOtherUncertainties", "shortName": "LIQUIDITY AND OTHER UNCERTAINTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AYRO:LiquidityAndOtherUncertainitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://ayro.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 52, "tag": { "AYRO_AccruedFixedAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued fixed assets.", "label": "Accrued Fixed Assets" } } }, "localname": "AccruedFixedAssets", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AYRO_AccruedProfessionalAndConsultingFees": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued professional and consulting fees" } } }, "localname": "AccruedProfessionalAndConsultingFees", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_AccruedPurchasesCurrent": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued purchases current.", "label": "Accrued expenses other" } } }, "localname": "AccruedPurchasesCurrent", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_CenntroAutomotiveGroupLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cenntro Automotive Group Ltd [Member]", "label": "Cenntro Automotive Group Ltd [Member]" } } }, "localname": "CenntroAutomotiveGroupLtdMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights exercised.", "label": "Weighted average exercise price exercised" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired erercise price expired.", "label": "Weighted average exercise price expired" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights granted.", "label": "Weighted average exercise price granted" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsGranted", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "AYRO_ClassOfWarrantOrRightExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercised.", "label": "Shares underlying warrants exercised" } } }, "localname": "ClassOfWarrantOrRightExercised", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ClassOfWarrantOrRightExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right expired.", "label": "Shares underlying warrants expired" } } }, "localname": "ClassOfWarrantOrRightExpired", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ClassOfWarrantOrRightGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights granted.", "label": "Shares underlying warrants granted" } } }, "localname": "ClassOfWarrantOrRightGranted", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "AYRO_ComputerAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer and Equipment [Member]", "label": "Computer and Equipment [Member]" } } }, "localname": "ComputerAndEquipmentMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AYRO_ComputerSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Computer Software [Member]", "label": "Computer Software [Member]" } } }, "localname": "ComputerSoftwareMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "AYRO_ConvertiblePreferredStockSeriesHMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H [Member]", "label": "Convertible Preferred Stock Series H [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_ConvertiblePreferredStockSeriesHSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H-6 [Member]", "label": "Convertible Preferred Stock Series H-6 [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHSixMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_ConvertiblePreferredStockSeriesHThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Series H-3 [Member]", "label": "Convertible Preferred Stock Series H-3 [Member]" } } }, "localname": "ConvertiblePreferredStockSeriesHThreeMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "domainItemType" }, "AYRO_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer [Member]", "label": "Customer [Member]" } } }, "localname": "CustomerMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_DisclosureLiquidityAndOtherUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Other Uncertainties" } } }, "localname": "DisclosureLiquidityAndOtherUncertaintiesAbstract", "nsuri": "http://ayro.com/20230630", "xbrltype": "stringItemType" }, "AYRO_DropCarOperatingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DropCar Operating, Inc. [Member]", "label": "DropCar Operating, Inc. [Member]" } } }, "localname": "DropCarOperatingIncMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_FleetInventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fleet Inventory [Member]", "label": "Fleet Inventory [Member]" } } }, "localname": "FleetInventoryMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_GeneralAndAdministrativeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and Administrative [Member]", "label": "General and Administrative [Member]" } } }, "localname": "GeneralAndAdministrativeMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_GrossStateValueOfPreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equals the gross stated value.", "label": "Equals the gross stated value" } } }, "localname": "GrossStateValueOfPreferredStock", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_LiquidityAndOtherUncertainitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and other uncertainities [Text block]", "label": "LIQUIDITY AND OTHER UNCERTAINTIES" } } }, "localname": "LiquidityAndOtherUncertainitiesTextBlock", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertainties" ], "xbrltype": "textBlockItemType" }, "AYRO_MiscellaneousIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Miscellaneous Income [Member]", "label": "Miscellaneous Income [Member]" } } }, "localname": "MiscellaneousIncomeMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "AYRO_NonExecutiveDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Executive Directors [Member]", "label": "Non-Executive Directors [Member]" } } }, "localname": "NonExecutiveDirectorsMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_OneSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier One [Member]", "label": "Supplier One [Member]" } } }, "localname": "OneSupplierMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_OperatingLeaseRightOfUseAssetNonCurrent": { "auth_ref": [], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease right of use asset non current.", "label": "Operating lease \u2013 right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetNonCurrent", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaymentsForInventory": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments for inventory.", "label": "Prepayments for inventory" } } }, "localname": "PrepaymentsForInventory", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaymentsOnAdvancesOnDesign": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments on advances on design.", "label": "Prepayments on advances on design" } } }, "localname": "PrepaymentsOnAdvancesOnDesign", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_PrepaymentsOnSoftware": { "auth_ref": [], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Prepayments on software.", "label": "Prepayments on software" } } }, "localname": "PrepaymentsOnSoftware", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AYRO_ResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Research and Development [Member]", "label": "Research and Development [Member]" } } }, "localname": "ResearchAndDevelopmentMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_RestrictedStockUnissuedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Unissued [Member]", "label": "Restricted Stock Unissued [Member]" } } }, "localname": "RestrictedStockUnissuedMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "AYRO_SalesAndMarketingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales and Marketing [Member]", "label": "Sales and Marketing [Member]" } } }, "localname": "SalesAndMarketingMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "AYRO_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHSevenConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H 7 Convertible Preferred Stock [Member]", "label": "Series H 7 Convertible Preferred Stock [Member]" } } }, "localname": "SeriesHSevenConvertiblePreferredStockMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHSixPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-6 Preferred Stock [Member]", "label": "Series H-6 Preferred Stock [Member]" } } }, "localname": "SeriesHSixPreferredStockMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "AYRO_SeriesHThreePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series H-3 Preferred Stock [Member]", "label": "Series H-3 Preferred Stock [Member]" } } }, "localname": "SeriesHThreePreferredStockMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "AYRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Life, Beginning.", "label": "Weighted average remaining contractual life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingBeginningWeightedAverageRemainingContractualTerms", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "AYRO_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Life, Ending.", "label": "Weighted Average Remaining Contractual Life, Ending", "verboseLabel": "Weighted average remaining contractual life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingEndingWeightedAverageRemainingContractualTerms", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "AYRO_StatedValueOfPreferredStockSeries": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multiplied by the stated value.", "label": "Multiplied by the stated value" } } }, "localname": "StatedValueOfPreferredStockSeries", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "AYRO_SupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier [Member]", "label": "Supplier [Member]" } } }, "localname": "SupplierMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SupplierOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier one [Member]", "label": "Supplier one [Member]" } } }, "localname": "SupplierOneMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_SupplierTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplier Two [Member]", "label": "Supplier Two [Member]" } } }, "localname": "SupplierTwoMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TerminationFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Termination fee.", "label": "Termination fee" } } }, "localname": "TerminationFee", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_TwoSupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Supplier [Member]", "label": "Two Supplier [Member]" } } }, "localname": "TwoSupplierMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandAndTwentyLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Long-Term Incentive Plan [Member]", "label": "2020 Long-Term Incentive Plan [Member]" } } }, "localname": "TwoThousandAndTwentyLongTermIncentivePlanMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_TwoThousandTwentyLongTermIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Long Term Incentive Plan [Member]", "label": "2020 Long Term Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyLongTermIncentivePlanMember", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AYRO_WarrantyReserves": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warranty reserves.", "label": "Warranty reserves" } } }, "localname": "WarrantyReserves", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/RevenuesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AYRO_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://ayro.com/20230630", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r461", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r451" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://ayro.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r176", "r431", "r507", "r544", "r545" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r176", "r431", "r507", "r544", "r545" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r174", "r314", "r326", "r327", "r328", "r329", "r330", "r331", "r416", "r429", "r438", "r474", "r499", "r500", "r507", "r544" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r174", "r314", "r326", "r327", "r328", "r329", "r330", "r331", "r416", "r429", "r438", "r474", "r499", "r500", "r507", "r544" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r493", "r540" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r177", "r182" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "ACCOUNTS RECEIVABLE, NET" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccountsReceivableNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCRUED EXPENSES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r11", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r118", "r178", "r179", "r419" ], "calculation": { "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Trade receivables" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r178", "r179" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net", "totalLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued expense" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r14" ], "calculation": { "http://ayro.com/role/ScheduleOfAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r113", "r322" ], "calculation": { "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r61", "r437", "r547" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r275", "r276", "r277", "r344", "r489", "r490", "r491", "r536", "r548" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r51", "r52", "r239" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock Based Compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r271", "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Compensation", "verboseLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r119", "r180", "r185" ], "calculation": { "http://ayro.com/role/ScheduleOfAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Less: Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable.", "label": "Changes in allowance for doubtful accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccountsReceivableNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r3", "r36" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Impairment of inventory and prepaid" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r93", "r114", "r136", "r163", "r168", "r172", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r287", "r289", "r301", "r317", "r375", "r437", "r449", "r503", "r504", "r541" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r109", "r122", "r136", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r287", "r289", "r301", "r437", "r503", "r504", "r541" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r266", "r267", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r20", "r111", "r417" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "verboseLabel": "Cash and cash equivalents, at carrying value" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r20", "r77", "r132" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r0", "r77" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r106", "r115", "r116", "r117", "r136", "r152", "r153", "r155", "r157", "r161", "r162", "r181", "r196", "r198", "r199", "r200", "r203", "r204", "r207", "r208", "r212", "r215", "r223", "r301", "r339", "r340", "r341", "r342", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r363", "r384", "r402", "r407", "r408", "r409", "r410", "r411", "r470", "r487", "r492" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityTables", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [ "r115", "r116", "r117", "r161", "r207", "r208", "r210", "r212", "r215", "r221", "r223", "r339", "r340", "r341", "r342", "r428", "r470", "r487" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodEndLabel": "Weighted average exercise price outstanding", "periodStartLabel": "Weighted average exercise price outstanding" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Shares underlying warrants outstanding", "periodStartLabel": "Shares underlying warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfWarrantActivityDetails", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r85", "r193", "r194", "r414", "r498" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Number of shares reserved" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r439", "r440", "r441", "r443", "r444", "r445", "r446", "r489", "r490", "r536", "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r60", "r363" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r60", "r363", "r381", "r548", "r549" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscribedButUnissued": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Common stock unissued" } } }, "localname": "CommonStockSharesSubscribedButUnissued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r60", "r319", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, ($0.0001 par value; authorized \u2013 100,000,000 shares; issued and outstanding \u2013 37,536,101 and 37,241,642 as of June 30, 2023 and December 31, 2022, respectively)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r29", "r31", "r54", "r55", "r176", "r413" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r29", "r31", "r54", "r55", "r176", "r337", "r413" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r29", "r31", "r54", "r55", "r176", "r413", "r472" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS AND CREDIT RISK" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRisk" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r29", "r31", "r54", "r55", "r176" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r28", "r29", "r31", "r32", "r54", "r92", "r413" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r29", "r31", "r54", "r55", "r176", "r413" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r53", "r422" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r9", "r43", "r59", "r88", "r218" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Equals the convertible shares of Company Common Stock" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r72", "r314" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r471" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of Goods and Service, Product and Service Benchmark [Member]" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r30", "r176" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]" } } }, "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DepositAssets": { "auth_ref": [ "r475" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.", "label": "Deposits and other assets" } } }, "localname": "DepositAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r3", "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation for fleet inventory", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative", "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r3", "r37" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [ "r235", "r429", "r430", "r431", "r432", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r235", "r429", "r430", "r431", "r432", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION OF REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r237", "r241", "r272", "r273", "r274", "r436" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r128", "r142", "r143", "r144", "r145", "r146", "r150", "r152", "r155", "r156", "r157", "r159", "r299", "r300", "r315", "r325", "r424" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share, basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r128", "r142", "r143", "r144", "r145", "r146", "r152", "r155", "r156", "r157", "r159", "r299", "r300", "r315", "r325", "r424" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net loss per share, diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r26", "r27" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Basic and Diluted Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Unrecognized compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r535" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r6", "r107", "r125", "r126", "r127", "r137", "r138", "r139", "r141", "r147", "r149", "r160", "r183", "r184", "r225", "r275", "r276", "r277", "r284", "r285", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r332", "r333", "r334", "r344", "r402" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Loss on disposal fixed assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r3" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Loss on disposal of fixed asset" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r73", "r386" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative", "verboseLabel": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r71", "r136", "r163", "r167", "r171", "r173", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r301", "r426", "r503" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross loss" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r191", "r192", "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r192", "r387" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r473", "r485" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Lease obligations - operating leases" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndDebtExpense": { "auth_ref": [ "r5" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.", "label": "Bed debt expense" } } }, "localname": "InterestAndDebtExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccountsReceivableNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORY" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r479" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r120", "r418", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r482" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r480" ], "calculation": { "http://ayro.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work-in-progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory written-off" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Investor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r13", "r136", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r288", "r289", "r290", "r301", "r362", "r425", "r449", "r503", "r541", "r542" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r65", "r94", "r321", "r437", "r488", "r495", "r537" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r15", "r110", "r136", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r288", "r289", "r290", "r301", "r437", "r503", "r541", "r542" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r476" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities", "verboseLabel": "Marketable securities, current" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security.", "label": "Realized gain on marketable securities", "negatedLabel": "Realized (gain) on marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r70" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized gain (loss) on marketable securities", "negatedLabel": "Unrealized (gain) loss on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r96", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "ORGANIZATION AND NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/OrganizationAndNatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r77", "r78", "r79" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash provided by (used in) operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r69", "r79", "r95", "r108", "r123", "r124", "r127", "r136", "r140", "r142", "r143", "r144", "r145", "r148", "r149", "r154", "r163", "r167", "r171", "r173", "r181", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r300", "r301", "r324", "r383", "r400", "r401", "r426", "r447", "r503" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ayro.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "negatedLabel": "Net losses", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingGainsLosses": { "auth_ref": [ "r75" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of gains or losses resulting from nonoperating activities (for example, interest and dividend revenue, property, plant and equipment impairment loss, and so forth).", "label": "Other income (expense), net" } } }, "localname": "NonoperatingGainsLosses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r74" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r163", "r167", "r171", "r173", "r426" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r309" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion lease obligation \u2013 operating lease" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r309" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease obligation \u2013 operating lease, net of current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r486" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_OtherCurrentAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other current assets.", "label": "PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "OtherCurrentAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r130" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Interest income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPrepaidExpenseCurrent": { "auth_ref": [ "r483", "r497" ], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid other" } } }, "localname": "OtherPrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r76" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r494" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities, net" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r76" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockConvertibleConversionPrice": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Per share conversion price of preferred stock.", "label": "Divided by the conversion price", "verboseLabel": "Preferred Stock, Convertible, Conversion Price" } } }, "localname": "PreferredStockConvertibleConversionPrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreference": { "auth_ref": [ "r43", "r44", "r59", "r487", "r505" ], "lang": { "en-us": { "role": { "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.", "label": "Equals the payment" } } }, "localname": "PreferredStockLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockLiquidationPreferenceValue": { "auth_ref": [ "r134", "r212" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of the difference between preference in liquidation and the par or stated values of the preferred shares.", "label": "Preferred Stock, Liquidation Preference, Value", "verboseLabel": "Equals the payment" } } }, "localname": "PreferredStockLiquidationPreferenceValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r439", "r440", "r443", "r444", "r445", "r446", "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r59", "r207" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r59", "r363" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r59", "r207" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r59", "r363", "r381", "r548", "r549" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding", "verboseLabel": "Number of Series H Preferred Stock outstanding as of June 30, 2023" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r59", "r318", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, value" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r484" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets", "totalLabel": "Total Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r121", "r189", "r190", "r420" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidInsurance": { "auth_ref": [ "r421", "r427", "r497" ], "calculation": { "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepayments for insurance" } } }, "localname": "PrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPrepaidExpensesAndOtherCurrentAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r1" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r1" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Gross proceeds from the private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r14", "r501", "r502" ], "calculation": { "http://ayro.com/role/ScheduleOfAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued warranty reserve" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r83", "r99", "r102", "r103" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r84", "r112", "r323" ], "calculation": { "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r4", "r316", "r323", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r129", "r186" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccountsReceivableNetDetailsNarrative", "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PublicUtilitiesInventoryAxis": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Information by type of inventory held.", "label": "Inventory [Axis]" } } }, "localname": "PublicUtilitiesInventoryAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PublicUtilitiesInventoryTypeDomain": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale." } } }, "localname": "PublicUtilitiesInventoryTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r58", "r283", "r543" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r62", "r90", "r320", "r335", "r336", "r343", "r364", "r437" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r107", "r137", "r138", "r139", "r141", "r147", "r149", "r183", "r184", "r275", "r276", "r277", "r284", "r285", "r291", "r293", "r294", "r296", "r298", "r332", "r334", "r344", "r548" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r164", "r165", "r166", "r169", "r170", "r174", "r175", "r176", "r234", "r235", "r314" ], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue", "verboseLabel": "Total Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r105", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r236" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "REVENUES" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Revenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r385", "r415", "r423" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r176", "r471" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLE" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccountsReceivableNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "SCHEDULE OF ACCRUED EXPENSES" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r50" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfStock-basedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r10", "r66", "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORY" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "SCHEDULE OF RESTRICTED STOCK ACTIVITY" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other current assets.", "label": "SCHEDULE OF PREPAID EXPENSES AND OTHER CURRENT ASSETS" } } }, "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/PrepaidExpensesAndOtherCurrentAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "SCHEDULE OF WARRANT ACTIVITY" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": { "auth_ref": [ "r7", "r8", "r49" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK-BASED COMPENSATION" } } }, "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r238", "r240", "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r266", "r267", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r7", "r8", "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SUMMARY OF STOCK-BASED COMPENSATION, STOCK OPTIONS, ACTIVITY" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r87", "r89", "r90", "r115", "r116", "r117", "r161", "r207", "r208", "r210", "r212", "r215", "r221", "r223", "r339", "r340", "r341", "r342", "r428", "r470", "r487" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r9", "r39", "r41", "r42", "r43", "r44", "r45", "r46", "r59", "r60", "r87", "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "SCHEDULE OF PAYMENT OF PREFERRED STOCK" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://ayro.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesHPreferredStockMember": { "auth_ref": [ "r477", "r478", "r506" ], "lang": { "en-us": { "role": { "documentation": "Series H preferred stock.", "label": "Series H Preferred Stock [Member]" } } }, "localname": "SeriesHPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r2" ], "calculation": { "http://ayro.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Number of shares, granted", "verboseLabel": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of shares, outstanding, ending balance", "periodStartLabel": "Number of shares, outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedLabel": "Number of shares, vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Weighted average grant price, vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r238", "r240", "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r266", "r267", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares available for grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of stock options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Number of stock options, forfeitures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted average grant price, granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of stock options outstanding, ending balance", "periodStartLabel": "Number of stock options outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r246", "r247" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price outstanding, ending balance", "periodStartLabel": "Weighted average exercise price outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r242", "r243", "r244", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r266", "r267", "r268", "r269", "r270" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted average exercise price, forfeitures" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r237", "r245", "r264", "r265", "r266", "r267", "r270", "r278", "r279", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Aggregate intrinsic value of stock options exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted average grant price, outstanding, ending balance", "periodStartLabel": "Weighted average grant price, outstanding, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r261" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Aggregate intrinsic value of stock options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of stock options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Multiplied by the fair market value of Company Common Stock as of June 30, 2023", "verboseLabel": "Share price" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r80", "r133" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r106", "r115", "r116", "r117", "r136", "r152", "r153", "r155", "r157", "r161", "r162", "r181", "r196", "r198", "r199", "r200", "r203", "r204", "r207", "r208", "r212", "r215", "r223", "r301", "r339", "r340", "r341", "r342", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r363", "r384", "r402", "r407", "r408", "r409", "r410", "r411", "r470", "r487", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/ScheduleOfPaymentOfPreferredStockDetails", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityTables", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r6", "r18", "r107", "r125", "r126", "r127", "r137", "r138", "r139", "r141", "r147", "r149", "r160", "r183", "r184", "r225", "r275", "r276", "r277", "r284", "r285", "r291", "r292", "r293", "r294", "r295", "r296", "r298", "r302", "r303", "r304", "r305", "r306", "r307", "r310", "r332", "r333", "r334", "r344", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative", "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r137", "r138", "r139", "r160", "r314", "r338", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r363", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r380", "r382", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r402", "r442" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r137", "r138", "r139", "r160", "r314", "r338", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r363", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r376", "r377", "r378", "r379", "r380", "r382", "r385", "r386", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r402", "r442" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/BalanceSheetsParenthetical", "http://ayro.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/SummaryOfStock-basedCompensationStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r21", "r22", "r23" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Restricted Stock issued, previously accrued" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r6", "r17", "r43", "r90", "r205" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r59", "r60", "r90", "r339", "r402", "r408" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r6", "r90" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Number of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r6", "r59", "r60", "r90" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Vesting of restricted stock , shares", "verboseLabel": "Common stock issued and vested" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity", "http://ayro.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r59", "r60", "r90", "r344", "r402", "r408", "r448" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r6", "r90" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Vesting of Restricted Stock" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r60", "r63", "r64", "r82", "r365", "r381", "r403", "r404", "r437", "r449", "r488", "r495", "r537", "r548" ], "calculation": { "http://ayro.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "periodEndLabel": "Balance, value", "periodStartLabel": "Balance, value", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets", "http://ayro.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r86", "r135", "r206", "r208", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r219", "r220", "r222", "r225", "r297", "r405", "r406", "r412" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r308", "r312" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r308", "r312" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r308", "r312" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r308", "r312" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r308", "r312" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r311", "r313" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash and non-cash transactions:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ConcentrationsAndCreditRiskDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/LiquidityAndOtherUncertaintiesDetailsNarrative", "http://ayro.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r33", "r34", "r35", "r97", "r98", "r100", "r101" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r439", "r440", "r443", "r444", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails", "http://ayro.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r151", "r157" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Diluted weighted average Common Stock outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": { "auth_ref": [ "r24", "r25" ], "lang": { "en-us": { "role": { "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).", "label": "Basic weighted average Common Stock outstanding" } } }, "localname": "WeightedAverageNumberOfSharesIssuedBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://ayro.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org//310/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org//326/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column A))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column B))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column C))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column D))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column E))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.12-17(Column F))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(g)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r453": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r454": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r455": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r456": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r457": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r458": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r459": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r461": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r462": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r463": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r464": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r465": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r466": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r467": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r468": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r469": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7,9)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org//275/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 70 0001493152-23-028602-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-028602-xbrl.zip M4$L#!!0 ( !:(#E=TL).A-@\ '"? 1 87ER;RTR,#(S,#8S,"YX M M'2C(F_D.]A87!Q.KHUH]73]0?OGYKW]1X._CWSH=Y0HCUSE7^OZLHWMS_R=E M:*_0N7*-/$3LP"<_*;>V&[(0_PJ[B"@]?[5V48 @(BKI7'EW>'QF*YV.1+ZW MR'-\,C'U--]E$*SI>;?[\/!PZ/GW]H-/[NCAS%_)96@%=A#2-+>CQZ/X3R[Y M#::S-/'9^YLU_?'1Q%\6R/L0]FWO@7ZV;>/;='3VQ[O?/IR@N^7]Y\M_3W]; M_?KEZ>V=]G"&'BQTT_6UZP5ZJT=%?J2S)5K9"H#AT8L#9E]LWL/IH4\6W9.C MH^/NEYN!Q>4.(L'S1Q=[=T7BQV=G9UT>FX@*DH]3XB99GW99]-2F*,T98G&% M//9H8'NS+7DG2!-DA=]UH\@M45PH^CX2Q8FH@W)R%,T.%_Y]%R) _N0T$0QI M9V';ZU1X;M,ISS2.V!*F)! %(3 OU F>UH@6BD916PF<@.02;-4:1'=9-$MS MU#DZ[IP<)RG5KZ:1)K*?B,]:,L_[Z/TI\T<7K9 77/EDU4=S.W1!_6^A[>(Y M1LZ!$MAD@0+6-.G:GJ&*G)*V;7N>#RX ?AB'L+#U&D,;3P,@B+6)<^*[: QZ M*^P!?%#,GD5T>S[T(0<*=BX.HL=,1DE6#IIC#_-B8W\[5CK,NT)F'CSRE!^[ M>6$QIY BQ_!^YL]K@B@DY^8,("!.'XM4IYW9[BQT]TJZT:\J91R>5.*^M7MI MN\S9K"5" 8UJ>3M(JK9/H(I9UX?2ZO8;Z%-+##\.\5H?Z;^I8 M-X:*.NPK0W4\,37%N%*,D6;R<*O%3<1M@*%/@F;]!&@8,'<@$YA=D,#&7H!1 M#-H.&2G$/N01&^C_F>A]??R5PV6,/VFF,AGV-'.LZL.QKK5H%76-X6IEDR=C M;N&%!\O"F>T%ZFSFAX"$MQA!+S9+49.4E4+O+(^>-;FY4F "5_I*!XO@H#X6IW6K#25O1114= MMW=JHAG"]_;414,41+5>'"4%P7$>@KC96X!%3]-OUM M/?!)/%O?_)2J^I-\U>M#:/UCP_S:UK58UR."UC9VM,H9&IC52]KVA?1MK0TJS,>-^;F*;&A@W+TL9M!U:(H ]38S[S M8HO'-5N9I%U86:043F]%G-A,.9Z/:3 Y&]T -FT_5CZTD!"E'I,.*EN!4DB\ M*QA.S(FV\9BV^HM(@C+V9R^BY_B],,,=&[U?/QF#OF9:__C[AY/C'W_B7C%N M1YHR.#IL8]%A>\#0^KG.&4P*(J6 $9;Z')C.I6J!A_2,&^8B?'G?PE*T6PQ/0NV<,K%Y""1UC7]PQ8Q _',>7"!Y.>J<%"7S%UZ]<6 MI"*05BL<<,Z1 >#S]3GR-BOY*@$ID(3E._C-C3YFXWN,D,$7[=JP7;&7$2]3 MBKZ%8*;&UBLIQ9(+E4'C1%C!6Y-+"X86-A-F:_EV)KP_];4/!5:+"CL1%O_R M5)CR)BFJW4+8&^$QHVIJX1NGD$)7X!?JH!L5U&);P7AFT$CL L)^]G6 M?ET:- M%E8 4+@*;4$:)MCC)<*-9;/*!4G@(G$+*D[8 /),PS6)30UX*-H&% MD"9/6UCKLZC;2%:)2($G,!45C&H+ESRUFANH"J*DX!&8BCS-VF)2BV_=FHB7 MQ4HA(YXN*.5>6XSJD[ "4*4B,FB=BO1%"2';8K7WN:L^@B>7#FW"F-E[)',. M2T@CA:9 9^P\EZ6\B4M2TJ):A(N\<;9$3N@B8ZX"/@YV0U95%IJ%!#.\M,>9 M&SK(N2+^BOEB&%6',==LXF%O04>(6$N;H+BZ8P=^Z5RE6HE(B_0^:?W)@!^P M5*%9]/7!9*S?:HJEP;Q4Y^U$^](;3/K0*5R9Q@WO&2;CJ&. 1)IJ#O7AM:7 M#$FQ/JFFEK:KMC7M38X5]QM[II5J&0(A4XAT)5+2]6!"TB'TZ9M!* M.H@=TE+P"KQ.UO'[NJ5>7YO:=>K5,1O7NK(,%UKLK*6Q4G@)O,^&'VV=K>:H M+7"B90-QJ: 49.+)D^S8*M*HK7/5IKJ+/4U.5 I#@?HII[];-ZSGABG]7>)] M0KP48 (9E'6Z#%?>NIK$;D6Q>Y5'2R$DD$(B*JT/2?J0S#9%B7O522J#ZUN1 M/LIX7HWMCM8SY9 OW-8H!;M26@I?\7S,%KX5.R(MHK5WL(I[7EEA*3P%ZD<& MP[9GEE]D9/>SRE<815)2^(D$S?;R(K<%UCJA5+=J/S&GXL/C',%0Z/"-E;)N MM5I:"L9*(F:D?F4^&(^@5QJ,E/UH6Z8%5 [0SZR_8JPH]%DX*%MKE$A) 2@P M,UD /ZNF&;&D8_V6;W.VL-79BR[AO7?+24%7XVY0.P+6];R2'>D2#]PA+06G M>*,HXXGEF]FM1\KL3A7CPX.--7NDQ7WL,S*0 ETD?#+[5"68_Q"/H<:(WV7Z MH>V>:_JVB6A \"R()SP[1M<=TE(PBT>),KYM:M;8U'OC='+4XOF,8T458ZZ$ ML R:[VH<-6J'W6?>!RV<X"*4@%>JCZOF@+K"RPI5=$RX"53R %K, 35=XQ M;7&5G5AMWS M.^"S0TH*P8*C/+E[J?_WJ+%_;&PST5SA;UT_9Z_ZOCB@F+WW M_B .6Q(TOSA@0':25W+_#F8?/J[<1(254/'6=8Y]OJ;B@I,L;#(3"@^9 M<"X8W+J;*)]D$." )1]EBE%8.3 QZ[Z@Y:X]K6LY)$'N*YH\8/F_AJW00.O: MFFO3KV1Q;U/*:]@-WE77[FV'?"6S^VDAHM4?N]NOPH??^=?E?P3#?1(HGO#. M_:H/)42?>!CX,YY511+VJY.DZ["@SO%)Y_3X\)$Z&TWK*+&IAGI*).GV4*+D ML\YNZ:'M;R4($>L1/-V@U95_J8$KS=9R<-'9==A+NXB @ M(>M-V>=ASJ&7Q;XSYH.!$T:+P0,E&AS2SZ&<._[*QIX>H!63A#J 62GTPR&3 MOB9^N+XXB++#(/(MDM"KD'F M0"U+&%,NU0Q3DMM"HY#,EC#NJPNH?":4MV:W8!,,RC''$P]3&B)GVYA=0DTP MA'UQ#($>'O)#JGLS?Y7KYZH$FF# E8M0D)[\W-:])*X):DL7= P[9)I@AF6[_.3VC4WN$./Y1Y ?'5 M$+H#GPUG//4@R*UL=XLUP9@^\=<]F\2?>O,6,.W;-J-*H D&)-P.NZ!?2L85 MTT%R29I@9%K[ \2VY/!B&1CS"47\IA^LPN*+?ZFK2XOO-"[:" N2J>H5LP M$DUQD%@7H!>^.K-5?X$3G)!W$BTPIC:D"4,V/&#TZ]FAV;@QO5 M;XE2IVQJ/$L!K)_.CI^2.JC?;",)QL:!DS_?]'+%.74Y1H_!I0M^EIA<0_X9 M'ADDV;R A9]]<@=UU;/7.&#?FX[L$$+W=K%7;IOQM9DGME0F]RCUL(+PAO82 M_!8TO\1%KWR2^8199$AY=//M,3S5N6=EPE,?4;SP"JPJ%/H>;$OXSD*;,I$- MM24>@T;$GR-*(36G.-@'BT.7C;I7".7'JUVR3>TD$O7CC2::FVB41S?5(/XE M:>?6=D.4O_D930O32:*$H+R1^7%H';_O[R6H..)3RK4M5#;EXG:*-=3;>#U= MYJ\NJ&R06G#1RZ>-2'RI5X4.Q(DN%^J@- FCOH5-*\9+VXNO+!EAP QRP TO MT0)[[$V,GQ&;+WQ^%=HN8\;:X?TSB6RE@H MG<4SIKHOV,54VB!GZ?>*9CTK)3)I-*)K3'9:FLA\GVC*6"B913.0_%,&((W_ M;^386%NU__W R#3!'L\-IO\IW9T/W9_5>N4)&2/E>9CM]FRZ5%?\A8TJP90M M:(B_,J9!5/TYZG'3,IZ516/I/MV# B*K+GU"_ >F/\RXKWS"F=C$? FYYW4N M[.C&2QP!0@]#,-U?8M^EPFF]1L!X?8'N*W8AH9(H+[.1+9=80 MZK)R@Z#.9D+C=Q(RKPF*AP@[-T1PLUCGR\X*8LZN_:5=29I*!7%&9$3\&4(.96,..W)ES-5[&W.%H3=F(9OCUGTT#491 MYPJ ;Q$KS\JF$7U],L]-N#P^,Z.BN1)RC;!GQR'Z9A^=W^;F(I:UC^^Q@SR' M]24B++52- *@], PV_";SV&QE3]>7"G1!)C8ZQKBMR#I_-H"4W2S-!%1JI/@ M6>3R"V&4T3>C9EG7("W]YYKVL1O=^X/'_P)02P,$% @ %H@.5Z)_EB-. M$0 [,T !4 !A>7)O+3(P,C,P-C,P7V-A;"YX;6SM76UOVS@2_G[ _0== M%CAT@77SUG:W[?86KJVDPB:V3[+;[7U9,!+M")4EKR3G97_]D;1LR^*+2%LR MN8<+BB9Q..3,/.3,D!R2/__R-(^L!YAF81)_.#E_>79BP=A/@C">?3B9>)VN MUW.<$RO+01R *(GAAY,X.?GE7W__FX6^?OY'IV-=A3 *WEG]Q.\X\31Y;PW M'+ZSKF$,4Y GZ7OK,XB6^)/D*HQ@:O62^2*".41_6#7\SGK]\OPML#H=B7H_ MPSA(THGK;.J]S_-%]N[T]/'Q\66SIK/A: MD?\&'$]QNT>SCYG)V=G_YV>^/Y]W . M.F&,]>;#DS45KH5%=_[V[=M3\M=U4:KDTUT:K=NX/%VSLZD9_344E"]QDH7O M,L+>3>*#G,!>VXS%+8%_ZZR+=?!'G?.+SN7YRZ$Y#Z%TP\GN "J^>+R[,WE&:[WNYU"^?,"=XAS+.ZMIF%&^9A!%(8Y_UJC?U*I*3-4L5[U[$,]@YL1>GOC?[I,H0*;%_F,9YL\J;$I4TS#? M(+N_BI)')6521(?S-$QG( [_)!!UXV" 3&(*5<"6KN!P7F]"!$B ($'M#%%G M3R>H_Z==WT^6J)UX-DJBT)?@ M5JV6P[EVX0.,E_5\59"'X8/X"Z" YC7L2$D.IPG)T92HA"FUH90 M!0]O>Y3"!0@#^VD!XPQFZ][:6Z;8Q'>S3,)9J=31!,<)&NUD8&&3N<#62@+# M&K)&>E:ZA!LM2/0I5O$F[+ZZ:VK3"Z&Z.SAL"W! CF0E=EJ*)3[9X7SU$F2/ MX[SP&JA3]%*(S+4;9M_JX\):TB;XF\_#G'ABW$)"##&:,TD8 M$?8A^BG*!B#%D<$#/&R&R*NM 4W[]S!81FC6W$4M!6&TQ/5[T%^F(6[9?O*C M90"#JS298VTNJXGI8K4WBVP\S M,)NE<%8HM/"YRKC)U=-!#W* MJN51-ABWJ6JQEK!)SB%]= I1?PQ(**C>-Z3J:9+S+QA '!@@$%$,J,RQF+Z-F8)R M'"1=0Y-ZY4P%E/4K5T^3,2B[0?+Q<+%::E3L+(=7W20R+LSR-/3S8FSMW?/E MZFEM1KK7,)"OIM65;57>]ZBJU95O=?Z5JVI^95Q]_BA'+^+4!Y&_C AL-^CW M'0KXE,,8S;?7]6"F9=)D\C#'!8NLI7.K@U.B9"M'KN:*@7 MN$& &%LE7]WA[T42F-L.95Y%0$L&\ M(=.'BR0+\SK[5"EFAC_G# JF2";I_"8$=V$D-PMAE=4;GX_ ,PY2I2/S:GG= M+HZO?4Y@SA;8I Y5[#NI]"L!B6Z/IP*06&R3,-KU$6N>GVN!JJ/3[16ET9)3 M@$F0E423,M!&V38."G_IP8)"*7_/\5(F-$*:!$0W"$(L M,HA&( R+HVAX.<=*A4$? M3D,_%#A)&5K=4K='DI6-'YNJ(:8Q@%.1K^ZX M,4_,GT^K4MZ@WUO/.&%?=K*3?G)Y:/J)]6*GE>];RJ2IN2IE1Z97?<+*=GW\)\_O>,LN3.4Q7QZ.0 M0<<+N>A?, 9/(H^V1V6Z[20#*N'J)&?AT]"^X5*_E$"RP;(OJLA\91.K#*6E]-$RBA.Q\%ER) M+(603+=-X")!608)Z4VR 1Z,(FRIXF"5F+854;!,)*#1;0-D@:J7VR245M=* M1HC;;C /XS#+5\G7M5#5$NI> Y#%2U(#)H&V$)O9 LO>ZH M015"-;V8CJA;X7NSWD!ZZO@>Q&,X7R0I2)^=^0*$Z;Q\Q9T M<9A^3>H] YC+!)^58MJ]*(MK7G3&*&EDX"DC5'WG-61'0O7V\)VE_-?[+.47 MK5AA;)7;^2=8)-E[:]7(##,)-0B4D(KL.G8>R!\HU7Y%C4YDR48.U2DE[[9.10 M7-449=3R$[D)\R/O7G3&U@&GO/9IPZ$8BA5ATK 4'HLKVY3:A43UFG2?93X8 MYGV59U('(-+C%\BNDK2?+._RZ3):GZKB@RVFD@/VC;G RBC%)!#-6NG[T5Q@ M#U[ZT^=<_S?7_G[Z:_65QA<#]?4GXJ2V3/90R#(33=YYY>5P?FLNSF)%F&3F MT1P]Q9%&'ZZ^.S%],1$?0#EJR;6,,W/Q5-&242.29GQ]WY%P5:V&3!)0@U>G MI/1B.)+%G4C]XG0?\VXD%8CEZI/$WN!5KL,T:7BGJ-Q>L8_IWI!*0FWPPI>T M?HQWR94;+Q1QI:@EH35X/4Q%2V:CRSGUKP(QMPI)G U>$%/6ETE@3>3R=8_5.HP]"]40&JU;5 9849%750[+.6 M-12@9I,;NIMZ ,HB-9D-L!/G()Z%B/.Z:84$J:';J0< RU./4:!BF2MWN&^? M%BGN>-_]H%1R!-,P"6A?7"Q5VD\^29]R00[MZ13Z DM_;#YT>PL]>J>S<53# M,".3'$U6ILB &))6.4QG("XVD)&F!B!?IK#^;H0?\>,G8>9'28;*HU^&[G5W MX/RG.W:& ZL[Z%N#[GCBVM;PRAJ.;)=\[K64(2E^1Y8MP$]5 6ZL=<^Y'CA73J\[ M&%O=7F\X04(,KJW1\,;IM2?-^B%2)K_G9U5^7?NS/9BTQ@WS104V:^=5U@J= M>8C'GNU\[GZ\L7^P!O:X)58WCPZPV;NHLN<,D.;&0_=K2_S(/'G)9O6RRNK( MM4==IV_9OXWL@6=[I0'6F[BNC3NHY]GCMGH!YQU)-O>O:.ZQ_2K,@HULQ.@6 M<=QF5Z@\'LGF\S6CO[H3>ZOEUK+1I3+NS]]0IFD\[/WZ:7C3MUWOG]_]=''^ MXWNBSG%;/9CS[!R;74FEO>(MU2GQ8:^^,<=^98S-,^:_>$#FK MP;CPM*2W]EP;.33+=;Q?6V.;^[PJN"WAUA&0B'W*1:[CH+:98P9$(DXI=\@+B]KF?!,?B;BEG.(F2FJ; M/9EP2<0YY2ZE@Z;V)6-&3R)A*&U=.P-4V[^+% ^[3LSO"4-ZV=C'!>E'4;&VJ;@V<[:OT M2*0@C):XM>U^PRJ[% :KJP7GBV5.FAQ.U]?HCF!*CII4WY?>40'MD7N?[/[D MAJP (5>,M'$S&3N?;V-TO0&)G)]@O+Q*B&*ALZ!> 6S60IG!?I%'",$G8H.RJ#W':][ M?>W:UQM$BRBG=1C7(9@<4%30L W&=(Q1*D(3(D!/L\O#CH[52KK7^G94FV^[ MZI*$7$BVARR[=+HWIZ1>H:U[N):E"I.R<+I1E#SBFZ@91Z^V4M1CJ5:-[JVR M?:#=1U$UF]S'V]QB"BSG%:@Y#'_BJ\%+;&;#0N= 36C*SJ$T-=;K$IIX1OK( MG+K@\1;D, U!1"YU7BX644T*;AVE;K//?/2:\RYVC?@F&?H-SU^2]!M.ZT]\ M*#JCRBNOVW2KP,,4U4A0KO"MNLBFD=O1)4"IE->=-J8""E-44Y) JNZDQC=2 M*T^T+SFF,Y19>Q7YR5?T6E3)3RHLQ.KUH[MJV#VJ5!O)2A'O92TX3X63!E=) MDRBTI+(?*D^#6 MQI&I'QC#N!L\X-;13WV8A3/6+4>5[L2BT>TG#Q\D?$T<&1 OF>:/(&6- HKE M;5G=5TTU 4!58A2$;G=^R M$[()MIMU!VF<8UW"Q0\QE;8KO=@\D;7?/60IZ/1'=/4(T1=Y2:C")(.Y\S+J M]H9/]',$&5=][G%ZL[D6] >1RAVB:?4:LZ N-M7B98-75(J C)T^\MYK.5=( MZ(#H[?W=C==*XI#V7=?*/0@RVY0\DB:#ZZ(9_(P3S/!=B.2]+7Q;^3+".1=7 MD+FLCFGE2'6[DUK5EP-N%6T8YDX(WQCD*!J#)_D.QJ31;?*E09.0Q3RT4/<* MEG[^!1O6&-ERS#R(>A% 76X:PD!BL5"R MT+#ZHX*FJF_;6'=<=:IOX]R$2C MJFP^J-*ZUQ_V,H(,K)LA8B0Y]K*R'#3[D^6IXM6R3R\7"Q.@LGTP'I3)=2LBU'RA^*(34< MD1-S/QRQ@VX@W5Y,0$26DI7.^R]!ZMK>V'5ZXXW!..ZHX_9.\=![K7 :X&@# M3W D4TXH:HU2?$3SJ*)QCVW*B49-Y87'.(]I+2M'.^7$8>3J5XYZ\D4H(@[\ M'^[\Z)/_ E!+ P04 " 6B Y7F"0%LH E ">: ( %0 &%YLXSCN9R5W)$NVHQI:\ M>B2;^^*B24CBAB(T?/@Q?_T!$"53(AL *9( -=K:VG5L--C=OP;0:#0:O_WO MX\)MW2,_<+#WY<79RU.B_Q6!R^6+@H1^?3);)R<2_7Y#GHW]R;"WZ7<>ALO@ M\^GIP\/#2P_?FP_8_QF\M/!"KL-1:(91L.GMU>.K^#\K\M]OSD[_=7TULN9H89XX'M6;A5ZLJ6@O M671GGSY].F5_73=-M7R\\]WU-]ZK/R:;.IRN$TP' MSN> 27*%+3-D%B+DJ 6VH/\Z63<[H;\Z.7M]\N;LY6-@OUCCQ)3M8Q<-T;1% M_Y\ O?FJ^>1CBNLI_<-I!Q.[)5PRDKF/IE]>T :DY]=O7KU_\XKV^[>M1N'3 MDMAOX%#S>]$Z+?#-<].ENAG-$0H#T;# 4];Q1BZ^<KQP"B$T@ M(=\9$&/W)\3^_=!TO-!!0D;EJ$M .5HL3/]I,!TY,\^9D@'IA6W+PA'YCC>[ MP:YC27";KY?]N1ZB>^1%8KYVV^W_Y5BJ8(@LY-R;=R[JHU#$!I=H?YYZ'I&2 M>#O".235T@D%BL\O11!L>8C'8VL.B4 MN:2SE02& K)2+,N/T$8+$C:5U;R,>3__TE3E*D3Z/J%NFTU]=R(KFZ>E6(+) M]N>K@\E\[(7QJD&,HN,C,ET/G>"GV"\4DI;!WV+AA&PEIE_ ;"(FVRN)R5R" MM(QUYRY ?T3D(P:=DR16F.SV=:V Y:Z$Y:^(N['$L2I"6N]7(\ $;2,XH KK* M_(0<[(F(J]X1=A'YR0WZID\]@WNTWPX1ZJT$35MS9$B[]6UYN;% M=;]>R\2WZP3F;.:C6:S0>,W-C9M4%ZU MYNJD3!UOG)[ X]*7:AOE$]<)L=(J(/=K,%R'6FA82#?3:61[;R\%^BJTLAW?OYS=U5^9#S__E&.GL>I MZ5MK9K,:)QD 8=XVM.NO"MZ Z=V Y1:<".8^(/);6QZ<7QPE/2 M]#1N1D.DU= \?L2R<+M+BC"4BYV-TFK9Y7TW7S<<@( MJN?+PV$[+VMKFEIM$DW-R T+&^6:?)MG\FO'<^BL?47^N<4W>@R19R-[S3GM M4"9++G1"VC#.;SQKG=!DR(C.K>3'N&453&1GPFTQ\YIPL$E<8MR0OLG.PZ8_ M!=AU;/(WNQ7WU%IUU?IEXID16ZJ6:Q9=E^ X;K?+[;-UM/TUW[%]2TXBJT'UV2++.K$GPV5?(P,3S>@/:\ZF M/EX(51FK#7,E2.J6,/*BA7VRM_GRXNS5,R\N)F;WY45(]K_* >JX9A#$WG_[ MT9&QKC1)J;!E>@ BF+:U#T $R9J!EBI<0.F2( M;X?>1L@GN[2OU[$CFP*'4LL1WV:9V7YH;3O9 !*5OW;CTC2E[$N76<,&IM+=W1;R#F'TL=S@0'P9WIM=(3- 0V*5O-M$4#9)9WF*9RN1"M M$[IK6D;%RG;Y5XYYY[AL?T3FQW2"J#@.(]N#]C&R7(* 2"K;Z2?8EXZAP32J MT"H" @ACKCB;\JW_C?E$M[_2F_[M]AH EGO/GR$!"(^R[7Y\=2(M)Q>A;)*& M@<01 L1)66Q@V\-4/'(>7/] M.RG)0"@3L8C?3G>$OB+_K/I*8W8M_:W[C6_VO=_8^F7K*\?[CD6X/MYW/-YW MS G;\;[C\;ZC%A&%XWW'XWW'9ES9.MYWU!F=XWU'K>'1_;[C#M.TJ'/0CL(Y M]IT_GW=.HACW+MWM1\USO238A[#2Y R";!\'/I/79E'A=4EN6<@@^H9!QQ5# M.P<\R^QZ01#E'6DKFH9!E6(=]"9T@F<0A>RY5,>;Y<,H0=A(H';Y!_UQ#4[_ M\D^&$L3:HR8K ^@2:H"/9XZP#IK=P!TG.7+3QM/7>Z52JSDB*?>1]'WI+N M71'IXJ^T'*^5_,[?S24.?FVM/GF1V/S.I;:*W;#N+K&,@+HYXV5 4PC?+)]P=/4-(F%;@A(ALK.\=BR9T.-@>(@O/5A@(+KQ7_67M+:06!8#^ MB]*Y=Y7"T(U\,BY6S#..=U]I?C!]NX_"P?0"^U/DA)'/JQ"S;\_:&TPI H). MDF8&L9H_*[$(^:Z;:A(Y)00]-%4V0;CL>19>H"L<'*(2N\ M32L9Q$\G3#P+^72+E:R2MLW_QUW^KWK_G/2ZO?$/QOQ@_-48MB;]CC$$/JO-1 M[[+?N^AUVOUQJ]WI#"9$AOYEZV9PU>M4)LP0W2,O M@]>[7+[M#X9O0G53&3 M^1)--F=GNYS%&AL1%CM&[UO[_,KX1ZMOC*OA=/-02S9WKW>YZ_6)WL:#X8]J MV-E^CB18#ZIU8]V6\:\;HS\R1HFQU9D,AP8USM'( M&%=D NOW(H#',;:9?YMFGDY<\81@D-GAYIHP7*$=Q"5ZUXK/9O-=AJT.)\:S MCJO*'Y5*%3U[GYJ3QH/.[U\'5UUC./K[WSZ^/OOP*U/FN"+K98R>I':!V=RF M5C'&[T04VAE<4XVRE:L:7HD+8!&3C!=:^B2=C\@Z-G2"G]G\IE:MSH L M4?UQO+PR2^T,#;*,M8:]T>]5<;U8.*NM.&49LY4*>> Z=99:IXAFKWMC.IIB ME@=L=3+ZU2U-H^@N0']$]/R/3K;9G+Y.+5&CR?F(6"N=J.AB5=5$)><%<+V! MUZE%3-X;:/VR[KJJ[',I^5B> R!=:A',(]VJXXID6SL]/.Y3"^/:]:F8MTP? MB,=H:A&$/*&*&=^X1#QF4TOAQC&JF#L9#XG'>&J1E/:3*A%RG%M)=+ZIB5M/N%(_;]$8/=*J>^5:>TYT*\?#3NJ^47ZJQYLB. M7!3S<_[$N!/=L.$1:7/=A@O+;I14K(;C]9N:,D EH#C>Q3G>Q5&-12/R/C6[ MBZ.P?)W6]SYRR #.:(TN7Z?UO9"\@H S76/+URE*SBV[?)V>Z;J PT/F^W/R MP9\<[XU/J"HIM 2_>TL$"#%U%T(W3-_XV(ZL\+OI^Z87/FT>U&+>:BX$Y7IJ M%J0Y9)+PT^O+<\@\2^&$*MZD(^C B4K% 19^3D"7)F"[09_"$3KW*%N65$1= MF"/0^B7NN;7I6E4@!KMDC.$5#VUJ=3.T/K*A;]P!?QZ3GP+38N=1,O&;4K^B M>@HK01KI:%%YW](GR%2!R8$3:ME8:1_2&I.^!].$*/QP%M!<@U!6ZSA17>5P;B+? MFA/WN#WS$>-,4!!$0*#LH>IX$?)L8H^=?S^"3_N!U3+W\P M[7FV<^_8D>D"2REI"S0]X&44%AH$3REVWYUP/D3N*H5N[BS'V"!;O/ )/,7( M$E#420PN+ MY "'H+*+S3O9L=11$V1+0 0'O#**1 ?'FD:HBL[V.22*TBT$VA9BHV_.19GP M:+FVE0NAINO9#K_"8JA9S57M^\3#A8N-S)*F;/(K="M:U9EB]9'SM)S:G243 M%NG%YQL?$W<+V>=/DP#9/2^^B>S-VD32>R=YI3<33LD^#AOK/$K0+C1.F:]-E^B%"^?X3X5]0*T>*_(#AEY>_GHA.#N2O3?\G"JGS_1Q/C&_5 MP'ASB X899'49>]&@%CX=^S_)#855V " M_;C0X1%$!*" 0]ZP?UT0/[4]$B M01OZ0T0XOP(@\)45"N*5Q"J._3;Y7P_Z#/DAY)6]-$=<00LA.[@@:J-\FI[% M F6;(KXPZD+2 T9<3G8(;15/UFV"H&TO=&S'C:CTSPZ"\6BY$>F*"D0S.J.0 M!;,'TW4EVO5#HW$:8W9>9/HN?N>KT9UYI[#G3]D=\(_# M*OVH!D=JI5H0KD]UVH6VLIGMFPOAT8^84LT!71WXR5A,6H\9$>E5A>#.VF[YTBT>(72C*:JWH^ MIB! L Q@<+/DN]T['$P\A\5@N*G67!I5Q:_S(B G" 3#1V6C)+[E*AH=6\UN MSU3EOA<;%AG,@[.5NA:_9;D#:/VHO:'''RG:EJ^YO M7RN*[U8<'BE1.1*9-+4%@*4*K_!QX86>-\7^PHS5*PK- M% SPYCY@+>S2-.\_JOBG'5FM(^+*+J.V%E8:!E1*P$G#2-78WF MSG))LTH]^ZOIV:3KF3 )'B)1<Q=1[M7Q/O%[FNZ2$50N MYAS2M[HS_-C[6)V#T2GWO^4W#C,._:EY1>TY03CUTR-UYIU^I3=Y@ M23]YF-ASU_=.HQP,J??WX!<;ZX=E\XPC%XW48WQ)-!)O.E:+P2ZO KVGWN1+ M,ZK\\'LCDD1P)JNMN@IQC),X5BN(PP#-M0G P"!D5(H#Y=;^WLU-=.AF-55TL2/'.,%B ;2;#[MHZ2/+8;L]SF%/HI6J M@@?2CD2*68WVF,F\,?$CZKQMP]OT4U.);4..%]6KW59L)$J]EO7%I G)"8(F=B RM!DFXV3SFR<7E]J#-_D4>2EYFKH2V]-_B M0&*B3N*.'WPGFD/PE? M,8-I5-4^+X"5G"S@]*@,L"MD!FB.7;NW6/KX?E4E3X08ATA5!8/BD(F$@3 K M.]]A/=)'>!H^F#X_V2&[\:VB^]A[SFT90D!*5W@C##,97VA M>091KN3:>30@OWW$,0<>5?,@%DL#.C;U1Y'YH51^YL;;5/E:F3AJO;E,?H0V M@7%N?#A=HV$[D6DX,1(Q\/I"W>83A80%^1/E6+BB<&]#W;1_4$SBR/Z%,1P2 MN4;C0>=WU9'NCFL&P6#*Y),(;@/-5<>S&3_G3XP[Z1!V!I$V46LN+&"@&E2# M]K'I44@69ZJ1I.""-QQA$@WBT# 4NU7Y!8)KY&'Z^:P[[>/?'E'#+$M[V%$?(=%'P5Q$ADB!6%@SD# 1<1H>SY MK" @8T(MBEQ)]U#!0*H1FUU!0(1JAFCD/.X%T(9>572^''BVQ= O,+_#-'M# M:A"%06AZ]*X0+_3 )505H,_C=,N(4':,$1A-;,%.TNV-=&1(PBH1T6N,@ M+T%-ZPX++C..,AD"0!!0:0^!#/\2D3>5$U=B&E[]&+ 8L&-QH@BR/6B-7Q%9 M0+=:V48(7$39G+QZ\&ZRQ-ZS-)R=4O[.FH!P4;' ^64VN:YGS D3 M021- ([// 2/LAV%3KW3LB]POXV50PA>7CUO3TN/* M;[(SC=-L)[(2T>/14.Y*^]MT501ZP/9U<-4UAJ.__^WCZ[,/O[+ST;%&=]Q7 M+T69 ;)IJA'R G,U!#8/OIX_/3>)SR7;#Z9OIPP86/KV[%OYR9Y(A@ 20OX< M<-]/:'-J6)XQP4>,Y>"A9>W%,9U.:-4/F\R8=F2ZD<5>)^HZ/K(((9RR3TDX% H*1!8=1EA:H'IFSSSYQVP)$-X# MW6EV> M>MIS:A;"+2_TLF6?3;%F95WRK^9J:?*!L9#/B;A5I5Z>26 M\!;JSWEAK)_<[:J&F_N2>H$BF?O"4DA.SMLCH]OJ#*[I1?35@Y:*KVT;BZ6+ MGQ"*7^X!+,)E'W=6[\!8>.8Y?Q*#8&.\@X,P2-E#>BB4_B'5"27E""2=7%+J MY[1)-*G(_,"LDPI T_Y*_.J5KE7 I7/$KV1(:XT'DOT+(OW/VY[=1??(Q>**K#P2 M19$^N2&"Y64H>PJ$+J6:+GL4X=KT?Z*0]QPIN\B9W5K518'<2N?Q#RF\[.*< ME\A#ONG26G;V@FB([-Y98CM7\7RBVI\E+:I_"3$@&-2]41J[.F4OD=:S1\BC!(G8=6TABVBQ,/TG,&+!?CU8LG1#J1L\Z4$/ M7A#C'W$)NL$-_=?H'UDW?-16 Y,(4&2U55S#3!05CM4M*Q9.^H- MVZM;972\88\F?$@6FLLF4[>KSD8!@(HGLT8;XATV13LKH+GB2G-<76,9 ?3; M^I8!C,Y;W=+ TS3[,G&V(\J\3#55M/?ECPWPZ$KC2Q:%3^YB5S!18:H?\4$L M_5.JWHV4]THJD5ABT]!8&_J.G-F<[)W:]V3W/$/&(_$]G ):A_5Q,!?R=Z$ M>M!S)DMM6]/"W^46?H@H2N3W';*"^Z851J9+LQ9?"RRR7F::89T*= )ZKDV= M+Q/I3CUO%9FJ;F[,^%@S+*T"F4$?6EM+ F^.P))6M 27S$GS;; *A8 G.RI3 MX';3-F6"QY]X*7!#8S0>]CKCS8LEVD2)CZ63CJ63CJ63M NS'RM)2-P"UVPG MU^@: ,=*$NJ/!YIO13H?3APK21PK251?24+?)0C2R>J$J.<102.FO$$X1_YX M;GKQMJY/"YH'1 65'9?D94%53F.U5TQKTYR>QS%[Q%DW0NZ$&RYI\>:N&:(+ MT_$%A;?KX^$PK;<^U?V%IEZF@2I#YCDY.$S3K4MQ!W>LLRWCOI-O?8P5T_ V!T?[W4=Q$D=.AVFX*B;HLED\FGZEFH7&QCL%Q['< M.B3\=VS>ORZY?KP90?]!V4K4BD97%E3X6'!"LL-+@_*(/V^>F]:P M($S+"TZVY4)W?.PXMSN?_['C<@^,-7PE]_C8\4' J*7G>WSL..-MX$\']]KQ M)PX6GQ2^-'-8Q> J#G$5K".G+"_E6$=.TRC2L8Z<)'B:!F;VJB-WIFC+OE\E MN3/>AOOLM;*DT02G'7/IA*;+YG7Z676"&)7_M0$VP$BTU[]A;<+,DKOA$!UK5U593GSI0PRM? M1?5$9FN?]-:I[YL4][.J)[[T%P_4!BO3E'9!D'W%30RYGA?Z#MDA6U4;(_S- MHSGFU15DD.]4&61=3QX=FJ'DD1L"_;WR5![>0U";.@I,'\$8D_UW\N_T,:@^ M#G^@\/F9J.0C21)I055^_O!,KD:U01;[H7$;A^85Q3@XNZU7Q.#Q4>7*"**I[R:XR!VK3TXIH=YU2X0H+6#H\6U2L M2O@TNOYB%QW,;BWZJW2QMF=W?&0[X= )?LH5O#C;+7C1&?0[1G\\9%4N1JUV MO]OJ#(UN;]P:]D:_ZU/V8DMR*F_*:K*69)A&E9.QPY&@Y@347IL"$F)84NX" M3P/:5WE(L7_^=(X\:[XP_9_\;$8QI;*$1@$F @ !#6AT-IYF>W'1D'$%0,,1BK+P*$;G,'T$F,[N/&Q M'5GL(3=QWC!,=7NFZ#)W0<#$LL"1"XU\DR=QL1K0L!I7G_9"(Y2L0S'-3D.-2&@I9.P-TJU%G98?WK V;+2 MAJEV=2_D4G:-!0R7/?\(E"JE447UVXKJ4Z;D6D7J'#]@*8UNVM5>>JNH4KOF^*;G=XAK3[OF2K77NB7,5N-ZK?S\ZKU"Q^86^Z M(HV*UJI4N_IK,A35ZP[+H&H+%V00J%8TQ:;:W9[I/L<"+,.+5\FJ)9!*306I M=K=GND^Q ,N@:LN>8@FD4JI-M;L]^Z"Y:@&60=5^4%BA92<@<(-\^@MSQKM" MR:-2EDFY?U)52@H(L(2 ]>4P+A9.R*Y]T 1&LI]UO!GR+ <%%<5.N*@4GI_;=E>J4Q0TGHN>Q=MIIDZ(( MJQVJNZW2Q]'RZO0YL=2^%2U!P(AN\7Y6(:C .4JO>OC91YL@[+5J/9HH+2/ ? JX9?7_$Z? MCY:F8\=E+CJ1[R->/<+,YOJB(.2Z4N^C8/HM\2WM*\>\% MSSGHR&B0XU<8A&>W0$K(/NCBIX>MX]D0K[3]]])T1=_,!) M 4RWU1X.@&5P==9N!B-&U,>>57@ZVZ+7'JX<8D 0OJL_6$>+.: _(L*90:U- M,D+W9C="-YJ)=YX;T/D$!=?(^G?SY4PML>ZFIIISD5/J$*DRAZV$2@;2$V M^M[Q*!,>+<.-Y4*HZ+5QH-+[L2T493!,U>_CK$="\ M":L15U*-8@S)Q\16.P7S^3=C\E-@6JP8D/!6=MZ.U*Q;?%SP?B+IMY:I@E?G M=:]"$ZCU7&Z$R*:>[?1O(M^:FP%JSWS$..,G-XKH%"U[18<;SBF:=G/P)L;3 M<KYK7')Y/LUQ&M,-2AI3']T"'#_8;0(-^/*\,+5B'I'E1=IH>'!"XLAW;3 MVS:C\:-T43C'/BUARCV9Y]#=OM-BZRP*[TH( 0&F+K!!65W5/>\29\>;K8K8 MKYA?62"=D0;3A#4^^T4\EV*??AL"> E":A=4V3;B!.//\K "^;)C&>ZA(2#G M$D>[W4"\['QGFY]PX ^=V3P<1&$0FIY-+%;H\8"4#8%/2@SMUM%,KN-7O1 S MM\T?@_BO >_B4)'NF@RPE&P0ZLJ23VY\;"%D!Q=$)>O'I =3(L,]<>=O7--" M2:\_:^:5H6\(KCF$@8"42$&)?T__ASZF1W[S_U!+ P04 " 6B Y7^;$Q MT@!/ #![%G1U!V/V8]:WMF-RB*:G-'+6I(JKW>B0U'B052M5VLHNLAB?/7'X!Z ML*KP+#Z 5,_&SDQW,Q/U ?B02 ")Q)_^_643HB>OHOBK?_^W__V_$/F_/_V?BPMT'>#0 M_Q%=Q%B<_H4]>F--_B:^#$"=H%&^V(3NMS'+-NF/W[WW?/S\[=1_.0]Q\GG]-ME MO#$K<)YY69[6I;UY>5/^7Z'^IS"(/O](_^O!2S$B[16E/[ZDP9^_HM\M/_O\ M_MLX67_W[LV;M]_]Y\>;^?(1;[R+(*+MML1?55JT%)'>VQ]^^.$[]FLERDF^ M/"1A]8WWWU5PZI+)KX%"OH$D#7Y,&;R;>.EEK-NUGT%2"?JWBTKL@O[3Q=MW M%^_??ON2^E]5C<]:,(E#/,,KQ*KY8[;;$BJE 67"5^6_/29X)083)LEW5/^[ M"*^]#/OT0S_0#[W]GG[HG\I_OO$>O9;FMAY?%A+-S3/ M COC(?=N7G&[AO0?;\B?6A#Q2T8F,.Q7(&D1"@O,OL FAK+LNO1XV2HWI-8\ M3OBZTYF1E;GRT@=6<)Y>K#UO2S[P[OUW.,S2ZE\NZ+^P1BC_X3JPX>CB?O[5OS$Q%*\0$T1_HZ+__:?O]D4?PB5OE\2,(&^^?_^&D63XZVSZ MVRB.B/N8!0\AOB-R.$FPSSX[)P8>IS]_Q)L'G'0JUDO3!G$.J JE4 \UYV3J MCY6CU5X9U=HEQPI]]#/Z6U&$*[HMB#8^G',M=3#$$U3*F'T-W==!01[P(3R\ M>.^:B?/@Y7 >-I3!L)"KD#$':\W7P< NW(/X]_W)^'>\$U=4JUU7(3>--*PZ MN88NWRKY]8NV> PK')0Q[_G0;:C&WQQ1/Z:FBP5Q#I.E@LJ M^,(E@T@!#M,,4':Y5HBBO>R)5@]'4ZR']7)OMDSM%6A#U<-"G.QN:$3I= $G%0]%%C ME)+G>[C.$9E+-W&DG[8$N&= M%_B3:.1M@\P+E7S1Z-CDCA'\)H^4"F X98*RRZ^]#J)*%T&$2C4X;)OAS LB M[(^]) JB=:JDF4S8)K_4@)O$$DN"89027I=*E3"JI.$P:$'*GJZ&24+PLB6F M8J$OD;7)'R7<)GV$@F#8HT+'SW,AT8X3+PN>,&KH("_R6W^?9H\X0=FC1RQ5 M2^FLYX9SO,P38BEQ>D>:Z-%+\7!-%@X4D:935>:9 VS1?ZV-UGD+[\M@BPD(V<2^<%3X.=>*#!7"CD;G-+" MI#22"CEGC@Y9ERQ,EH8H[*6A[#1.HB>025L]T5!#;IUEB$7!D$:-CYN$:FG$ MQ!&5AV)9.E51'\&*91V22''L*A*$2B"U#].ECU.WY2Z)_7R939,Y3IZ"IF2+D;$TISQA5:<#Q>H91%OA!F-.M@/W2;ORR#',?^]>D M)VF00)ZQ.T335;5'=8>3^:.7X,N=N "%YW36+UK=#C]_T[4VT\_W.3"#Z_QU MY#;R&PJHL;0M_F$ MC!>77HI]=.?MV,Y88R]V@(HRX,P",[(63X)E9A)W)9&U>U"D@-L^)Q((@J&5 M"AU_2E3)VHF:Z6"[CX(TS;$OW[37*%C;L#<"7F_6*Z6=$\48HI8ME18G>D(V/3Q CA-4U+2\ Y4U2HNN0H9>!0H5QS:Z)]6S)VPWP%\-KQO0T! M,%00H9+M=IQY,OD8I$L*"[O*82M32):P/4$(I5TS@,C>%U" MM.11H0#(4.0/8;"\SX*0+=+H&5)$OK)3[#:H5:R:$0/P+:NBD'=.KAX@12=_ M3.:\D2?7(<99_2VYN1'+6;,T*IBUD1$).:> #EFWWYDH:O0^&*N2Q%N<9+L[ M C<;1CZ]'+6EZ_3+G>80V$C3LJMB6I6. Z-3 M4ZO L5;7>1(%69Y@4J/KX(7^21W9K5*P:9OTP)LF22[MG%?&$+D9L%)@W*I4 MX%#K!GLI?HQ#?[+9)O$3VZM6/<9X2YYAXU(MGXKSLZ)I]@9/-A#1^1 T4Q2*?4'H786V2 M.;!R]<334]\YO8X W:4?8Q<771\2C M68C.R<(37&NC1W9U3K J^[]BOE1JV+WPIH7>OOTF%7=..G.,_.D8.W*M55"E M<]ZY=X933-KHD9CI*_R$PUBS3:V6MQGLI87=C/62"CMGC"E"0:074V%;B@VE MLV?5\D*<$IP?O>0SSF174=2B]B[QJ\'NK^Z+Y6"00PV."T&FTHP4M?RY*5$\ M!102B$-_$T1!FA49)N3,T&E8(X@9])HG:G$8=#'"V&5-J50D#VFIP?%P1C%S MO1(V*\Z"]//E[A)'R\<-X;G"S=&KV4W#9E:)=E8VM8YSWO4$*DBXO5=#5 _5 M:E#VGYA9G9%I-LKQ+=;<[1;+6KU[J8+;NGZ7:\E:(@R&5'J.!@8*T-S[*TXRL'1.N8DHKI=6R2C.S*K2HIE:!0S]?,?+ .MU_4MV M=;]343CKT>%R&>=11E;62QP\>0^AF"AZ<:OA5AK0K<@KB:QS AD"Y.*Q2G&T MEX?#IE&<9M/5ASCVT_):\4T@\1G-5.SN;^C!MS]M2URIW-@1"UCM8OK/!2<#J9MW. M1MW3\?EW-JIO*9>_ B'KO2U?_G(2L'I;M_RM>]O"\IEL*L.YM M3@)&;\M@27O;PJXE(92^MP5"-L.M-;W-2<#H;1DL[J$/,J1//F^WU@(I7GZ[ MCI^^\W%0+ /('_;>/_G+;S=X[87C* LR44(@H80- BB@T=X7_.R\Z^68^"O' M1 H58F<^A\(1AT$)[-<3T$%$\]SQQE<3;D9=,MYBN(*/U)%K*V:,0ML8;+>":,5))&%S1 MP>NRI)1'M<* WKCYUM9;T32&;!1'3SC):)J@O@]'&ZE;?T6Z1Z6X)Z4-=&$0 MK3]@V6/3Z(^H48"=AZ?U3LXH)HB&#S0L>YD)INW.[[8<'"&LRKUI_>B<)C)$ M_%;X$XNM*:5L=_15O,PWY4M8@AJT?[;5S2)052\W?P/1R0) W#13BK X3LL= M/"0?]NG'KT-O+8#?^=U6%PMA57W<^A%$)XL0<<>FE0RB0JZZ^0JGRR1@#S^H MZM$2L][I I!+IM+^JK8C'@VC*/?"&=[&B8H^;3';K!&![)*E*0.*(P)@4FH4 MLJ@0=L2(O^9>DN$DW&E)P4G:YH4$:I<:'3%0[!!CDQ*D%G?+D47B16G HB]T M).%%K2\W)&"YI4='#A1/).#D2Y):WBU3YH\X#&DF22_2&Q21L&VVR %W^<)+ M@F*,%)Z4,TP#E2IP:,,>6;XB;I)A91OR+LG#P5;QIQ8&2Z$N0D,6%2]D4SU' M3+K#21#[Q,U.=!SB)&VS1P*URYN.&"C&B+%)N5*((R;OGB3CR#>B2"WGAB = MF&)ZE$( R=%&IJ/&F":F,ZR!=>F&!Y9K\FR@N1"%KFR!2N%V2<(*@B")# M)R5+H5!QAJDX)EH0N6=D&24)TD+M7S& MD8M:.Y35@*W/9R5R((BB KTX)HHSF3I=6IRMFEP%BD&T6M&4 ,4$(3,*& MO2Q+9>^$$2-V=RV<1#Y^^0O>2>O%R=GEA 1FFQ0=(4"L$".3T*(41DP:$7$G MQ+A+@HV7[.;!4C-5\()VJ2$#VN9&5PH0.230).PHI=%\,G(YDRR\EXE/B!JL M@B(9N(8E4GF[9-' ;G-&(@R(.FJ$$@81)=36]ZCJ>_>D>6]*FO>@2?/^(-+0S&@N:3,B?YPFB_A9 M%)PME71"&1ZJD#![,7ATX;#IR$(5J#]#55S2A#E6T^0NB9^":"EWF67B3@@C M 2UD34<6'G7$ '7\J1WB2L^IK2F<X=UC',D#!'@1:RF+).#JG$6=WT'TN 04E[4H9K%F M5,[1;OQ+AJ-4;+X;OUF;V;MPZHF\^@%$[W;1<--T];OEWOPE";*,IAO9;/*H M/.41Q0U*Y&SULA)FU>-"(1"]KT+694(IB]K"EFDQC\-@&;"76LGB,PD\4:U$ M0K8((0=8L8&7 $$%*2PNET\MB"I)RR2X2S E(28=P2X!XLC'R72U$L[V*F%; MI- #KL@AEP1!$BV\+EF(PL6RH8$*%<1TW-)FDJ8Y3GJ11Z#BB$)2\!(BB26W.\S,G\N'O[[F$19*%H<@^FR1(H38I>E#&*P]27)"I;1M4B@@=_DA$ 5%%3D^J MQW9&2Y;B;!*MXF3#OG]-_B"HI43.6DY+%G0JW*95@K M[E-=VMY*+P(P?L%A^)9E["[Y(G(,DGD[#)' K/-F(X0(*:(D4D8 M4@NC0MK-!>TB>T3M9%&#)TP!HQ:W?%U;";IS:ULH"X@S2H"R.]QESH^];UQH M.;IBF6'Z7D3PA*^\S"NQ2>LK$[=]J5(%NGN;4B0+B$)*@-+[D[4.317C59QR MEC(F&1%7:QTKHL0[4O83QW 0^=PQM0@@>HAP*3+()*B2=<*%^<8+P\L\#2*< MRB>BCI1=+@@AMKG0$@'$!1$N"1>8**IDG7!AO,')FDQO'Y+X.7LL\[-*ZR:1 MMLL-)>0V1X2B@+BBPB?A3*6""ITJI:X;\KSL$XH761;E-16(6J:-%&R',YP< M),+(P'%L"?&2[K?')WR&I-5"E8IDU4\+AI+F.8R F&=Y(;SOH M56PQR!1\Q2.=/ @V&8+L4N7DO(LF7B=9WEX $ -X5+(4>4P0 M,4DG_7_I19^3?)LM=W=)O,281EFEM;72[;\9:MOE3*\JM=EDI J(9WWP2ABX M+P(URA@T9BR7FWDT:)QF/'FG :9ZE= 8EP.2[X$HER\<+!A7H'#(H M- !1SP"F[,"!:18/@0]0H8P:VH[69^D^"R#V+WPP"_9)?G09\4* MPT#7]NK-N#K=Q9Q6$00)^Z*5+?52U"P /= 8L;((]#=:"&*EG/;]\I67/K!Z MYNG%VO.V!3-QF*75O^PI6O[#;W7TR,)[X ).94(V2*<&2-DEEG!.(R4L+H2P M$B*LH&* "'$31)@N)KL''"I!)\3@@ K)44O!(T@7FH(D5)0M\5/W3!FF*<[2 MX0--X+_L.O,R(9L,$0-LLJ,M 8890EA<0.!\/E[,@;"@=.:-R,#)VN>$!"Y/ MC8X@,(:(TW_&8SH_.&3/RTL=AY-/_&?^>!T]>2!VF83;RDF1''/5/7IC+ M/!%#79N,ZE6=)L.,%,$PK@]:CH%$R3GM/GK)9YQ1)ZN\MQ'@5+P19:1ADV(& MT)O$4HB#H9,>8Y=$>PV4UBK.654>Z:4SO,1D4!!TMSA3TTJM8G4R- #?FA,5 M\F"890"2III&F3;+TJ$J30P9J8*AE MCE60CX9J(ERHILB+?!2S$_YERWEWSD@3[CEDF99/[IB3Q9D7WI@NZ63WU&DA MT#AQE\1;G&2[.P(U([2GRX,MW:Z23UIJ%;MV20^^;9#D\H LD18D;X(*%69Z M<"5_$B_(VR4Q8\V;[]^_83Q:_0N*JV0F<2L$1'PW.XN32$#G7[U0NW"NZ/YJK-D+OO!W=!#7;Q^X* MN]C!%@,6[5VW)<'P1PE/NE^]+:0A\";)L<\/ GEM9?*6V:.&W2&06!@2AY0( M!32B\O6VHW,:M1>853UV:B[IE&P2RJP"35:I-W!ISST-B.N39@9I;+L4C#E)^3EV6.%/]! M*;MD^Q,*:-)@OSBSVU^XK57>_W'P+^^_'[PE95,1\M=W?W@[^/X/[Y"74F_I M/_((H_=O!HA2A8E MX$^BD;<-,NXM2:VTU365I=8% R_U?BX;:Y:&M$HNXL@0LM"P3F-9CCS M@@C[8R^):'Z$X7*9;_*0WAF^PBOZ2J:D!4P4;9++O")-GNFUP%#.&*I@D[42 M1'XAZ9QVO/=I[*:Z]OO-_'U82T4I/O&*,96Z^LZ)HSM9/_! 'E8LQ"$Q$+ ( M9XA6NV'!?#' =&POA8J4+\/:935:/_%*[I:CL@K(5Z9=#3#3I1%,[7JU6%\T M5B' &'?G)=.$96?PV3KK#B>LJD:-(E=VQT!=A>1,E&D"9:0&KI:9]1H9&".+ MD<8>\>EC_RH%U[:O#5QG]PIIH P30#2U=\5V"DAFR?/D&6NYYI@D4YZA"FBV MZ7/ER2@7GRE/WI'[PSTG6"--1[O(?:96 S4P/#3'*ME^!C>C&H*KD=)=DTH[Y97<49.(PN63TD43<@F(?]8CB;&9 MBE-&:=PRT.F+>X T(A@D;XSFL=W@.@6E)F!(*FTW,8T2FH41PS4+T'V.,H)]3Q8#A[>'8NYPN2W+.WU&<9M/5ASCVV9D*3IZ" M)4[G<2AWW.0*=F=:'?#V/"N3!L,M+41^CDU95/::JJ"4"#IGTXM1]D3);F"Z-MD+>R?T0&6SA MO9"N,!A+HD,H3V%379ET'WP]PRDFS4=S\UZ1J3*,6>*FLD+2V5FI8]=7,H#? M]HH4"F"898*2]W0*'19UX>^UG%-LCL.0^FJ17^3@W0\86<"30L%J^)@6>"N, M3"H-AE9:B-RU$2\LPW@VE8)S.GW $3&C(:G$T-\$44!-+HWK5G-*JV751S*K M0LMO4JN H9@93LZU*K08T[R6GG.Z<9.\J3/@V+4R R>.) PYCSIN!P MI=A)NR%+!5U5FY).^,)#%3)F+P:4,QQ [A8V7;W11JB8$T?N&7,;1W&[!E7^ M9_6"SD#/)IN,J]'DEE8)S*1FBE3\RG90;*M_79JI;]PO^IKU^> %44K'AG1F MDTJ[8I@ LHQ7#5&0;.+QF7$(QOL2#!L_.&2F6B9M==Y30V[-?6)1,#Q2X^,/ M]S),$&0EE9QS1_2"SWV48"^D439T7"C<)U-EUZ\LR2ND>W")UP3#NUYPNS3< M"Z(UD41?T_WT;U $/?[DUVD\W6"Q+V MI&^/UCST Z[I?ES#Z(;$8:6#'C9'58G? &X.++ C2NI,]W6^@2QQ>BUM8"V> M=3!?DR]ZBS/MKDM'QBI]1/!:E&D* *.) %J7&D0&QM%XE6&ANCUPZ:7!4E(Q MB:Q-7BCA-ODA% 0SN:G0R:B"B.DI0E8'Z('*@^/.51#FF32T7BKMDC\=R"H& ME:)@.=3&9\(BO]!PSJ-?,'V4"/O#)S*YKO%M3I-135?-"P,JLV2N;I-I?2O5 MI)ZI+A@N]@3<)2?[#3V7A2"O* 4U,Z:!BM*75+<<@:;70WJ7 H"^NBH:L%A6 M!'0R:W!S;VL5XJ=A]3FC=@Y-^O3.:H>1:2N(_7GF)9G*]U;@Y(T.^>L20\G3 M:6HU'-L%HY'O=FR;4L5P(-<\*:Z+.2?*T/^?/,W8SM8BEN1F9'4CBP3L$VM# MMQW8^?V,)I)*@PR74?QWK*%F>!FO(U:**D'L^3]K-SVGG49LY_D\[S?!3*"6 M*BI,VHTN:9FH6:CS$25'E EFQ)RH(MT1\8FHTHB_>(7VI12>)]1! M4G*,/N\LP9:"6 M$)=H(_)&<_(!<;G[WL$:9ASY/1>[[X]>[,);.[K8:-"UO!0D]-5CG:UBNAIY MZ>-U&#_K;L.J5>Q.EGKP[6$LEP=C-@U \BN=*N4(F;^H$F):D!*0$#-/@=TE M\5/@8_]R=T^699.HOG\PI(^+%#FS-:'[!Q1D.5+AP(IVYO2>I8#A[\'0N<01 MP_G/Z/IF^LL<7<^F']'T;CP;+B:W']!PM)A\8D_$*R\#P''*[#H+3SAYB%-L M'I,B\Q+ 1*6T=I#H]D^T#$+8M[0)UC_SOXJ:6BEALUA8P"]R7Z%.!@2ZS%RI]0-C>(Z>4/'.;NJ..]I M1#,K3%=D[)%1D.WN2!TRNN)E&3LDC6&J;#630:\*M1(:&&G:8>(/!1,CO*;) MIU5N1R_4PAO(A)9^D&[CE%YA7Z%5\$)#*=(40 AU%;G9/L)2[1@(A*V?W4L! M$)SP6O&!'C6@)Z5BP_3[ZC(8)35?$J:!9&K.F[59?^.A?C+LW M[LTK*7_R7E\&&)X>")QS&!N2[,2"%G01KRZ(;PC$%C*O."7XKN/D*LX?LE4> M#I?+.)??Y%.KV'VW1 ^^_6B)7!X,]PQ \GO5-!/:0U9EB'&TUW+VF\&6#A3, MW:2>N!67A+^FEQF_*5:1AUQIM-RM(&_ O@IZ'%DWZ678DD!@K\.RJ7-?HQ'Q M!-?26!"9L-7=.27@UOZ:4!+,A**$QZ7/J.6HPQ)$3^1/<;)C6PS;!-.7P9U3 M:1(M$^J77>'B?QM[>660HO[Y!>,"++_(T+-BG4<:#+7!4+,W9.[HB=C+->YL MLU*^%]D\&X_TNM]RY2M;N74SO,3!$[78QNTD4G5+57EEU"3E]:!-XSTP"YZU M9X+TL*"4!,C#26GF ^F$K-%QRSP!?#7E&@KPN<:#Y5->E;,T0&K=%3[#5?F> M9I5/,/*9N\M<$W/.F17FEHQ]*JQFJ4E)\.G;HQ:"5UBI:IWWEDWI,(.\KPW_G[0Z:UVL]&)-ZIQIF,WJI!"VDQA2P="[?%F(P69?D9(3N MW=X^;<"I.N>>I#):^G7T7@4#Q9@%)*2"<'*!*Y9P[/"DJM+.N"VD^D"6XN)J M&:[$V\JO82$N1,P=^5,A%#^$P;K(.(XN&BORD/[JGJKF :_R8$SC F"&,HO8 M:JX-+EU;/]RBJ%EMJ!Y4UM)%7WJ*@'QE00!8;%!1 S8K2@%CA ^&K@O(G]Q^ M&L_[!.3;"3WP=E6J@>7O>9#@5I 962'J @7[%& U+*%WQ5I!"L;:T!;_O9%S M"WX"ZI$Y$BNT+779HA]7BO!(*SKC-6T?L:Y3JJJJHV2I2!$\016@5=P4GK## M2 _,57$29:0: <&JW&PUT'/*2UDUE)SL*H'GHP2PBHM!K0)E,]3?)"S$YWJP0C] ?BO[3_H2%9)#?A M-U'*T*[QRY+%*RD[D)+4$?L4)OP MNH=]W0)7Y4VG#TF<;^ECUD%*1@0Q<3GVI_4KC.?HFMX07LV0/[!Q3S;@>WX? M8J94!_7GMJ)(H0/T@-=!%)5YNPKPCH+9_Z$H"3 !DY/ZBTF):32)"1WM7$K- MM]N0Y0;RPBJ=T"1:Q7N^G:T*:W MII=AG.8)6]ZSA1/= HWBZ(+]A104I73A1!A^]":^MTMBQL4WW[]_P_@X_'4V M_:V,,KBFE[:%VT92*1O\TD"D/)*(..>+&I0KB/ UWR"O8XIP@TV3M1>6MYQ$Q M4G$8^%5FDSO2=M3,T;].5]=!Y$7+P OKO'BZ,^P3E6WU(OTIFZ-UN_X4!8,9 M!*>L#?>>8Z/L 6J5SN;69OETTJV_@/:? )6CT:,IDJ3Z2T:WEZAV^'B?C9&T^LJ'>+T=GXF;^VJ]AAO M K)8\H-L5\77WY,N2C(OB!3Q00>68962DCHHV* MEVU;^FVR5_O)U>3 MQ:_,!$X7/X]GZ/YV-)XMAI-;&G7F?.HL+W'0!PF(#[ T2#.J4+":CD +O)62 M0"KMG&?&$"7W;^@N_4D=O/OEP.[F>C(:W"S09O$&)QI#:*QMDZ,]J]0DJ:$J&);VP\MO(#%M1)L/ M5?KHF12 JA(@&5--977FU%P=$%F5)M54][7056=69^-/X]M[ $9SE&#B#]-, M71K[*!*T&FPA!=HZ?^:DP#!&"HT[OF6"[#$J2#:KNA].EDZWC/$^WN>'T5DL M4V4'2P[#"@F6'QI-,,SK!9=;EA2>WAS-QJ/QY-/P\F8\0+?CA7,^UFEA]CM) MVKQH"@V[MZ^UT-OWK:7B8#BFQRA-ZX/V*I#LG:!&.BNG5G',,*5%4\E#YIC. M>M&KH;>+Z>Q7YW2J,@2-XC1+R^Q_-+-IF06HG3'(V*0=7:K=ETU.T@3MUT^. M*A(,M4]3#_X5E:)4Q(H=H$;! U06/6!'Q,7!25$\4'O,((Z*Q%@%4)TY5FI8 MC9'00V]%/LC%P1!6CY&[U3<;WPTG5VC\GW?CV_EXWCA#&=W/9F.ZJSB?CQ?N MU\32>]T:8VR@9_GY +-J=-X04"N!8: I4C[M7J%'+"#59.:OUH5D\*05-'=( M^Q4!@IR&#FL???B4-7=H[V8TWJ8\@1[_]7YR]Y%83A@K\C*_(-UG8*&]7JC; M5%1J6+Z0KX/>N8HO$X=#-BU&CENE!C.)E0XDB]A)9%G5K)58T-PX'ER:BTW* M ZLLVK7L61080A^'7["O.;L?[]U1Y^2FDT&VTQC,KI!-*HH!-AG6E@!#'"&L M+A\*(4C6CMV$>(Q#'R=I@>XVSK"Y?>NA;_T.2Y]J<1=<3)3!D*\O8BX 9S$= M_>7GZ#;_YW_ZUW=O__@3\_L6 +8TZTI,5\T'+VQ*3/7)9 M90/2[6@>6:C5#N M_V6S_CJ#?G2I(,>&N@D.&ASB(E_?Z%#60SA17%P.Y\2I'4T_4J^67JPW8&6%B3+.Z(=2F-,W]93-5JS%O/2K3BH(ST -#Q!Y@N4BYZ>UH?+LHKQ^R+='1;'PU6:#99/X7 M %S<;(*L<&TB?\0RN*QQM&SM4^C"+ON589>=!U2O3=,>!0#B:W_4'''W93!S MVBH%Z/F[4;WU-K9?(>#XK+&[?4IX78S6V^*/'R<+>AA5&N(INQXTO@5Q-VB> M/Z3X]YQ4;8$H-NIU12BP+AF0:@'S.J$H<%?*03&&W+MJ=6+F\ M2SZI=UIEPF 9I;_*>#D?__6>!AK1VS< HU:J5K8CJ).?6T4[I]Y]BJ>K<9H%&R^3 M9JKO"MFDEQA@DU!M"3 4$L+JDN:^>-V@%G/.!]%3(07_)=54*=CDB1YXDS-R M:3#\T4+LUY>/W+P8,:[<+,LYH<=>0I/*T_,,_.CG\=7]#+R:SFXGMQ_F MZ&X\0_.?A[.Q\V%Z%:3>>IW@==DFI4.V,$G&8:AK.5K(O#J=F""](AC*]T&K M8O'59#[\\&$V_E!3M$PHY)R7C4%=ANO3<-?T)B9>&''+RM33T=H\=64].Y?]K3ENH+<.; &E5,ZJ\JM<%0M3=DC3<*ZT+QOG9L MA_MR-PJ]M*B7MCT$&FZ8*(4NIAXG#I!K,HP9'@C?0=:+&LU9$D%MQ6K)!($0R45.BXLE_&E9M#?J#QB"N[9 M(QD2QK.G1 N H3*;)X4J8%AFAE/IQ U_I5Y;N="X'I,%Q15BUQ0!48^XJWZ^ MS'[QZ$WB;%=Y +N>GIQI,6[(V:^28K::E0&0OKV J_C\RW V*QX_64P^04C MT!BBPFB(X3(+GOISN5]ACLSM 1666.$>)0%D]P'P51P'>XM<5V,V217A/^E) M>6]2,*0Q8-X0?<:#OM17,S:,JZ)Z"TLR3 ;%+VAZQZXD#R#.%;=Q](33#/O[ M5[=9D]Q'07;HT#FH3#>CYHCJBP?, 04"'"N'UT(UGY#;D;.J1M*/)Q.]16 8^S$ M5>.S"C3T6ZFQ6$+7QM^+=/_9HQ>AMA*8C<7C6TJ['WG23]B]>7GZQFG?U#Q= M^6!&X1DJ=8[Q9[@_>T9VW>)L0IIC@VE@NH@>+8'?_F"GAW\H>CBBH9/8OU%T MM!A>MZ^(% J)@/JFW'F;>>2ECW=)_!3XV+_\M21EH6Q9"C\:^SND-GB#Z!L554;LZ"T3ZFQ9)V+ M]P4,D$=[O"@#/=%"''6HZ'IN&80EZD:%.+S.,P&KN'V9[V^J;#TONG&%N*3H M6DWG7#L(KO"R+BJT4:&."OU!<8&2V!Y21B'A/@N"I*YL%CR0I%U= !P55\> MHFU%Z P5HNU#4%8 *'X2)WR)L9_2.Y84DDA9#JHVJT8G MIEJM!(:/ID@%3]TQ/41;"U6:13(JJEL$A3DGX>DN AMMPY_F(Z_SJKE^^_T4 M7P S<,Y2+56<;O,SC6Q,J/I0,1(;GV)9P,J/[;- @-F'/[+9N&WF3O^*><3O5@+L!%!A]9)L--_2J]7GZHRK[%8VW=G.< M<+ 5!7\I(ZU5F^XP6\0@]GRZ,;V3:!4G&U8A,]]/JNB*M$ME,E'4BG=#*17 T WY5RDTX%. M.]VLI*">^[FIA%*L(2+V"LLO0?8XRM,LWN"D6&/0T!T:4)5B?^&]B/KP@&+@ MS6''5$*XK*HZ^ERQ$N6]QQE.,#D+DG@^)NRJ M5 0+ SC9WK.>!TG5W'^D*WRD*^:AF_]RK!*OT.JUV)CGP*@Q>X> KY+V1LR M+?Z(ZI(0684CORP+>65ACAP=OBXT6KF/:=G+6W9=,NI+*/O.!"MWOE(J-4S, M $7XZ,!.2V:FB+R91,L$>RF^PL7_'D5N69'PC)"Z\OUMDK@\.//G\97@XM$? MZ96=% 41\M3VJC$^G ^-291ATK@T^>(5?L@Z&XB=5I,)VZ2S&G"3J&)),!14 MPN.> L$^\HD4F"W,.M_QS'O^2#R!)/!">CUNGF^W82"-4]6KV>62627:K%+K M .*7$5#NM2[O&6TJ<3@THU<*)A$+4DRUY.H(.Z&4$+"02"U)>/01P1-=^+@( MHHMM$J\)$$"\N:;G/X_8_Q#'OI8W'6$GO!$"%O*F)0F/-R)X7=Y4,FA-A1RM MXVK$9(FC;'#R.[1UFA ;S( U[ "5 MTF".,FMH-YK#2Y&@$]IP0(6Q& M8(I!ML,NVS+.::(!IJ=(*7]^DS&-AOX3_13YTQ5.@W5WOC!1<&$^Y,!%1H27 M=LX18X@JMI"9QBNUZ)]]IF>#-?-XE3U[2==FJ 3=L*0+5,R.2@H@*SK0-&Q( M2VGGDPO+V%;:OW);7QW"H%*P.>'H@3>G'KFTU\0XC MG]6B>+5/T1T&:M!VK_I %H=#5OU5%I&RJ/\B8V*UA5$4Y]PHM&XZ21Z],[V6 MIE1W=CO-H%+22VH*73#&I"=@P54BIC1 3(TQM58$L]$FK9INX\U$$<3;F=(ZLFC7O@U3*H%@8:L"1@QD&O#9UX0I8QZC'*XT!FA- M=9R3;;AG9',.,*M *]F 4@., M$V,$DS._<5IL.#,5+T2KX(788.\DVPR2_>?RR7%B4U;$^!.0+"_"*([2/*2Y MZZ^Q^*ZFF9ZUW>D^U:@WJTV4G#.J+U+!U1FJ2M\HJ'6+Y/:U-EIA"#?VRCI2 MHH;APGOA,MKSSI!4P;(CJP'><4TETLZI9@Q1RK%"PSF5.F_M,GA>R%Z.#E8! M]M6\,M9VD#/)M$J"_$DZ53#TZX=7QL7GSIWW,\^?I $>O51FLM2BUF=)"5AN M8NS(.6>( 3@9'7!UC./R_*T$4[W]K7ZS12H,;1&K!RH^8?,Z7>/N4'2%"=[B MH='B]89IGJ49<9*(831^S<#1*WEF36%R+SC1M0B]/LA>42-&&J6L)/TS6T?0B!TI,,1"P*+Z:56L4<@0 M?$T@C3P,^IB![))G_#OQ$%/&&G;B")C/JE<_#TDINJR5T)9J.2=HHT(B3Z%X1NA^ M&T?[ZDH:ZJ"2[+Y:?'!5VX\3]RX&#)D/QZXPN\M]H2AEY90/_&R]: ?LH9]& M-=FHK7+/RZ*SY/)6(^)TL%LA<#)A,"S4(=3[ARLO2-"&/?Q93/0RQIUC77)B MI^ F^#T/_/+0GOZ E5>'])KN7 %E5>1>@% -#%O-L2IL9'FEX#50K_4@=/^V M*-6!D5#ZRK6I+NQM'2WN5T!-MLL_795[_]-D%JP?,\%N7->ET:I9]3$-*]%R M*#4Z5JFW+9["S;PD4]'/$#/WPDKA'N:1CY.0O:1>GM6DS2SUCVGYJS3FYL"RG)/6M+I:)NL*>C7T-JP(E\8*TY]I, \QZ]Z:/AA2E%/L M )R2^+(=I"=HBT> ']]RI7/9EX%CCAKGR M1FKO; !H W0/)$#"=+YD@-\V6N.45 70;9VJ!!0&JW.=PPA-[0?Z9^R+FE^:FRW8.NHQ8=#,:B+L91&9(BA[V)=09L6YYEN?2A]I">&SM4<% M^EM!+:-?VZF#W4CF8F-V'"GOP!MC/OVYPY>[_?Y:^MFX(O^@&_!C]M_@=]_[ MPORRMMX/ZR2[^^[],$()C #>/@XWWD^895#;OJFL@#L ?$3W14!=X]=#U5HMO37[" -O%N<35?7<;+"098GXK=BCRX48-^>K$K< M^]G%7:!B6 ;L"RP#UA,I]/@#B!/=DW"_0QIMM&.\PGN/DB5A/B6,9,A@L MN>$,+^-U%/R=F&8V"CCAA\ ,I'/63K60J1^!-@ MQN1YZG6&T0AI6Z%L#^R+FZNLC*3%396M)C?M5:%6_CHC36BKD%ZH83Z'?O 6 M('_*56QOG'JK4?Z=5[&5K&NFD^PLRSX"\:+DN2HIWVPK%DUQH=Z,W1B@A^I2 M%'KPPE,\]PII/';.FUO1,.?O'/777^G8-6G2,XUHU:>_\'%N4/4C(KC 6H$' M?>,]]&X\6=3).U4WVD9BW3JX:6K.4MB% 6;QZ*[N1\18H:]WV$O2;V#8BB,, M;>-09!(5B_$SF73AEUZ3)Z!HJE/.^H+/P!JK9ZF;H0,_0*M]$? 'GS0P3=X> MY_#;3PX#U+ ]4R/W&M,GQO!Z!OQY*M[3H3>V"H!G%T=[1 !O\YROD@?M$N'B MP0J#Q>'K8!?478POFXE&53]J'\.UI7E@Y163%0L@&WSIVYAULW1L)\O,=.5E^-H+$E7V:9L 7M.F M9?^&/>5>I?G7P5H!F[77^@0LU5BU#GH-)N$L-I2UW]FV,'M__LMP"<2-:LB?@1)D&G1]$M*M_U)1O$\6K&.C'-?$I-P-Z0GC]P_ZH>O>; M^U^])=":R$_,2;W_;SFC_H1CM$5[3V%TW*WYAO?5S M/9!;B+;:Q;H3<'I\7Z*)L.LXG!KIHDIERL%T^.0% M(;W 3UJ$C?]3SXK:S[V*]8-AHYW$B=)\"\P8.W,%M4/1JQ1I:&0Q 0&)ESYB M;O[4,^ FN\G:%FIH,-[_5AC+BC;4^UC5^>P//;#8$:CS=JJAO*VS'?I-?-=1M5WD4<_/"@-]@ MR0?)KQG:X0PE]3<' MR&-Y,+^X4WM <>KPTM "]&$53> \OQS%2+^,OT';RW=)5:K.*67 +R28 UYN!3C0:I) MEE"2;6NE,[T"3U.5!A'[XC7NSF9""6MOGXNAU<^.MW]VWN]R3-RK#'LAM,+N M'9N[!&^]P"\W?4=YDF!I$*)$UJ:U4,)MF@FAH'.>F*#K,J:4K5QA]S%V$[(N MB$BQNU^2(,-7\7,DJ:5(T"99Y$";3.&EP-!$"JW+D5H0/1/)C/QKO%HY)\IP MN4QR[-\$WD,0!EF TY+IP\@GJ\NETMB8*EM]?ZA7A5J'A$::8(C7"RYW[ELH M@UF[TW\Y 3RFHT3Y"*10U&K8@P)L:^M8( >&/@IPW%YQ+8J8+)CU>J<. MNM6Z7-PA>Y0K=9DL5!;I5ND\DPS7Z.=U5U>8V$J_\2SO,,\>XX1N=4K\5H4& MO*,A0[P"I[900TQO@ I-M%=U;P!43X"/Z.9XD@;TJZ]3- KK6#C3):_C\]A[,<#:&RFW94D4Z$DM5%">(*0]00QU2I[62PM<_IN6OJ7C#_9"" MH'>O,?X>?5Z568S5ADQ:"[G?O+M+XB7&?GI-R%)=OI^N".(G+\-WH;=D$5M2 MF;'='N$^%VM..B288'O>"VZ7MAR0FM-V612#:A"A[9*\\4'6TK?0M6RMV M<-*8\SK+">+_X/3GC[A[S;&'VF]^O+36?^1;+)*Q%?'7/"/JA5EP1%@[?!W' M 17ZZ&?TMZ((VRM>H]HMB!'#!_9F0_=U=2D/_)!^O7COM&?+F6Q7)G!)N>[K M"L#J(PDZ+JU2*5:EF4F_A3B*YL'+@6.HUH35.WUA'S1^OG3+EN?':&S>P?TM< :$]**19GIZ@ MDG=BVAIHIM'0?Z(^+/G3%4Z#=:3J#EX:;*=(H:JZ)HZ05VK1/_M,SWT7S>-5 M]NPE?/R54 IPEW0@:KHB+:6==$#3;6Q/AY)I0Z< JUL,T7+;XWL_N#O%NYQ9 M]AY*GZZ2B(/L*#56:3=]#ZJ;%L_QXC'.4R_RAY&_>";UWMW$T9I&8TY8W&WP M1/=0(DF_]=2'U9&'@>_V[+LW[]X@JG9!]5"MB*BFVS&8T60&+!4%W0_C%Q#\ M,-1IP.I 4[C=+ON8AUFP#0,R!!]V;+LO924563B<3&YL'Y+51U@=KJF++N6;-=6N>=)#PQ^5#;W'!3"L+K' *G\9OESXR@G84GYVR M+J*APE0/4O\HSX=[&4.SLEY%[_:H"#?-M1^6WY+1RK)U4!+0O^11D+TV0RMI MB /ML*ZTU\\0G14_@B,@;;RF,7I- 29E?0D,.6H"03AI,*5YF9(U!U^V"M3!(F+"8#+J-I&\#E?JH+@ U2D W MP0H/4/W1+W>(C-E_PQX?_3#^ PZ.@QKHJ)%1?-')L&ALV!ZU5?UZ]ZF/WJ1& MT#:IRTNQU\$+H6^:XHRW-+P(K/Z1XI-= %Y12>0Q4>5 .B*%R3S?;D-F9KQP MY*6/0Y9_-!TF04J&+XV5G3YDQ2 OXOI7]REN=T#+F!U3G+7D*">H]'Y^.[PL M6/0\OB+\C=)]B6A)BBRSVZ;(*PHMXJCCJMAR+4+6)SE9@1CP_ES\N G(U.J3 MR748^6Q2O2?R"4-)KX@M\$MV&8J.6TP58?5\3]3=;J[5$9EY4$P+0'FK!/0W M6@9ZH(6X";^-D\_4SRG>4N2ZK?TSK,X18N,\LT*(##(FY6303"/,!GR $XEK MQ4G :FD9/*%9(T*(*+B-RNB5XPM46PNQ:7)]N=F9Q!%9V<3#/(LW,76%/R1Q MOKW)?%D(N5H>5B^8@>5V$0LMM%=#3 \11:?CX2J)MR,OF6XQS0(8KV94A[5"@.ZA/O6[9VF/"4TD!>>M,6)( A#(N(ZCMD MZ9*V&,SN$&*4=D4E[;07Z'5P(OM(F'2%GW 8JX:'2AA6CQ@@[?9+I<*&2$/) MK8_JA3@EE?CH)9\Q70[*/%6Q'*Q.48/DO%8JS3JCEG?:%1]P1);D(<$_]#=! M%*3LH8(GF=U2B\/J&".L7#Z=0HGU4%O-:3?=TN=;\3*G0*Z"!"^S.$DE?:20 MA=5!>J#<;8 XNJA54*UCU#5'G$43=R\ICPLOXR2)G^E1HY?AZSBYP=[^]>!F MY?0ZUDZ53>'7#-(IP**1(5H^M7ZMAAXJ/930I%DTGP*]MA52]7,%.-SB9P9O MN$XPYMV3UD"1B5JCD ;LWO:(Y6 11@V2LSGX&3%Q5,N?V][,EX_8ST,\7=4; MY@Q!VHUO('-;(Y4_2[#.Q0"T?)73%&PO'N:4#;%W*T]1*BQ*G[)*G,M:EDWC M7^*J],(VIJ+(&.8[A?N/E)G_$0NU8!_Z[W/9U';E.W47OX'40\\:[?M48Q_$ M8* $B[0]$'.1B"Q>B_*.+*=2C/]?Q<0L9DS,(Q\GX8X2E9&R^(L$-K,:TS "NI0/TB6M#?59^ICP8\MV8,5/TQP"0WY?*1SDGA;];'%&S[$FLHN3@-75,GASU8O=,/=+?/INVY1N IH2B.4/GDEAV/J'+]=JU7 MOXP=(XVZ(__(J%(2)BIU(;/1!+B.D96/OJM(R"R]*2G/>':3)<$R*Y/KW$SI%?G@CEX;5@290!<V" MV-[]0M@!7.F[(TWP2#L1B@>4Y;#Y'0Z,5IJOADQ>$=,%_'2?T7_;LN\(/V1U.Z&5L;RT\!CVZ2&N+ MBA-5OIWA\O#R8#'\-)4Q>;PH]8JM*:\JFIW&LG]-]U;/)\73S%%E^>=:/5=9 MC"HC6[S7J&:\7L<:I4WA=Q][D2K (J4A6LEC,&GMY!2YR%(+?-*X, A]'/MW:5]N3] M)5NI*"PV:7%RUVSK@$BB@2J5BA;HU+O"C6O M=9AIPB):7]B"RQ\;^KH.,UGE_C1+N;(OPX+1:M2B =[$93?5=,% @ZJ(Z*=0 M \L]/68E\9ILZ^?1GZ$;J\=]BZ@[P0ZR4*!^3MY.Y[1PEYVBQL7M%S.I 2KE MG#:RO'7!-:NF/1TU8R,P5$%87@I0\RK \=G!:E'7_&U T;0XS*8V:6-'3[1QU4K7!OPJ$1K_Q,Z"F%Z$2GS$40H[:MHZ[&K_0 M--IB(\\) 6IG.39YB%DEZKK-BU0=-X0$RE;?BT%L=P$Z>**^MZA33?0 =6DON,([]O0<]>M*_1M$NK@J >V+ -.)D^B)<"KN/B]LI "Z MVT0X#?NKH0JFG^X2O/4"_ZH\+RTGUBI1O'Q'\+"20/=LKPH8=GE99N7&LP4J M*PXYW:*46Z,[;]??XI9*H'M7AK6OK2WU(74<#377['V:Z$'O/AE<\QYD,?GN M-U-O<48?8"&.& U'\2]W]RGV)U&]]!PNL^!)VI7FVH 6' > YA/(9(B6@:I" MT,,.?4W+(;W[S3XG.MJ7Y:A_RT?^ +0O M 4HW3J*,X*<71N1NKU8)LJF4GHVBH]>/(4: /JR - ]YP\ MZZ+<3YX4)?T/M?)/7HC9#DEU>YN]6Q?Y[7]H2-[A)(A]WGM0,5VL-R%7(8AO&S1\2NX^0JSA^R51[R&^.JN,\^ M!0"RM8?A%N09Z)X #%!=-+OR.4JP'V2(G@:YCL\C:/--'A(KZU_A;8*7 >,> M^7.(V9OHD3_Z]5\ZG*AD214U=)P)[J ZCYA0&JOU$D<&]\90!T M3=ZZ,5:\6%NV"OT!DP(^>6$NW-XA?Q?Y.(3)#LRD3*SEL6 MQ,6;;ME4UPAE&+/_KO)##COY(4=DGDR\999[(! #]-JXK9VR;F.VOXK],QC=OA__$OA]<)W/P/ ""VJ *0-\ M,@)GS_\:$00#_J!O\P>)3:GKT;$H'V@NH"OZ7) 7)-*EEKVO0Z.YW4J?S9*W MB/R/9L8_L7I/HN)8P:X5;W\;T%:$]2J[L^$%(!;6R2 )"-[\IQOR)_+/U3^1 M_Z(CG/S+_P=02P,$% @ %H@.5V;OQJ3B. P*L# !4 !A>7)O+3(P M,C,P-C,P7W!R92YX;6SM?6MSXSB2[?<;"(I602QN[VRX; )'G)%Z) MS,0__NMQ[7<>2!1[8?#/%V^^>_VB0X)%Z'K!ZI\O;FV?DK,G/G0\D M()&3A-'?.Y\^"0A] _9AW_N_.V[-^^=SLN7@'8_D< - MH]OI<-?N?9)LXI]?O?KZ]>MW0?C@? VC+_%WBW -:W"6.$D:[UI[_?@Z_Y^L M^C]\+_CR,_M_=TY,.A2O(/[Y,?;^^8)]-__LUW??A='JU=O7K]^\^O?'F]GB MGJR=EU[ <%N0%]M:K!51O3?OW[]_Q?^Z+5HI^7@7^=MOO'NU[__#N-6OW M3P>%DJ<-5O')]A,[LG)(EUWQ86;K@/$R+\<;-JRIWFBA4M=JME>]>R=8D7@8S))P\>4^]%TZM0S^ M2+WDR:2;@&8:[K<3WU_[X5F #)+N M8A&F]#O!:A+ZW@+06[-6CN_UE#R0(-7WJUSN^"_G4L53LB#>@W/GDQ%)=-U0 M5CJ^3\. 2DFW,-HYI%+P^&]/(K)Q/'?PN"%!3.*MMO;2B$WQW3@&+%8F;331 MXY".=CZPV)2Y8;,5@$--M48T*TK)#@6 3HF*-S'OFR]-;:Y"M.V7;-OFL@TY ME97/TZ NR:L=WZ]>2.?C(,E7#:H4O8C0Z7KJQ5_T^T)MU2;ZMUY["5^)V1=" M/A'3,Q-@,@=4;6+=N8O)'RG]R(#-28 51ES^5"M@LRMA\RLB[+MSMO8T),-A M6\VMZ; ^BDNWM+[#N@2HVN!:#^N3I/AIUGU8%\U;:FT/ .TPH'+C^P&P#LHK MM;$W ,XHFGJM[1,,NJ>KW/:)L$_H3WX\/"[\U"7N=12N&9IIPL$<+P=.%-#U(YZ0:';O1"3O MHI:J&\X3PX7KZ))0?73Y5M!<-T#M--GS MSXQ MC&@)-(]H'&/U?7;."D8[X/ +32)J^0H8(POK)TF]Z#B#_)?CS>9J=%0 M68YONDEFIB1.(F^1Y&.KMN;#VFGM1%IK&,";:=6R;=KW&DVU:ODV[[]Q4\U; MQLW/C[#ZJIYN(A+3NIRW&_J+@RKD,2$!/7!O&V*]AOC))%[""N9N2V\Z+YF/ M4\K0I3]F)?-.;+OAAXN#+_O,%R@L.=YL_:JXQT],%M^MPH=7+O%>,538#QP> M#@W]Q^_\0]T[.@_<$9^W_SLM4RKRZ@2]VB(QIRV*.W58HMRG(F'= M:-$)([IL4JRW;3G1XH"FJHM47N+5AOOFO%S<>_Z.X644KF7HY$B$DHX6@:*? M. V:7?I]E_7AVG=68CA+18!XOL$ 5"@-%J)]$B\B;U.\3)4 >U 2B.];5'P% MLIT8YNW8F9*5%^?KYLZE2CTO2*H @7^'.5,HI45BH!L$J>-/R2:,-, ?E@3B M_3TFWB+9D&#^5^I$"8G\)PC2E<) L/^&";9$0B2\Y_30'WL,'PC@U=) Q'] MW7A(9$2"?'9/?)\=W9P I.6B\D#8?\2$72ZG!<#SHU"?+BUP[ M5@/#_9 O\ M%6F1&)B0R M=NJ1' .PKA8&HO\=$72(A*MZ#P(6BO2L*/O_@@UT2#PGJ:R]> M.'[6HVOZNU@-MZ X%'*4,Z=63%38?R-.! :]4!@*.6AB!A M0;4J?,LEH1BCG#55PJ'@W..W/OXP<,GCK^1)!72E*!1IE#.F4CP4J">1QVYI M9]Y"/VE4RT+!1CE9J@5$07ON/ Y=*A7WRV0@Z4&75H%BCW*L!(F+0L$P6(31 M)BR8BWO,S3!ZZH6N-! =A92NZU*XXOP_-UY WJBH$!8'WQ'A M$: 0TQ+8WYK!_A8..\HY5"NF);"_,X/]'1QVE+.H5DQ,V'OTQW$T#[]*;J"E MA:&0HYQ%-2)B LY7FG$TB<('+\O.HT.]4@,*/>(152TLJL)GBSQ$V[&=&"YDK4:D(%%^4LZI0 MG%-#RAB.B"-7W\,24$!1#J B84Z,YTW([C[NPT!ICZV6@N**\ 9^7"S*(!HOE[*9 M5U4>BCC*64\O*"[RPSA.262*OZ 6E 648Q]4Z%//,UEFBZN0'/ORG#N13GQR81"PC;S M#:ZN#M)QBF(45P'$VF(@K1#UU_!X/^6'O"41KWH]K^H,8=DE1*. X M(9(J\4X-=>IZ"7&S+EU[@1,LZ)%JGQA=@KJV%I0 G!A*H- HYOW/Q/=_#<*O MP8PX<1@0-]OJJRS\TBI0%A#O$#7BHE#P*?13BE+$'4$CR1B0%(5"CGAW*!$/ MQ_K3W9PS$JQ&4UH, C7B*JA47R3TL(Z[/W0/I.XN0]5.$OJP'%'_%" M42TLFO]\U*,+SRI4WYF7"D+11G2%%8J& O)L[?C^51I[ 8F5U#%'Y-[O/83A78D@I0T!$]6Y6BXH#_N(\CS^+?E,@+2H.S M$R#"+A42*^W&+M'QC+_E%TE05Y6'XHX:6"D7],3(\URLQ?T3[\R0GMM43@_Z M6E 64(ZK4*%QUM9")+]R:3TH!\4;\6 J$@PG9BJ]\[W%M1\ZRGWY03$HOHBG M4(%8*/!>.<&7*-TDBZ=)%"X(8=3XV@P#$7A.MUGLN5 MOY(0C].$OZ-+^Z_ MV2MC_HO?=UT>+W=&_4F8G1<4.53SZK#:QP^LHR3CC_P 9,C+Z09.12&;'3U& MR!X.+(E Q;[W M[J,'X:%:Y1SIJ$I12/B+0TJQ2_UP[7@B+XF\L*BL933(5*O$B$B2?2[K6DP( M'B;Z;3K^G:Z[=!>2>%0[#A_MF)'((_$O'XG$^L%J0RNC9=]5P'F(NXDTS>R) M:_(QI[7)4:0+@!)TML2 !5\2 1%1T(GI.?,^> M<:'_8>])/3@^LS%TDYX314]>L/KD^*GB) BL#LYBTRI1,@[".B)9PM]')_I" M$K:=WS_^*C6(G4ML*.W!1Q!Y$@*.V; MG)3#4MB[91,21/*A@W[X!NKV"=0#L>1<@"H#*6K^PJ4&109HH#,'Y*@>&ZV= M88QF+0WNF^WQYB:36MI#WKTD3!R?E\0;:]G+MQ.?/7!Z^/RM:I"I:@'Y;-YM MT63[#1&\)?/ F'[885?:-\2)R=1;W2?CY2T=VZS?HS"0CQ]6'5P;2$/SCHP@ M&HQ$L61ZZY,-NS?*!)./CE(Q\&D4=3P(94-'7 >U*<8V'/F?P:IQXSEWGL^/ M573JK#X^K;?6)'9K"]H%P>2E5KI@( UF)[@5AR&XB)4CJ!5\12?P3BLT0V<9S9V[L#"4I-8,(\:T*&1&YZ,0!J-S@*B4A#+1HAW#D F9M.@T M=%V7>^\[_L3QW&'0(DPQO#V# MKURB+]N2[!)]>8F^O$1?7J(O+]&7K=)PB;Y4[.LNT9>7Z,M+].4E^O*4=N\L MXU W3>[#R/O/_A"D,X%7ZYU+="9,?LMHHJ? <<1%=+FY>$(BWG,H7?+ZV/&< M-7G3 6(9?YF:\?SWAD-L6P<[G/.H\74HN)7"YG,@J#)V7">8,@,H;*(-OL-05L+>J=>AR=K-1:6/NI5)6@$[VK,^+9:M M28;I3V52U5F-6CM"U2<'MA2=\NIG_X34>)G[%1:?@#ZX]OD>=NVS;[(3+CO[ M1O'3;;)\IVNRZY_^CD=: CP>/"3YEN ML: Q^K_NW'E4>4[4: SY-*PAL.)%41LN"^;-.!DO/X2AR^^<2?3@+4@\"WWE M:B:O@WT>-F-.+STZ01^B,(XG4;A4>2<=%,(^ZII1()#OC-U;=B[S>4X,0)HV M117LX[ 9DUK9T7JX **!S M-2.^S];,P,TR9NWE4]RG*^I@'X!-6=++CT[1!Q)0F7S:Q:Z[]@*/R<->$-3R MI*V(?2PV)0N(!#IC%;D,EB7\\[ I*U)IG\,&(UN;;T+ALXUE (J%L5,@U=Q4 M5.4]8Q9'81 >"K;-H:;=+@*J8F=7,F,8C 7Z[%GLZ0?'"V*FC:HY5%H!/>\2 M''0Y60((T"GB"0BKPBFF2%D%]+1-=2G20(!.D2@![FT0$<=G=SQ,J=2+&K0^ M>G*FN@2: 60EG]-29WQ L>AJN-XX7<3.^&>=UOX&>":I) MO3@.:'3=D4)18_]C0>*H)E95(0SGO-4E">2H4BJ&GF3*< \K$O*,2=O& V\= M8ZZ4G1OO*):&"CB[ ^\DOY6QRLI_TK'"SK%[_S9V83QWSO9Y_#]E0J!T/4R M<8&J7T+4CPI1KY$_Y!*CWBHGEQCU\Z/C$J/>-@W'QZC_B#<^LJC3P^@>:43N MSE-#40G;']*4%@ "+<5&%X.Q@02P>OIJV/Z08 I@XIR"A)GW:$Z!M!*V&V,= M C0(H)]4=S)E6\%>N-Z$ 3MU %=S<37+EA+0BBZ6I#"HD>QUA]W2+>R2XI81 MHE*VLME.+!#Z$F^VMEN^J!OP8?5L5@A@TS$B*(KM@%V'#JG$Z%Q(LOCJ>-%4 MPW:_KL,1" ETOLHY?'5$R[3%/!+G_K7.OAI9R!7-N=)8-?]GS1.^(W,/)1,Z5SZ.R$91\.HR7QDC12.9,?W[(U^V30OJ0_F,*(K1*O>D/A9@G1^D.>X#?_]+7[DXQ$;<=;]1G9R@\ ]VXVX M 8>MN<[5WXJW2"&:]Y43WU_[X5=)!J@?:OE:T38[O%&K/*IVHAHY4@EJH:U8 MK"^3*'SP*,]73[>4AF&PB\OM+A+O(7NS1A^[6J,M6_(B*XBL+H(U$4-?*=L- MUF@M[*8^X&V&<3R0Z"Z,B3W&#W9H#A:>3P[DG(>-C>]VOH9M0VM,O=HD WWJ MZ!/*R\++6 G<[CJ,$N\__)]RA5%6PC9NM4I7",?!$H*W(:;C8.;X9+RD4E,Y MDZ>)[V1W-CR-E)QK:'UL*]4):3>#U'PA>I\M1 %9L>TR_NGMJFS" @AP>6;,3R)"%S&WGTNR3>D6 MN'S?PY>S*X%73%!\IDIT7:>G#A/=9>2754;DN.UM8Z4\#GKRU>A ME%%*)?"<.\_G.RE#1:C4MB''7@NZ($'IF:G#H6UW*Z_".]&@"1NR_#6M&!J\ MT \1<$^!)GRD+$@'V*3GC2%R9YQ=52(LVTG'#;G4*=M"SS78G%,= #/T68%N M:;:!3XL_4B\B!]?\=/<+<)XP:0/L+W7B60'"55A;ZF=P:JB(*[+"&^B(N#I4 M/4[MKMF >JCP>EZ:,:2$!2N/2JJS/P"J0C7BU!Z6#6B$#*>SU@8X7$WL&^#Z MT=Z+&4WIASER9[S-9)*R_V.+Y(/C$VZEW\9*LC_0!?3P%X62681E]0B67_D. M'A<\L_&4#H;!8:"814_;"ZABMQ^P?2+%KLG3V:YV MJO?SB>1.-QN? ^WX6Z"'P3*,UAG7^CA9: -0E6H_ MB2L]8K*2HH)0V-N+M3?$,%3+8XDAL9 &Y8UBS%G-S5Z#98D(BE M#CTP]1R,UY_*X_5F^*_;87\X_XT/UO'\E\&TT?:^2#H/KXXUINI!7-USF *%_8Q:NEX[ MT=-X.?-6@;?T%NPR+O/?8KG9Z)2RD ZK]^5A-;O]^+$[_8TM>[/AA]'P>MCK MCN:=;J\WOJ7#:O2A,QG?#'MUQ]?QH1\5P0!Y,!1UD+:.*J94 W&[#P/61U[= M]&25]Y=&N""/NREY($$J&5EO7I='UG3P:3"ZQ1HW>6>O*45TG\$Y^.PE][TT M3L(UB?2#"-P 5MIU9?< 8PK> O*H,J2RDJ/=#"CD058-:!F11#SBWI1'7+YH MS>C0ZPV&G[I7-X._=D:#.7CD\4]YW%.\/>WUTH@A4K(V'XR<=^61 M,YD.)MUAOS/X]V0PF@UF!:-$[W8Z'; CU&PVF"/M_K8A7KTP3N+,E"RIPC-@@"HK(8_/A@@N)SO2PX0^A#,/Y*+SL72#^'UUU#+3 M?FY"'/SK=CCY2$#_7*)--JRX%:V\',Q'!]P-%-6PCVCY5W;]NP@9--H ML-5N$'O_\W8P_GZH6/GGX]ZOOXQO^H/I[,]_^NGMFQ__ MSM>_.=+)+^N\?O"5R]GR@,DH3(C1"#-H GE,B:G1OG.B0<2&@?.R\KB9>/14 M7$7XZ'EYU9W1%:PW_LB6,.X>@G2VVW5MO#Q\JG&CW:?"0-U4-G>#ZFK83U( M7F"(]=!HL875QK[5@]!5>;4<#@OZ&%NOO2S=(1M@W)U^10*I9\J;BF<*76D_ M#N?,0),/L#'W1QF,\)Q1%$*9&%$-F\$:@H!.@@:C63O8%X-U**X,TSK086^1 MT[N8_)'2I@;L(D<\2M]6O%QFMUI)D%Q[,WP7KPJ/<>T@0BZP&5E3.87\@ MATIY%>QGVS1T5&)N-+*CCPV(QZ72\_)MQ5L%[GG9^FATI%?$>Y'/9#B,9LB 5%QU^4QR?3 M%3D7JCK8+P@:\Z(' )VCW*V3)9)?L3 %@QD-4!7][3]3QL!PH!,G?E9LO,F# MP(;\A.\]$'8GK!UUM1I#?^'/.$J@/F3H= ^<**"2LB0Q7 SP*-561'^*SY1& M(!1GL=>?\WMG\4Z_XF9KLM//&K[L\X^981?WQ$W9@YY=VB_7\U,V.>Q7\NSA M).)F(1'K3;H-N2TK*.0(WL*WSNU,T1[>E@1\J09[Q3-X&_:%/)2?>_P7Q=Q9 MK2*6#I+K4M[=.3!,!5@=^X[HJ,@O(XCPW0JK85^J<5?Q[94%?R&/P_., BM, MZ3DQS+\GO@D=?E^>YZ8(5D:A84[SN6!&= E#M["V<6:F8*#'K2BCSM3#;:*.R\X^@QY,%["T&2#6J( M1L-:WP:V"V(K06KF(*(/?V',FFK$5UR0%9%KR&/\FPIA.R9PS9YQV7BXFFTC MKA2DIAII%=?>B4L"5^=*G;P-[B!E'IID#A'U14HD!4HVS M:N(Y:4@:\H@[L]BTG=IP/JZ>>KX39PH#&4B"2KJ14U&^5@80+ Q-)-SK2R# A:U7"?W%Q._@ Z%G9U4PL3O'Y.ZQPSCRA;K&'W4=/08VB MRKG2HQ"IX">'/W#ZX=KQ MBHV9:UA!.=GBD&S%:2_3:ERF?=X%#F%^MB^>ZTQFLW:P[X&:R,3QW'86C3%B[O/YXC,PS]N M6DT@;6,O R@Z P?=(OT9A?SU:%)XYY'+<1MXR1&J4ZM9["-ORUIS!-16OT#5 M)_0G/QZQW1-S71?O02H!W-H7J3I_R5ON[)JNMR]Y%J]4-3CF>Z%/90@S2+ML MS[LBVW0;5$D7DC_/Z4\Q%8#-;^ ;DN:^A6R5;.*UK!;1L>"ZYGA9*BBI^AI*4OP;4P()"NBW5E5)';%P4F-Q MWI)Q0W8H@%*9RWF8345LYR*LD-XAC1;W=%?<746$=T)IT0?4P[YDJ:F-13,_ M&)UVCH-QE!2&'?W7?LC1?_P^9[MS%@'@TG.'FSJ^9.ZD925%[1@V[<^;<@0* M!U)$XEA,(S^B,@GNOM:N1S:%%D'9.$R)I848IJEA" MJUI-]=S8,@&6NJ:;!R7%L7>,6A53$V+9'#@BR9#.!VO"@K;E7)2*87MSM&"" M*K$FQ*7 UF;KT'.38241['UF6 ]8=HF\+"+3/2>^GT0A7_5T&Q-W&(PW MA $5K/*;"4^52M*D#>R[P=,HB2&D9ZU!3%:6J9O^A\4=/#@^AY-B$$5/5-Q/ MCI\J+@N U;%O!T^@-T9 FJO,NTQE'DAT%\8$565$*4+S4&2YHB@K82__)U / M &B82B$Q$GX.HR]4=_, =HE%L%P(W9&W139%\EJRZ^/^",,X3HG;IPH6K"8D M\D*7.SW$(_*5_TD9Z .KCYU\\P2#U0Q*6YGG*TY]XLO5@;S_\/QX%P.)3CO= MHBX(<6.6(X]US0D6F?/3.O=GDU,.J JD^\%-91G.?++&35S5W M;^^70?_V9L"2]W9'\V%_>',['WX:=&:#WNUTR-V\!O_NW=SV!_W.]73\D;NC MW\XS;W1::="=CH:C#[/.9##MS'[I3@<[M[!+EE\KLOQ"/<&:^8X=IE?$)+^V MN'L=*4=E7A4,FL:^8(?2M#/DRIXAC8&&[]YUI"Q73^(&U'=YK7[THHC-X(CO MK";LW,A9:Z\5]37M4)(3##Z0QA21P;ZH'*PW?OA$2"'21W=9J:B"?1$"U>'R M.R0Z$- /M:7X&AU%DN+8-JJ:]"B%;RG#0S6@B=L_E#Z@FCI ]-_;@CY )$M& M1Q[EKAL5I6+0R:H]A]QZPT$H+3H'AVD_=%2(2T,9:SHQ!RYZ^FN MF5F@MW(XY #;[ IZ#@T605MY*\GD8;2&0FDOUM.2]31/ M'3,,EF&TWB=B@1A$I54M.0#6MW%*)<,W6U:[!K!$*BO9P198(ZOW5W+16C(! M:@)<\BZ-HQF)'KR%S/>>%A67/%-"I/*T8^R"DL;V' M:FTX[>K>!&Z-#):, \W& M,+L38]H2QX3^KSMW'FMO[\6-X2?_!NT=*TXPM7$[XT-O+C7P.K'R!GU^C+7H MLM#R$ZTLX#5_1F)*68T>A%%S/ 2T4@QYK-4\A8IED4Z@2$%/V65F/"4+XCVP M8X#2 %1Y,OX@CBF[7Y_1 =,;##]UKV[033\].DEY"4M)HA\3HK)(SC854CY$ MM%M:X[FN'G86&BD994<7D/SHFY"N[X=?65SC=1CUP_0N6:9^M>MZULR:P;:J MPUFL \]9YWNI2L<2WIB/VF(M].PN]0=M5?C:>\@D3!P?<09G\:VSVD*$1V=H&"2$ IAT [=/[A*MBX&L_-DLBFJ!K3D%LGS# M :7[27GX^TEU^!N./@U&\_'T-^PCWUZ675?UJYBR$E[V:]ZEJ?/U(]W:1I[C M<_-MNMGXRJ23^IK(RQ* (D%"; @8%LQP>4=9(K-AP+/@J/+$RLICKSM'4"24 MW!YBKIE?%YWX/H2A"R&F5!Y[Z3F"&*'D]A!#3U0 .G@I[)R61Y!0D/)L3\/E M[8+F!/R^O&^H[A70C[S/;M>06UXT3H"2XG8X*QTQR@[%P7?UVW7L1N_<)RIK M&2$BY9)1<6-3YJ1)>N=[B]N$O6)/MXV[3JI3'ZEKG1\W:GG0)C;YQ[A,*XL+C M$,H'Q&$I6P[^E66P[ 4ND,T::]DD(AO')GK5!*K#&G?OU89 MTB;3P:0[['<&_YX,1K/!K/ *>.]V.AVP1 :SV6 ^PS:T]?,C"W_^/4_8[OV' MN#D\6UAR/ RVU4+ M-^KCQ7@RF,Y_X\>*P;]NAY./]$AQZ("&=*#8RCKQ63*X@L#Z(P.@J@4)T<1= M-,F+IFS!$KL6E$55EC2EG/CF?&D/*W8- U6]LGG% M;8.:BP%(Y>=-9E%2_)L#J6B0JP-(93O(-%!:*(_MWR%DR6GI5JWP5>5-@JH" MMH7&0-.*9TL]!NCGDNLT"KR$[<,#]]I[9#_%NAP#JCK8%H(:3 &DLH2L&^: M?Q_Z[G"]B<*'[!$_'5O*2MB'QOIT ;!HR8ZV'=5;8Q%H5BL7QGX3\L@932P[ M^@"12L4C2FML!O)Z^*DH@0<0Z/I_@ :9RGMA$*<^>X[FFDAS:L&J M8D^/>O2+)T\3.&PXT/#.,FI]?^X\ MY"4-5!G^G@7 &DL82D/$GF-FE;+EC/ M=ZAZ+3WB MPR@ V@GPR,Z3/$IB5+VU:)TFAQ[\2J,52<(2JET6W2]68ZB=3H MXR;OWXWGW.7Q%="Y350%VR.M]M0FE_]LS\J%6^/,)9)'/Q2>*57N_93/A4RZ MO[&3F98L"T[8L3/) H\5A2OX/U?$8BNGWY M17.##:N,?4:5*]'A!;8)%*UY$*@[,:>U=6X%!BU@'S^;848 "A(],^_Q*'(* M];&/ILU04P$$_8Q:ZN8]Q2(>ITF<. %[\$)ET]%4Q,[QJMIC5F-G("!@WBU) M1B!?2MU/CI^2\A$T4SG)R /4LVF9DA((E*7569"["/%."/L@84!;RZ;%2(D_ M4'[+IKK"5)W]&'-?'D\3$0]LP:;ERFSVT^."3J1\E>4S]S".4^+>;L)@+X#B MF%2G,6Q;K F]1Z"%SG2QBUP')R3BOU-8).15L'VX35C32H[.S:$RW7A_I)Z; M.T2R/Q!=;A%]92!?/]C EP$:Y\ <7\F/HB]O =M]OV$.#W!I^#R Y.IUV6A:LW'WX:SM$3WI_7=56NISD;XVCJK>X3 MT$%<7Q/Y) ZZL8+*7WO,;?@C+?28$B6H/IY"00>/)%IX,>$K_>Z/MG MS>:P#_?U=0(*%;:BR PV; ]WY<0L_1\.Z56U8L[2RV:42MO38CU^YU@&B\?F _[_9XC( MIT1;,SO6( /:(K9)I"979H!A4%F++3@AK5D[CB3$QN%S%"7Z-K'M'>T,(61" M-UYDRE=>!=MT49N. Y&M&CXUR("U".3J)^NX,@$,W7#8GI'B][=@#M_;=R8M M"=+( 700X ;^VV"G,- *[LULF5I Q+-!5S!-%0/^_\_!3F':4ZCB(MG8K,7M M_.]6V.T12[A%HC@#"I9#XX?*[0J+^OEE?-,?3&=__M-/;]_\^'>>2F-NT0.! MYW7+4H@&T*E^+--]> C1L9^PPUO?-.#H6*GQPY-J3XLW^EBF)MJV0R\:'TLB M#Y@CD6HIIBJ.DH(>T7_M=8C^X_#M M1%B9\O792^ZGQ.="QO?>9AX.@H2MX[*0*Y% ND:0.99SH.=*)UH[P5FC,* G MJD7*=CM]+R(+6E&>U)554=9 NP*O@VAU[PY ]U>E,T VG3QI6+/?/(3"UVX MLK9TTR.55@Y M7XK43()WNQO,^==P?A^FL1.P1]CF7VG7GV["8,4,D\-@0?])]UJL*\I-IW$K MV/.=>J:J)9(E$QB?5+,8FGX:><%JDOEV\MB:TMS+Q[PF^WW=]I =L)NS9U52 MI1R#+[YZ8$27X6U;:K-L$(IV?CF7C75X1)+Q\CJ,EH0_@M/D=%%M&MO3V9ZI M0P;[62L?!74=!H5HW%EZ%R\B[XZX5VER&W@<((57!; ^MB-U:VID!J UF<)Y MAU_>E0%1!M_]J J^XU?%+Z^ZLT&_TQM_9&G#N_/A>(0=A+?O\'A9E)3;.O,G MD#EQ=P7F \WY*%N$JX,]$\XF2 M2PB^BF[T1]O\JZK#8O*2M^>6BCA0,],*NF=SB*IJ68'RP#MA7'5KOF2GIH( ME>N^&[A]\D#\4/^4L+H*MD4#I%-%.R4$@9;B869.EAK_HQ-](>R9%27NTM+8 M07O&D&OD;BOE'@E(Q-^UZ;IKCY[RDLP)5@FZKA)V_(DQ]C 4T,VL^:I'7/&B MF#^7I7 / =;'3G/2SA:[[#9B!.8Y>]&GZ[43/4EM)?S7>;0!*'G13Q7[R>W' MC]WI;RKSR5_SES?&$_:OV5^M26YTL:L('R[0&41*Y>S87K9CR2B)BF^"V"]L M "]Y05D[R!*KF@Q\JP[ANUYE$1U,U<* JQ+LB0]QM7.D12P)^AFZU"W=V5E2 MW#)"5,I6-GR)!<+V:BS<,>D\&@5%L0_12J62WZ99=H:H?8%8C4<=I6H.6_@4 MMO^/=.5M*N1*AS)V,CZ;]*\4"7V0). D6JGN /9\A:&L$$J>API7CM%5O.Z, M\9(%\[_5J/.I.X/N3&6DVCA4G?U*7W 1&P:98:V]657X,71GJU/-H JH[5X*=BK,Y!6R))/NUT^+CC$%2KM:N*?%.-+;D[+))!:T^T1BH M:VN)56T[T[2HQ#C^U.6 )'FD=E3 M]L'Z"?KZJK!V[G_A2ACD!EWN ?E=OG?+6)-%\V_$^VW8$9,7LWL]TRW$( M%L:TWGP7T;T/SGW,7)8"&^TO5G@JG)]J"U!\/@XZWXP)QD#Y6WMP]QD889Z+ M9X\R/Z+Z';V_O1:^HZ=*CHC^BM[%J^?BU7/QZK%T*UF9W2]>/=^Z5\_E912C MEU'P7'HN+Z.8 :Y_&:6!9U&>VYLHY_,@RL4;\?(@7\T=S,4;\0R]$7B8HJUCL+-.>5J 4.?2H_J:,IWMWYM^)H^IE9H!39FO-RI6+6WQXW1Y\0 MH'9HNSSO?MR&2ON\>\,O95Z>=Z]R?'G>'7J"O+SO?LDHBF$(!24C_?Z2C/22 MC/3TR4A;V^\_CVRDA9[UG(V7.#X?_^S=2A(]$/JY16K511=>'VI!D+DOY$A-W'QS/9TL&E92[=K1PX:C](K;EW3X/-"!)=FCA M$5Y&GPI>=%MIVW,-$W_->A,CE@N8BAP[-.^(0)4\.14;56VGLQ-\RGH;*%;\ MD)06.Q3NZ-&T=8??>4^^:7NZ$WW1>ALN[I0G)^GLM; POH9!$GE!["W:UD/5 M-Y]W7$VK1*'KHF6/[)U?@$KMA_4L?M![%S? $8CG(3U3%__.O()'8?(;2?9O M$1;?U0-X";3[^6<;$7)2^M"5M;W@K[/-J/'3V:GLJ4EL^.U2!(V/F:&28L%2 M+E/9^.\T*BJN@OTR<;LZI8+IK)6@8-#.!)VE=_$B\NZ(>Y4FMX''Y0;=#2CK MXUUUG_!* ("@I>NB+ MVO517_,YD%41"CT.N-K%;0=UCHWZFI8R)M%)+7=E\; ]'F>.SWS 'DB0DA'1 M1LA(BF.[-4$5L'Q>4@F/?M[M+A9A&B2T@POB/; 90L>.O :VC:LF03H(T#EB M)XWQ\D,8NO$D"MUTP1^AT_L.JVJA'^YJD@7!P@+"*A.Y/F)?6#U;M+2D <% B8+^Z/Q/&&VU2A;P1PN*REDZV\F"F44B MH$0RLR#Y\?*@.ZJ8945Q_.ADN?X4D%=(T$X0\O8K8\46F144E$-;$]0X'6(J MZ7LS\X@&4Q"@Z+EFZJ)Y4BCG7T,0FH5R:&[F=0&MR-@VIK04;- ?E$1S4:R- M:U7.EI#=;E^4H)8+X6W33 $5B]]DH#/U"3! =TU:K[TDRVP?N+3#B1>L2+#P2 QS37I; M=4WZ^'$X_S@8S7._I/%H/AQ]&(QZP\','L\DE> [2H;-(">=TCWQ4"IG MB]&I!E.RU%'6>"SM>E291!2\W-CFH236+!GX-VUY),5D\=TJ?'CE$B_#GOZP MAYS^X_<;LG+\ 4\@)S&\TE*50N< LJC?C3H/Z<$=J'-!TB(#FQ(]BA"K8#HX M0?[&'@GH[B#LIG27%[*U\$,4IIN;Q%7;5'2UT R!%=@$)A68R"V="?I1N.DY MT7A#V-XC6 V#A1)J17FTR'\ R%HQVSIRD6CM!1R":R+:9_ C2ZD0=FXVZ3I\ M<,X22H9^R)I$9.-X;AYIWTLC)K!\'R$ICGTUKZ= W7]+R.@N%E%*W!O/N?-\ MC[G3:PE15$%/ZP4E12LV.C$%'S9Z@,B#D.)9N)=>Z_0I*C5YP=&Z& MP0,5)(R>/D=>0OKA5X4[F*@L>BHH*!=R0=$YD(Y@JC2C,%C4GL5*]=&3)1T] MI0D!0;;@L?AN\D=*FQHP#0.:[=Y57GR]O9H-_G4[&,T[@T_<>&>-J:XLH=XJ M)Z^!Y:)WT!^=&4Y8VA);A(:+BCN>2!0+K&^'_8+8X*0UK"1&:8^3BH(?)U@6 M0^O&+ZUP[K14G/?Q0@$%/=,^CB>O8BT<*(H93"('>O!1\>&9; OO['\SIS_%= ?#4G-H M8S%-&[*#0J4ZEL\^IB*VDS1:W#LQZ:XBPCNA]CO3U\.>ZFIJ MXX&#&A0=])EP=^;N^4X3BY+.^$P)F;10I>TD9B" MLI:0H5.PLDU4($E;4UA$!^@O,Y:*H,>26T6)1S5ELDW3IGZ1*AOF!BU@3VMR M=3J!)^"% M3@"J%M!O>X^9"_30G/6LD"]L^6O:XVCJK>Z3<9K$B1.X5+NUNR9%3?2K9#/> MH5"@CUUA1_,W20A7S=T?X_ROL2HLH5YSZ)?3#; +!0V=\DD4+@AQXVN*PO:Y MR_&2=ON!'A FOK/@IP359 VKCWZ+;3I5F\!B=)>=_X7]/_8,$/W-_P=02P,$ M% @ %H@.5SIQT$,O" ^$H H !E>#,Q+3$N:'1M[5Q;4]LX%'[O M3/^#EIGNP(Q#")1]2-+, $FWF6&!A71W^JC8=C^1F\&G\]Z[G5#)M$D:!TE*!CQFAERP";E6,96>N^&1&Z9YN ,5H>K5 MU]9KD9CJ$9=-@D4/6B1E=VF-"CZ"6YJ/HG2G\ZL7<2'/'W]ZJBQWVC7 M/\*TP_TZ]ME9T[C^R4S*P^GZ1E:LRCH'X3.9,KW6U3GK70_Z[_MG)X/^Y<7- MZU9HR:?Q(4#9BVH.M MHK%_DD8T;6[Y4%>OU^#D]+Q'SGKGYS=7)V?]B]_?[1SLV.NKDVZWN/[J@4YX MD$98].!-BPR5#IBN 1Q!$P/PBK]VK-]H#ZZ_OH,QKHQ/13%]J4IVJ,$9/2 ME,4@C=!J*7@J,&M.!0FI#["C@"AXK.>>@NA-QSQ(LU! M"0P!FZMMH&Y3"9TJ,5(E1GZV7W@FS'1O&YDQ8 8Z*L29#;$>9R\/0T"?9B#J MGEH%@\ A(T5W>6"G,@T-@#H:6E,@Q0 MI: -L69"T:XR05%GP@ MDEF "35>KE@?J@8&AP')P.N>#I%(/W57VCY[)D;GG:^9M[16=)"@?'!@1W^="23"?@ M+(Q-._@^B#J+PN8D1TPR307X#'C"$O1(6"23J?,+X+EX DJ\,N'--.'*,U3; M:@T@_:WT#&Q,18:J>O9^A84A\U,^!IHS*W*C9<[E"?&"NYRE2^]):8P;H"+( M?..2LD.5I8_ >$I80\O2#'//X>,OC<@04]N8U;8.+I\3 -5R<*"'RN@VTN@J M+J^VU3KT\E9R>4Z.!9#,A3T_;)2D[_"FV/61WE^YE&/IW+GBRWZN#$ MRJ3P$(]J0H,&MBKY[(X:D=T'T(3@(D!P+Y3.T?O V?9@ YYYD%D);L]!BZ@I MDTXHU:TW84&>G0*M;V^[)ZOUL >I4NQ5BOW;%^'X M!;[(LT<62ZKS9MH-]>0\R_K*C+99&56O:_[,FJ1GU_"Q"@'?L-W\?AJW^<,B"@/G,M79A-&;S$(=NE( M&P;;E*H]PUD<:GJ0XU:J-_=BB^J2B%<((1I ;<-*'?0@'^:)6*@"I ;VY+EP MW,!\F"P&7H&)L"/*E>C*@V!5J+WA,5$5:E?;JGJA5C"XS(_%AQK4GP=\RJQP M!4:VQ]ASZO9<+,KE6(DQPX!4TE%^)%_G6I?%B5!3!D\GD7+JEMYS#$#D7PC9 MBUC_BK&\%NOCVH)F?0LQ&L."D\=8CAP>'1S]62ZYU%)6/ MV& ?\7,6)S?PH4I3%>=82&/_&-JW9]$<[)\[,^U^IV[J#OJ#__3/^7HFSOJF[TA#8!R /\R]?>>(/ MQM9G$675 ,(L>YJ.%Q6CBODI8#@,6PH6%*<9N2BYPT-8H]WG>]-'1F]GJX%9;+O'VT1*+;>!V+;9JNP[36.WUSEOLH*O_'J/U!+ P04 " 6B Y7 PU!(3L( #\2@ "@ M &5X,S$M,BYH=&WM7&UOVS@2_EZ@_X$;H(L4D..\+O9LUT 2NUL#V22;N ?T M(RU1-B^4J)*47=^OOQF2DAW;:=)KW-J-\B&.I"$YY'">>6;$N/6A__=%^_6K MUH?N:0<^"?ZT^KW^1;?=JKM/>%KWCUMG5YU/Y+;_Z:+[;B>6J6F0@_W,D#Y/ MF":7;$)N9$+3P-T(R"U3/-Z!AM#T^EO;-4E"U9"G#8*B^TUBV!=3HX(/X9;B MPY'9:?^>#G36;-6OUSA&Z_W597^^XUI,$RZFC<>ZMK*:_YSPBKK MG$3(4L/46JUSWKWI]][WSD_[O:O+V]>O/EYVNC?DMGN.U^1H_[ RU69,HA>\ M?M6A8QZ1+OD@A>#I4$^D,J, MHG"L8D94=/8\FFNME7_].RB2\Z[%Q>WUZ?G MO&1&*+K_IDD&4D5,U4 =03,-ZA5_[=B8T>K? M?/L 8[1,2$6Q?$9F.SX"M?J=_UOA_;W#$YZNSP@'>Z4!^IWOT??'>HA3=$3' MC"@VYFS"(O )KLD_.54 I&)*;E@&/D-D2MY+E4 WM7^(C,GIIYNK@/32<*\Y M/W/X=;,IQO]A+K=%%E_6_&58[' K_?.,:A8Y9<'_DBFY2^5$L&C( N>FRCEG M)&&05!IHGAK*4T+3*W M))"RD&E-U=1I 7()O6,P^%S'&NY%H!&,*Y ;XT H$'(5Y@F(I= 'J .Q@DQ& M/!P1G>.O6?L)4\QW@K-(N!:,1A"O ;[-"&:I,Q:BEEX+Z#P#)64$$X8="* U MF,XOR O2OSICUCA]86?_J[TYUPVM4<8G]LC>Y!QS.%R5[^U3MPC5#$+%^#^?" 8 MNC5A %0#P?4(6Z!8 @P*611>1UR'0NHP(F( M/@[#NE_"$4V'C)P";;G)!4SXX(C6#DYVF5/EX"1R5^Z28]4J=:"%@Q"D-7-8 MYF %%7I@(*?%TFCQO=%B& UGO AS(($I8&.U#]1M*:']#(61J@;R2]= GC4$ M_""=Z=MM!,&(:1BHX&$VFWH\HUIG\6_#T:8]9HF:34#+0R0 .Q94;1KW)!D5+"!*TFLUP2 M6KCT=#ZUAK\&# 6!\$%[%KU IO",CKT52E8$=-LLMCXE![]*@'@RQ5R*$T\G MIP^%BT*-6B*&!JJA : @?JJ ML3%R63"W..WBS3W163W"J6.Y_Q<_M2Q7&00+;2L,80BDSFIARX]#EC)%!<0, M>,(RC$@HDJ?&Q06(7#P#TEVY\&:Z<2-5+JL)M@;T&^2<&,8^PH['DBJ+/N,."AI.]F5 M7@L@HQH9+WQB,;Q 3O8YYS 1"Y!Y&MI3"6^KMW 5;FP(WZK>PGU=:^$/(&&Y MDP.4X2'H2SE9S,O:ZB MJL3<%?2&1M!:LY+=/ A]OKP*30"_P)\"EV1K6 ^=)P AL!!V1IY?KCS)5270 M&Y[I5 ETM:VJUV0%@J?^7'NL@.@%@*?,U+,F$G#)X.AE)1V3IO< 0/Z51+S(X)^(_'OK)HGV]_&?>_\ZP55; M811_DZ<1PP%JA\=[(%IQRY_*+4_VWZS/ AU\:]#P!PWS(6P#07-J_]R5:?7:=5UWJOO_:=Z[ M_T_-K7JO_57S9C3"\Q3E/.T,-V%N+]4EK1V=7HO&))6C;J3)SD>1]2SS)0,_]/MO5A)] MF,1OM1H8D(FH0:XA^VI"=Y]SEH;839-<9;9ZWB 7%'AIK588J]/[=Z&CFU(9 M_O[ H1\+_3#-68HQGU(LIASWJ<1RKK"04RRL 0Y3^N$*[[IO ,%BVZ+U: M;7/B-A#^S@S_80M)V@,?,[REH<,%#IQV[J.P9:R>D1Q9#J&_OBL; MNPG)-&%ZT$+#ASBVI-7S[#XKKS0VKZW/PU8^9U[WVSV\@OZ9UL :]EMF);EB M:V7=;'9&O:\PM;X.^Y\*KN"J ;5JH,!B"QK"#5W"1"P(-Y('!DRI9&X!!^+0 M\;;CFK @MOH/'ILQE<_5 MS\HULW+;VCTOFW)%Y>Z(I?$Y9 X8G&Y_8@VN!MVV-1C=3/.YVYM>?P+3?E?? MP\?JY7NDWL+A]RA4S%WMCL0XDF%$.*:0$A!26S'!=7A N* \"E,B9X33L#1Z M\.D*VK;2+6?5ZAD4PVBV'A%"D9P"X0X49Z>Z0VJI5K^H&F![),!0P&4]-LN4 M3Z'VDP&WG"GJP%01A12ZPJ&G1CY'B>VETT?(4ZBC5L^I9_8ET MKH118BS)# M"RYAFG4@::@1&-@CGR.^CR%!VHSX"# ,$%)HQ"-=Q@FW]7,TZK#8O)X2>T6^ MBI-.!#3)K7#3!T0_22 BN,0@=F;""5,$&<9\+@-9_MX*VW=&6.W.L _=_G X M';>[@YN?/Q6JA?A^W.[UTONM.2V9HSS=M?JA"3,A<0TL(1R?!"'"2_\KQ(6M M:4VVG^!>+WDV\=-<5"(HK,MDT^JE]@+B.(S/2S.AE%B@Y?*%=LS6/"ZJ'W87 MF![*V6DDV-O1'!<5J)TG>9Q%R^KMCEQ]A]PZJ\;?-X_N,.29J#5B6L)-PL#PV$\+D,OS&E* ]MSR=T3J59&;0>NP+_3'8M M_[=O!/>TZ+PD@:,"N?<"0:LM0?N2Y-[E=O0@#ZRD'6,MQ1RJMVNPQ4_795V/ M41=+2RPS%;NG,$KV*T\JFMB/!^:2XE@RK%L#XB?XGS$\?43Q/9F/%N2_NT/> MDZS^8=%Z=%7XT9;>^RFW>^2>.= OPS5N*3$,X5)(Y;W7VN_KY0X6")3:^@V] MH3?X#XOMH ZDODOYMD?$_X,L.[PM1K)/N,I.@X]UG_",8;Q+RCI!V[9%Q!6N M4F_82%3B@^#6X9U@(^(?2B5T!O6=!HS)G#;1W%U$N:W--&$4Q ?^#1@2K.E* MI33ZO<&O*<8$?U8*7>JI7RN/D.9?9^>/S\HWS]*?EEO/#\$W#LLW?*"GR5XC M+[PFS:T=E+=F!5T9^K91_&HZ( D M3C\\:9D5_55-\IF-_AKG3U!+ P04 " 6B Y7TEJA5DQ6 0#Q]:W/:RK+V]U3E/VC[[+4KJ1*);@APLOP6!FP3VV # MMA-_H80T@&(A84G8X%__SDCKJ?[NGNZ>GY^?^&/85X M [HA:^J_)_0WZH0 JJA)LMKY]V1@ME/9D_]W]OG3SZX)KX/7JL:_)UW3[)]^ M__[^_O[MG?VFZ9WO="Z7^SY$UYS8%YT.7:]C*(K^_OOVIBYV04](R:IA"JH( MICB;R8O8;\O/1K^*LUNF+^8_V[_Z+C4=+TT;5]J M3BZ5#8UCZ,PZ.NPKIC<,5UU+(YKA",'O\]K-['+3_?K9I=]-75"-MJ;W!!/* M$#TIG:*8%,///21E -'Q(/CO;QWMS?,YV11+3YZS)!SG2-'/+<&8 MO!/^ .]@V,F%.FBO?"S_'?XZN7!@I#J"T)]>W!:,EG7A^ ?'4^%WNJ8 P_5J MZQ?'Y9*II\Q1'QCNI,"?OZ.?T3U4BJ)3S)0MHC9037WD/M;QCXY7&;JY3!3\ MTG%1_D^M.KU*&.G:-U'K65=0/$N=6"H)! G^3:#_^VG*I@+.?GZW_X:_]H I M$.C^%'@=R&__GA0TU02JF6K 89P0HOVO?T],,#2_VYK['=WW??S8G_])I8@+ M&2C2*5$'Y@^B(O3 *3&4AC^(YH0]&SR#*]AWT12]S>WI4A- /$/: MX7\E%7)_5(!LU06EK$I@> U&30K:/"K+9[CT)L_-S3TWWP.J!/^8%XK0:;8% MQ0";/"H[]ZBB)@ZL)\F&*"AW0)2<\]LS#0]>DC_P!!+ZE2 M43!!T_[YIDX-;V7JX_;^WW\W> 5_#J%1;-+-L06U'P:_VN093+/>%71@-)FF M-6'8#S&L[S9Y3A'1X O4E- M/HUO;VG2B##,D0+^/6E#I3\E:*IO$@VY!ZFL@'>BIO4$E;2_(.$K=+EMF1=) M?IO<)\E&7Q%&IX2JJ<#Z41Z>(CL!=&2 K'_)D@14RQRA?\(+*Q!HNBS:EF9H MUI"5O]"U'M(R9$$IVM3LSWP*6C1"A>."KP+RJ:L>G9S-%.GG=\">6-JS3TY"R5HADXQ:]YZX4NB,@A&#]N/-6>WL%Y&<"G M2G53$U\>!64PF53&E.6-:GN>&EGZ]P1BE9$1RJ$@X4PW4&7[6JA"<-XS3E59 M@1.2#A]U-J%H\OH 26+L,2^3Q.V-I#&7FA $)IS'X%0-77)3;BG ^02DG<"X MN@6]%M"7!D!3^^;IK@.@DR*!1E<'8,4HF%Q2Q+!N%.S^P+2A+.KR<,48N&Q2 M)+%F#/M#TRK;G=Z?H5QEN]/IP$FJFEV@5S15ZP,=AL1JIZS"&&.!K/'\RZ0H M#LZ_]B4F2T34P,!)DJ:P6A+YL"HH5>J/L MHE30>GV@&E:2LH926X9L0EW4WV01V+%4#8A:1[6>XC*1.",F^Q,;"JS9X#4U M)JP*15W8S'&P*Q U9(/W;&/"K D;X MZFKJ6!\%[QC'C00UZ&K(*I)*@J]"= M,%8P@@MIHBD;Q@!(1>CEJ!U[/-8@:L P=5DTQPC-OPNZ5 %FM7VAZ6T@FP,= MN#LW$=C<$-SLB%@1BDWE@@^+]L*.0&QF"!%.Q&KBUQX$;Q@AX79TB>*;?2EW M".'<-N,*15-#2&#L/K9 U"Z$@'47-'K[%>G@'5&?<5MHFL,''[5M.*10E(8/ M?A%IIV$%HB]\\%9N7VXM-U5!*Y\?.*PSAQ,%+; J%'7)'$[ M)9=@:AA-OBD M9$R8Y7\FS 8?6,:,!SX]ZFQ($TT(H4/8-C>;G"@J"IN:#4W[79!H[=?D0O>$?4? MMX6B.5P(Q8,;#BD,I>&HD!+(VPXK"'WAJ+V54- AE5!P^RNAH$,LH>#V5T+A M/JQ X!=""<6^X1="J4,"5^YMQA6*IF;VD1..1.TRP:O=+FCT M]BLR>ZL+"4]S0EI:\3^D<)1F;YG@$/4EA-*!?<,OM[?T=JCPR^TMO1TB_$)8 MQ-M75.7/3;2 M3$)V7$9@V1ALV1SLP)9MQHP0VFG%T[*Q!V/9V'UL-XW 3(50 ++-N$*Q.2'T MA-A];($8$&Y/2R=;QWYA=:7PE5L+1W/"ZB#@?TBA* VWMS*W,/5EGPLFX<- TZ:4\H*74'OK&_CXNS)O4AA<$8*G81PFA=%>)]T(0^! M9)&Z+>O"TDG;BZ>W9E@(A3%YU90E61F8\ML<4&U@0E9"VE 2>6!:.>1J>Q+^ MP!C$2C/G>^B(C\W\PH6@Y4&5+;:XFY*,(\-BGT$0]V'300R;#V/8-? &U &P MQX<.&!#-)]GL%BP*@3ZU1TA[X']20QANMK'O5C9$H$"3#+2!8;O7*P880M%G M7E&T=W3L$8Q^B]J@9;8'"K0)2%30](I ?D/F>'P2X9?*]@X#)EV.6KN;SS)1F4S2=,-[:!Q^:9[,!3%\Q_B5H)B40 M@$XFS2,I%"9-'(7$,HF9'!,5/I(F?K3/(X3VQ=*9+0,=E F8^V'\DP2)&?85 M691-FU9"DN&5]D&KLZ 8FBTKDV!/F?8BUE V3L[LF=07%WY^=WWA/+'?W:E- MDOI@9"0*&3&T&?/G71TY/.98@:T'QDB,,1)#.S([K>W($3)E!+8A&!\QQ4>H M]F/5:D#"0KW%A P7KX3,RI*]!'.9V8;+3#15K6BQ2X;0^K>FHOH3)SW;$9+,^2V,C0BN.#7%LF&S,XM@0QX;QQBN.#>,3&^Y#[C@VC&]L MN \\X-@P3K%AA A(V)ILQ$P*[)RK0U$D'$!OB58Z@G1/H$>8'2YB<0 =>\SB M !H'T/'&*PZ@XQ- [T/N.(".;P"]#SS@ #I. 72$"$AN !T%DP([1^A0% D' MT%O72X2?[@GTB*C#12P.H&./61Q XP ZWGC% 71\ NA]R!T'T/$-H/>!!QQ MQRF CA !R0V@0V62LT8\W$/I&; ,=QR+XUC\R$&/@WD< MS!\XX'$V8,_9@*0#!Z<38I9.2#J@<#YB[_F(A$(H80F-Q'!YX9@DG ?!>9 MX![/#I4K3P7#>1"9!X0LC1[AU7*N (/1"X;]MW/_2$U#+<<82.(_0C!SV.T'&$?N" QQ%ZG"+T M! ('1^AQCM 3""@\8# M#BGW'E)&C "\9HMCPV#0RD2(5AP;XM@PV9C%L2&.#>.-5QP;QBLVC2&L1,/[,2OG-&M 37&3ARQ MLVU;[6B;=F'LQ!$[VVYTWF//P%*OKV@C *QD<;6/,H;)QLXT_PF?*\G*P)3? MP"Q * U%92 !"?$%)L 2"#HRKE]6\&D^808 M?H<#OP3Z@AA^AP._!/J &'Z' [\$^7[C(H0%'CZHLF$,@(11Z(E"JR)A+?OV M;0F3X@=B*!XV%!/D$V(H'C84$^0?8B@>-A03Y"M.0I4G 95E'DBA:20ABH-C M^[9\2?$',=R2#[<$^7P8;LF'6X+\.@RWY,,M@;[;(39KB 1U<6BOD'1/#H/O M4,"70+\.@^]0P)= +P^#[U# ETB?S]I:DVS4>>\1<@QSWP8J>:X9Q@CVH+P\ M*(P1[.AX.3H8(]@?65MK=BL;(E 4007:P"BKHM8#APH7:^UYY7CW;5N2XJ-@ MW,0(-PGR6S!N8H2;!/DR&#3D8.?% 3OS\'/<#0^TU M/:#G50GUH>_/NNXF'C6Z!AEECNZ@"VS.#^]\-&N^:X%G-0^BAE#D1[#13(JE M,19BCH6QG$+%PN+JT,5 5V5SH /(B0MYB#X=R,$;OL PN7@U&X[$-F \Q!\/ M^[ /-T P0%=3I'*OKVMO5KO^8P3$&CX4-(*DD&V=KSBJR4+6& MC][0V@3H>8A9:7F*V[)'UT8J!H58$7KSNK2A\/>?.9Z96M^98V8N:1A6_@]K M)-;(H]!(I^LSKUKA37MNRWE8R;"2':R2)6C!U'))&3P!8MT\1MUDMG%)F0A< M4JR16"./12.=9\2'YY*Z9^.P:F'5.@[5"C_)22/U9=CI)PXK&5:R@UH6A$MF[NM'Q0T]0WH MIMQ2@+.!5AV^#AA7R5:-Z:'P)O0#T/T%13"@L;%&Z"BE\,,%G/X.%%J-K@X. MI&AG5WS-L0*#+%"0U>4AAIB#$1A@/NI+Y[R'@_4;_3E/^C0"2#\B,VA[PD$[D$>-9L$T,;BI-H$ O:@SDA) E#W>L1*5 #U['>[\815#^8"A'-5.3_J,9\['5296M,5SAYHHCH753'JN9PUP,C0&SK'G>%8O3ZT!3C:#@7.TRU*> MR<'5P,G060R .*=D -_NWS MS:91SHTF6L?4SP5YZT:_[QDG*3XN!E*<@90@GQ<#*/X3A$R/X),\+PO") M$7R2Y_M< A7H@@+YF)=ZLBH;IBZ@)?%C0='Z\>_;%B7,$\)@BBV8DN<783#% M%DS)\Y(PF&(+IMCZ3/-@3!%DDFK% P".(Z6?A&7^V#@Q $X\9N^5ARN MBZLV]E>U$=&1F2LJD:WD1@V\ 74 *L!<+-*WG!J@%S2KMXANS?8UV5CHLCNY MK*H>B)^S--[ST3E0Q6Y/T%^<:'+EGS>:=B1F&=4>D@J&(K35X5;XJ^F3MQGS MW0<70;!OTQO/G$9$JHCU\-CU$"OA%HG%)2,6C'8F50^#-OA8]W%:=E-5;+QK M6!5]JN*45U@5L2H&F$["42)6BV M56RBQ)@EZ*)5Q>E\@57Q>%5Q ZZ)@U$\T9>7O@?]"$S/0/'R67)5L?- MM6,=#_>@(1[2BB!^= (!SX[[5\DC7'#$6KE"*_&Z8XP4\PB7'[%BKE!,O JY M5C%7+WO@&1,KYN'/F+%="HE6,?&,B14S7C-FG!5SQ2$:02HFM(XX\X,5TU+, M)2SL6S'C668>C6)"ZX@5$RNFI9A+6,"*Z=85@EY8J00JE):6'\!_:*B'SZ6N M#?HWII1L?9* ?'H#.H)2LNB=7VY4M M [P.(,VE-S Y'V*:O@+B0)=-&1AW UWL"@;(=W1@]?-:O%"'%UW542$Z]!?? M@&[*+07U:S-\4U@F3 M&.08Y$DRSC0U^[0>MQB.^S%T-+6%H:,#C*$&JFSCYJ%>7 )!#PC&0 =GLJ%Q M#)TYA==,'C;YR?D*]+05SZ]W!1T8*U\Q9H)UT=;O@/3=K7B/)+]!]"WS%MU; M&?10T*2YV*$->+!(H]M3YUY:!*K6DU6OUWKS9?&];@^>_.[@@@^&0ML)/$36 MAQ^W%E@9(K+C8GTF#[),^?@BGR_Y^5T>GD)F:=#L P-]97W3!8)D:?;/[Y ) M\&_T_S_[A&&.%&C#VE W3@F:ZIM$ UH7@ZB =Z*F]025M+\@">3XMW\0/4'O MR.HI@2Z=_OE!(,U*"8K<@3^AU04TJ/_]'\U3/WY^[Y]%\++I:_Z32A$7,E"D M4Z(V4$#J3N@ (I4Z^PG'/:' ?F[*U/K6LR9"=ZROCBR9/MZ^EOZKUC?N3P^;.!H0>>106#(*C/(NI_ MMLX>*N5&J?CY4[V1;Y3J/[^WSA(\F'JI\% K-\JE^N=/^4J1*/TN7.4KER6B M4+V]+=?KY6HEH2-DQB-\$HRNK'9,324_?RI^*WPC&"K-Y1(Z*FH\JHD6)7H0 M;N3[-]0VO<+ U#:RRG-6=M$N'[#533ID)O;JHEJ[A11;CT2^TE :-G-4N@DD M(*=214T<],:13E-$D0$,MNAFT_K$LU3S@WFD>@_/+^>O718^#[I JJ9:/JDL M$N-0H ;:BPMOIC9;J3DA5 $%>&C18?Y])VL3B37UTS86$_# MT=.# DDXU/\=&*;<'@5L'K^@$T0_?ZJJX&N(VLIPW[@TB@!P"XG6"9,). !, &EB)6%1*;D$I[ZR+2W8N MV5TEGUGY\O*F =+/G4!44D*+[/"^KB2,1D#0@>JFF0["3LY^#51 L!2Y-*#\ MPH N9 ,:RS_PN1?P&\-]2+?<4ZU4JSYF2D* _O'"JT^LI/U*2W(D'G12J(>Z MI.F'QW[L]43L];"+0;HNJ(9L;3=8X_9H+Y+"?+S].5=?@G1[VH)BN/H]BU2- M'1\N\8Y/HY:OU,O(L\&>SV%;ZZGG8TZQ/'%]VE!+B.;L_Z#U0**;^RJIXTZ\ MU-#AN+*!"C@^?VK+<&I2!ZCLXG2E7V<7.U_ 2RL#N\K*S7[FVMW6\$;C:YWM M?=29E5Q\)ZIGH5,LQW.KW;E#L7R<^?RI7"MP.T-"C_7!H*HOGY$V($H;4) M?WK3\95T]3,P,0 Q&@>>,.;7! M\,"YB%T%-!X$E_LGZ.J3%44$]OQ35D5-[VMV/P1K^U,!]9G61P5-6C$-7M/5 M1KNCWG<>NT&D*E(&$%$!M GZNO:&I@5G/M@'G2=G1: ([P(J1O6>,X/+8"S( MC@E4= LJ%!K5X2..=B"N(0S+XZT HB7-=6%=X>FV5[CBNW_[4F NUPH"3LYR MV13%4%PFG?4)HUGZ)YY6)4BY?K&4SB9/TPG-[ *=^#O094.212OWHK5# VN" M]"I0GI>_U;[5O]GTE7I]11NA4OCC!* \/P/,<*AW!%7^L+[\F@BA)@A_3C-I MDUG1OGV-*@6./=*C\$B=F9B\).G ,,9_H:9AM+MO<-?-O?[* "HSW'[);-$W M<'DY] LH:FR"OQ%518)#,TT%Z 9QKL&0\DW0I17^PG*Q0LECJ(S[4"]Z/>VZ M\%@V6R#$H3(G9_6!; *$6^Q([UM1ELD^IMG>Q4QDW72G #]6]8;VKKIKSE/Q M>:14I?1U;?M@=87FS%Y]6-VC4.:-M'7H5+)?4$AP!"( ]3]#7X- MO7!@X @G:.9#>-K$(9!&%MC@Q=H-K=NDJ [-N7D="*OMV:AR,Z0N6\]W-T$L MTLZ_#Z(E33-?5YBPY=UZD[3GC09MT5U74]<6L+R S&_1>/@KIH.@>_&=,(C) M<2DN1V<.<%7YRVP1_7__EV7HS ]H3$V@@#YBP+C B"2@554&**8G!"A1R-1Y MA4_8D).MX+/^3)\_V>O_0 <2T1_HQ@ 5 I@:O-5.*M/,E]97-"NB0K^\:)Z& M-6:<:]K-G?)J]6&S:><@FPTV-X *AF53 5/G"PABE["Z/P88MXSE.V6.Q99X M94 B$A]#!2X^74"\M0=4'_5:FO+%^(J%%X+P."YHX:&:-Z?J@:'811W]"&C[ MW[LR_&8V01QSE+C*(1Y/I2.::5F&S-VY/'^3S[/]IU^MOW0 SN7B.T^LHN[) M I'5 Y>$:J,3;X(R ,1_J6^H&R"JS2>L7F;1;3$YZMAV5:YQ;#%M6^F.%[.5 MJX\:@RM!#@ NCO?9%:X8 7M!0&'!:)3&QG9UR?-;OV;>I!^S_"476)89F?CE M!+,;32=GC>YX?JCDZ\7\O6U<"-3" IC$S4W!!Y"BR^.$L*$MX?U&RJJ$B@>@ M#%LC0NP"*#MT4A2/D*"/ZL=Z]J^ M#D1@I09HAK"VIAO$%_A "%W"&$ GQ.AJJ Q]LK_,[ KF(O'O@I-,:W.3=?-X M$%])0E EX@OS]?,G-,H6U !X0>LO' .ZP;H6WH7(&#\([=0T+"HL*@7#)'(4 M(0DCX]O24I*SKK,PT'5XL[VY$UE?4S!7;H8W+R3A\>KYXVK[EAN+:P#N[S\Y M^P-6K1,1X\X;1$4CIGM1$XK[XU);!&:(XYYLFA#Z0(%XUC45^=;*B #0SQX1 MJ(VK+HC66D91, 4"[:U;U.K9,^8S0:AL__,GCDHCQ:V!SD 1+)6OIQIAJ[!- MT%0Q@?'UVW*:EUVHIYX.%(USK 8K4M5_6\*'H9;K;!!-*-:]'^M=(LC?4.]D M@Q (!5(*"$$4H=[I E(>A%0=S36NWQ(0 2G7'XP>5%B@HY3LV&A#%/;@V$9H M;H6/@],1XDJ'Z.C:N]F=_/H-C@=8M$F@+:O61FP#*2M*QC/4CU446C_3/R:7 MS5U@[PS6QQ>0DRO&!!)+]$V>A*;7\;4K:)U<*:N678&VHI5B)AZ#PTWXAA/- M\4PT;TPPDPXT;76#X&Q3M83I@*+"D/*(3MON1N(DR9[]9X:M8(82K SR\[8" MT18"]^E@4]4N[(]3_C*F&9*(R H$[$?)PD/%\**7?['4C40O0//3T?21NW.? MZ=ST[@OOQ6NF'5SFS'JY9>O$\&#=QV\@E1W?K$ MC4:T++FJL>/MJOZ0-I2LP9P/#%D%QHKL$>#J?]\&TEU/#J00>57#5A=Z-FG6 M>JAV*C$317P5-C$LQ!B."UFQPW!IG.ZPB7'F/&+'V/49U,E0+JU!%.PQK.@. M(-:R?^G'RDU/#'+J66J:N8:P3?IFXI7(/:96VY\_K4YAHN)@._5*.#.O2E M]8TN4)1I_OT+!)V57+<;HZU.72-Y?_U&_('TC86^M$[LW$991^]9:V3??M5> MS%O=$ O;[Q#S;V3GZ4&AJ\>B55(KX!..Z+SQ^1-$7G[0@<\F:)HDD+3)95NY M?/[ N;-,P2H_ZNI5[F6\LI, ML7AA+7=" [A4@K#FV2<.Z.;G#OFF:2=*$ M0">/6H^8G#S+9L@,RY!I=KJ#?D+?&3$6MWV>*])XI[ M)]G@#B5=TRAPQ;&DTV-,2\D\A8C9VNL\VNJBVNNSI0_/6W/$\ MF8"/YPETNX;/X21X^]\B .R'KMT62'T+^D2EUME=_K(4^G8_J$*04QT=]6Y" M:J3IIX3>:7UA*(YDV"S)I--? ]L2�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